PROSPECTUS
9,383,899 SHARES OF COMMON STOCK
FIRST MEDICAL GROUP INC.
This Prospectus relates to the reoffer and resale by certain selling
stockholders (the "Selling Stockholders") of (i) 375,891 shares of Common Stock,
par value $.001 per share ("Common Stock"), of First Medical Group Inc.
(formerly The Lehigh Group Inc.) ("the Company") (ii) 8,645,508 shares of Common
Stock issuable upon conversion of shares of the Company's Series A Convertible
Preferred Stock, par value $.001 per share ("Preferred Stock" and collectively
with the Common Stock, the "Stock") and (iii) 362,500 shares of Common Stock
issued to certain selling stockholders as payment for early termination of
various employment and consulting agreements and in lieu of payment pursuant to
a stock purchase agreement (such shares of Common Stock offered hereby being
referred to herein collectively as the "Shares"). The Shares are being reoffered
and resold for the account of the Selling Stockholders and the Company will not
receive any of the proceeds from the resale of the Shares.
The information in this Prospectus gives effect to the 1-for-30 reverse
stock split (the "Reverse Split") of the Common Stock. As a result of the
Reverse Split, each thirty (30) shares of Common Stock was converted into one
(1) share of Common Stock and each share of Preferred Stock, was automatically
adjusted so that each such share is convertible into 8 1/3 shares of Common
Stock, and has a like number of votes per share, voting together with the Common
Stock.
The Company's Common Stock is traded on the OTC Bulletin Board symbol
("FMDG"). On February 17, 1998, the price for the Common Stock was $1.875.
THE SECURITIES OFFERED HEREBY INVOLVE A HIGH DEGREE OF RISK.
SEE "RISK FACTORS" AT PAGES 4-8 BELOW.
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND
EXCHANGE COMMISSION NOR HAS THE COMMISSION PASSED UPON THE ACCURACY OR
ADEQUACY OF THIS
PROSPECTUS. ANY REPRESENTATION TO THE
CONTRARY IS A CRIMINAL OFFENSE.
Neither the Company nor any Selling Stockholder has employed an
underwriter for the sale of the Shares. The Company will bear all expenses of
this Offering, other than discounts, concessions or commissions on the sale of
the Shares.
The Selling Stockholders have advised the Company that the Shares may
be offered by or for the account of the Selling Stockholders from time to time
on the OTC Bulletin Board or on any other exchange upon which shares of Common
Stock are traded, in negotiated transactions, or a combination of such methods
of sale, at fixed prices which may be changed or at negotiated prices. The
Selling Stockholders may effect such transactions by selling the Shares to or
through broker-dealers who may receive compensation in the form of discounts,
concessions or commissions from the Selling Stockholders and/or the purchasers
of Shares for whom such broker-dealers may act as agent or to whom they sell as
principal, or both (which compensation as to a particular broker-dealer may be
in excess of customary commissions). Any broker-dealer acquiring Shares from the
Selling Stockholders may sell such securities in its normal market making
activities, through other brokers on a principal or agency basis, in negotiated
transactions, to its customers or through a combination of such methods. See
"Plan of Distribution."
No person is authorized to give any information or to make any
representation other than those contained in this Prospectus, and if given or
made, such information or representation should not be relied upon as having
been authorized. This Prospectus does not constitute an offer to sell, or a
solicitation of an offer to purchase, the securities offered by this Prospectus,
or the solicitation of a proxy, in any jurisdiction in which such offer or
solicitation may not lawfully be made. Neither the delivery of this Prospectus
nor any distribution of securities pursuant to this Prospectus shall, under any
circumstances, create an implication that there has been no change in the
information set forth herein since the date of this Prospectus.
The date of this Prospectus is February 20, 1998
AVAILABLE INFORMATION
The Company is subject to the informational requirements of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), and in
accordance therewith files reports and other information with the Securities and
Exchange Commission (the "SEC"). Reports, proxy and information statements and
other information filed by the Company can be inspected and copied at the public
reference facilities at the SEC's office at 450 Fifth Street, N.W., Washington,
D.C. 20549, at the SEC's Regional Office at Seven World Trade Center, New York,
New York 10048 and at the SEC's Regional Office at Citicorp Center, 500 W.
Madison Street, Chicago, Illinois 60621. Copies of such material can be obtained
from the Public Reference Section of the SEC at 450 Fifth Street, N.W.,
Washington, D.C. 20549, at prescribed rates. Such material may also be accessed
electronically by means of the SEC's home page on the Internet at
http://www.sec.gov. The Common Stock is listed on the NYSE and such material and
other information concerning the Company can be inspected and copied at the
offices of the New York Stock Exchange, 20 Broad Street, New York, New York
10005.
TABLE OF CONTENTS
AVAILABLE INFORMATION..........................................................2
PROSPECTUS SUMMARY.............................................................3
RISK FACTORS ................................................................4
USE OF PROCEEDS................................................................9
PRICE RANGE OF COMMON STOCK....................................................9
CAPITALIZATION ...............................................................10
DIVIDEND POLICY...............................................................10
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS...............................................11
SELECTED AND PRO FORMA
FINANCIAL DATA..........................................................17
BUSINESS......................................................................21
MANAGEMENT....................................................................34
BOARD MEETINGS AND COMMITTEES OF THE BOARD....................................35
EXECUTIVE COMPENSATION........................................................36
COMPENSATION OF DIRECTORS.....................................................38
OPTIONS.......................................................................38
BOARD REPORT ON EXECUTIVE COMPENSATION........................................41
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION...................42
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS................................42
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS OF THE
COMPANY.................................................................43
SELLING STOCKHOLDERS..........................................................45
DESCRIPTION OF SECURITIES.....................................................46
PLAN OF DISTRIBUTION..........................................................47
EXPERTS.......................................................................48
LEGAL MATTERS.................................................................48
ADDITIONAL INFORMATION........................................................48
-2-
PROSPECTUS SUMMARY
The following is a brief summary of certain information contained
elsewhere in this Prospectus. This Summary is qualified in its entirety by the
more detailed information and financial statements appearing elsewhere in this
Prospectus.
THE COMPANY
On July 9, 1997, First Medical Corporation ("FMC") merged with a
wholly-owned subsidiary of the Company (the "Merger"). As a result of such
merger, FMC became a wholly-owned subsidiary of the Company. See "Business -
Merger with FMC."
The Company, through its wholly-owned subsidiary, HallMark Electrical
Supplies Corp. ("HallMark"), is engaged in the distribution of electrical
supplies for the construction industry both domestically (primarily in the New
York Metropolitan area) and for export. See "Business - Lehigh."
FMC is an owner-manager and provider of management and consulting
services to physicians, hospitals and other health care delivery organizations
and facilities. FMC's diversified operations are currently conducted through
three divisions: (i) a physician practice management division which provides
physician management services including the operation of clinical facilities and
management services to medical service organizations, (ii) an international
division which currently manages western style medical centers in Eastern Europe
and the Commonwealth of Independent States (formerly Russia) (the "CIS") and
(iii) a recently formed hospital services division which provides a variety of
administrative and clinical services to acute care hospitals and other health
care providers. See "Business - FMC." The combined company is currently
continuing both lines of business at this time.
Unless the context otherwise indicates, the "Company" as used herein
means First Medical Group Inc. and its wholly-owned subsidiaries, FMC and
Hallmark and their subsidiaries, "Lehigh" means the Company before the Merger
and the Company other than its wholly-owned subsidiary FMC and its subsidiaries
after the Merger and "FMC" means First Medical Corporation and its subsidiaries.
The Company's executive offices are located at 1055 Washington Blvd.
Stamford, CT 06901, and its telephone number is (203) 327-0900.
-3-
RISK FACTORS
Prospective purchasers should carefully consider the following
information in addition to the other information contained in this Prospectus in
evaluating an investment in the Common Stock offered hereby.
RISK FACTORS
- --------------------------------------------------------------------------------
POSSIBLE VOLATILITY OF STOCK PRICE. The market price of the Common
Stock may be highly volatile. In addition, the trading volume of Common Stock
has been limited and the price of Common Stock will be sensitive to the
performance and prospects of the combined companies. See "Price Range of Common
Stock."
NO DIVIDENDS. The Company has paid no cash dividends on its Common
Stock since 1995 and does not anticipate paying cash dividends in the
foreseeable future. The Company's ability to pay dividends is dependent upon,
among other things, future earnings, the operating results and financial
condition of the Company, its capital requirements, general business conditions
and other pertinent factors, and is subject to the discretion of the Board of
Directors. The Board issued 1,037,461 shares of Preferred Stock in connection
with the Merger, each share of which is entitled to dividends, pari passu with
dividends declared and paid with respect to the Common Stock, equal to 250 times
the amount declared and paid with respect to each share of Common Stock. The
Board is authorized to issue, at any time hereafter, up to an additional
3,962,539 shares of preferred stock on such terms and conditions as it may
determine, which may include preferences as to dividends. Accordingly, there is
no assurance that any dividends will ever be paid on Common Stock. See "Dividend
Policy."
AUTHORIZATION AND DISCRETIONARY ISSUANCE OF PREFERRED STOCK; ISSUANCE
OF THE COMPANY PREFERRED STOCK; ANTI-TAKEOVER EFFECTS. 34,582 shares of
Preferred Stock were issued pursuant to the Merger; each such share is entitled
to 250 votes on any matter submitted to a vote of stockholders, to be voted
together with the Common Stock. The Company's Restated and Amended Certificate
of Incorporation, as amended (the "Certificate of Incorporation") authorizes the
issuance of up to an additional 4,965,418 shares of "blank check" preferred
stock, with such designations, rights, and preferences as may be determined from
time to time by the Board of Directors. See "Description of Securities --
Preferred Stock." Accordingly, the Board of Directors will be empowered, without
stockholder approval, to issue preferred stock with dividend, liquidation,
conversion, voting, or other rights that could adversely affect the voting power
or other rights of the holders of Common Stock. In the event of issuance, the
preferred stock could be utilized, under certain circumstances, as a method of
discouraging, delaying, or preventing a change in control of the Company.
The issuance of preferred stock may have the effect of discouraging,
delaying or preventing a change in control, may prevent a third-party from
making a tender offer which might be beneficial to the Company and its
stockholders, even though some stockholders might otherwise desire such a tender
offer. In particular, the issuance may discourage a third-party from seeking to
acquire the Company on account of the substantial dilution to which an acquiror
is potentially exposed. It may also deprive stockholders of opportunities to
sell their shares at a premium over prevailing market prices, since tender
offers frequently involve purchases of stock directly from stockholders at a
premium price. In addition, the issuance may have the effect of insulating
management of the Company from certain efforts to remove it, or affording
management the opportunity to prevent efforts to oust it.
DELISTING BY THE NYSE. Currently, the Common Stock is traded on the OTC
Bulletin Board. The Company has withdrawn its listing application from the AMEX
since it does not currently meet the listing criteria. On November 12, 1997 the
Company's stock was delisted from the New York Stock Exchange. The NYSE applied
for and subsequently received approval from the SEC for the delisting of the
Company's stock on December 31, 1997.
SIGNIFICANT HOLDINGS BY ONE STOCKHOLDER FMC and Generale De Sante
International, Plc ("GDS") are parties to a Subscription Agreement, dated June
11, 1996 pursuant to which GDS paid $5,000,000 in order to acquire
-4-
a variety of ownership interests in FMC and its subsidiaries, including (i) 10%
of the outstanding shares of FMC's common stock (the FMC Common Stock"), each
share of which was automatically exchanged pursuant to the Merger for 1,127.675
shares of Common Stock and 103.7461 shares of Preferred Stock, and (ii) shares
of FMC's 9% Series A Convertible Preferred Stock (the "FMC Preferred Stock")
convertible into 10% of the shares of FMC Common Stock, which Shares of FMC
Preferred Stock were converted following the Merger. Consequently, when GDS
converted its shares of FMC Preferred Stock, GDS received shares of Lehigh
Common Stock and Lehigh Preferred Stock. Together with the shares issued for the
FMC Common Stock, these shares would give GDS a total of approximately 23%
ownership interest and voting power of the Company. See "Security Ownership of
Certain Beneficial Owners of the Company."
The existence of such a stockholder may have the effect of
discouraging, delaying or preventing a change in control, may prevent a
third-party from making a tender offer which might be beneficial to the Company
and its stockholders, even though some stockholders might otherwise desire such
a tender offer. In addition, especially since the Certificate of Incorporation
provides for cumulative voting for directors, the existence of such a
stockholder will have the effect of helping to insulate management of the
Company from certain efforts to remove it and to afford management the
opportunity to prevent efforts to oust it.
Management believes the only risk relating to Lehigh's business is from
competition with larger companies with greater financial resources than
Hallmark.
RISK FACTORS RELATING TO FMC
DOMESTIC OPERATIONS
POTENTIAL EFFECTS OF HEALTH CARE REFORMS PROPOSALS. Numerous
legislative proposals have been introduced or proposed in Congress and in some
state legislatures that would effect major changes in the U.S. health care
system nationally or at the state level. Among the proposals under consideration
are cost controls on hospitals, insurance market reforms to increase the
availability of group health insurance to small businesses, requirements that
all businesses offer health insurance coverage to their employees and the
creation of a single government health insurance plan that would cover all
citizens. It is not clear at this time what proposals will be adopted, if any,
or, if adopted, what effect, if any, such proposals would have on the FMC's
business. Certain proposals, such as cutbacks in the Medicare and Medicaid
programs, containment of health care costs on an interim basis by means that
could include a freeze on prices charged by physicians, hospitals and other
health care providers, and permitting states greater flexibility in the
administration of Medicaid, could adversely affect FMC. There can be no
assurance that currently proposed or future health care legislation or other
changes in the administration or interpretation of governmental health care
programs will not have a material adverse effect on FMC's operating results. See
"Business--Government Regulation of Domestic Regulations." In addition, concern
about the proposed reform measures and their potential effect has contributed to
the volatility of stock prices of companies in health care and related
industries and may similarly affect the price of the Common Stock in the future.
DEPENDENCE ON CAPITATED FEE REVENUE. For the year ended December 31,
1996, approximately 85.0%, of FMC's net revenues were derived from contracts
pursuant to which FMC received a fixed, prepaid monthly fee, or capitated fee,
for each covered life in exchange for assuming the responsibility for providing
medical services. See "--Significant Dependence on One Client" for additional
information. FMC's success under these contracts is dependent upon effective
utilization controls, competitive pricing for purchased services and favorable
agreements with payers. To the extent that the patients or enrollees covered
under a capitated fee contract require more frequent or extensive care than was
anticipated by FMC, the revenue to FMC under the contract may be insufficient to
cover the costs of the care that was provided. All of FMC's capitated fee
contracts contain aggregate expense limitations on each covered life. Given the
increasing pressures from health care payers to restrain costs, changes in
health care practices, inflation, new technologies, major epidemics, natural
disasters and numerous other factors affecting the delivery and cost of health
care, most of which are beyond FMC's control, there can be no assurance that
capitated fee contracts will be profitable for FMC in the future.
-5-
SIGNIFICANT DEPENDENCE ON ONE CLIENT. A substantial portion of the
revenues of FMC's managed care business are derived from prepaid contractual
arrangements with Humana Medical Plan, Inc. and its affiliates (collectively,
"Humana"), pursuant to which Humana pays FMC a capitated fee. 85%, or
approximately $45,070,000, of FMC's managed care business revenue, for the year
ended December 31, 1996 was derived from such prepaid contractual agreements
with Humana. FMC may in the future enter into significant additional capitation
arrangements with Humana. FMC's operating results could be adversely affected by
the loss of any such agreements or business relationships. In addition, a
significant decline in Humana's number of enrollees could have a material
adverse effect on FMC's operating results.
INABILITY OF FMC TO OBTAIN NEW CONTRACTS AND MANAGE COSTS. A
significant portion of FMC's historical and planned growth in revenues has
resulted from, and is expected to continue to result from, the addition of new
contracts in its physician practice management division. Obtaining new
contracts, which may involve a competitive bidding process, requires that FMC
accurately assess the costs it will incur in providing services so that it
undertakes contracts where FMC can expect to realize adequate profit margins or
otherwise meet its objectives. The acquisition of new contracts, as well as the
maintenance of existing contracts, is made more difficult by increasing
pressures from health care payors to restrict or reduce reimbursement rates at a
time when the cost of providing medical services continues to increase. To the
extent that enrollees require more frequent or extensive care than as
anticipated by FMC, the revenue to FMC under a contract may be insufficient to
cover the costs of the care that was provided. Any failure of FMC to manage the
cost of providing health care services or price its services appropriately may
have a material adverse effect on FMC's operations.
HIGHLY COMPETITIVE BUSINESS. The provision of physician management
services for health maintenance organizations ("HMO's") is a highly competitive
business in which FMC competes for contracts with several national and many
regional and local providers of physician management services. Furthermore, FMC
competes with traditional managers of health care services, such as hospitals
and HMO's, some of which directly recruit and manage physicians. While
competition is generally based on cost and quality of care, it is not possible
to predict the extent of competition that present or future activities of FMC
will encounter because of changing competitive conditions, changes in laws and
regulations, government budgeting, technological and economic developments and
other factors. Certain of FMC's competitors have access to substantially greater
financial resources than FMC. See "Business--FMC--Competition."
VIOLATION OF STATE LAWS REGARDING FEE SPLITTING AND THE CORPORATE
PRACTICE OF MEDICINE. The laws of many states prohibit physicians from splitting
fees with nonphysicians and prohibit business corporations from providing or
holding themselves out as providers of medical care. While FMC believes it
complies in all material respects with state fee splitting and corporate
practice of medicine laws, based on consultations with FMC's healthcare/managed
care inside legal counsel, there can be no assurance that, given varying and
uncertain interpretations of such laws, FMC would be found to be in compliance
with all restrictions on fee splitting and the corporate practice of medicine in
all states. FMC has not received a written opinion from its inside legal counsel
about compliance with the state laws regarding fee splitting and the corporate
practice of medicine. FMC itself does not practice medicine and is not licensed
to do so; rather, it employs physicians who are licensed to practice medicine.
In certain states FMC operates through professional corporations, and has
recently formed professional corporations or qualified foreign professional
corporations to do business in several other states where corporate practice of
medicine laws may require FMC to operate through such a structure. FMC does not
employ physicians at the medical facility it manages in Texas. A determination
that FMC is in violation of applicable restrictions on fee splitting and the
corporate practice of medicine, or a determination that employment of physicians
is a violation of state laws that prohibit the corporate practice of medicine,
or a change in the law in any state in which it operates could have a material
adverse effect on FMC.
FMC currently operates in only one state that prohibits the corporate
practice of medicine, which state is Texas. Risks associated with expanding
FMC's business into other states that have this type of prohibition include (i)
the issue of consolidation of revenues and (ii) restrictions that prevent FMC
from exploiting the physician-patient relationship in pursuit of profits. FMC
does not consolidate the revenues from Texas, but operates as a management
services organization under a management contract. If FMC expands its business
into other states which prohibit
-6-
the corporate practice of medicine, it will operate as a management services
organization under a management contract in those states. See
"Business--FMC--Governmental Regulation of Domestic Operations."
CORPORATE EXPOSURE TO PROFESSIONAL LIABILITIES EXCEEDING THE LIMITS OF
AVAILABLE INSURANCE COVERAGE. Due to the nature of its business, FMC from time
to time becomes involved as a defendant in medical malpractice lawsuits, some of
which are currently ongoing, and is subject to the attendant risk of substantial
damage awards. The most significant source of potential liability in this regard
is the negligence of health care professionals employed or contracted by FMC. To
the extent such health care professionals are employees of FMC or were regarded
as agents of FMC in the practice of medicine, FMC could be held liable for their
negligence. In addition, FMC could be found in certain instances to have been
negligent in performing its contract management services (or refusing to perform
services) even if no agency relationship with the health care professional
exists. FMC maintains professional liability insurance on a claims made basis in
amounts deemed appropriate by management, based upon historical claims and the
nature and risks of its business. There can be no assurance, however, that a
future claim or claims will not exceed the limits of available insurance
coverage, that any insurer will remain solvent and able to meet its obligations
to provide coverage for any claim or claims or that such coverage will continue
to be available or available with sufficient limits and at a reasonable cost to
adequately and economically insure FMC's operations in the future. See
"Business--FMC--Professional Liability Insurance."
LOSS OF OTHER INSURANCE. FMC attempts to mitigate the risk of
potentially high medical costs incurred in catastrophic cases through stop-loss
provisions, reinsurance and other special reserves which limit FMC's financial
risk. To date, such protection has been provided to FMC through its provider
agreements with Humana. There can be no assurances that the agreements which
provide such insurance to FMC will continue. If assumption of capitated payments
risk through contracts with HMO's could be construed as insurance. FMC believes
there would be no effect from state insurance laws due to the circumstance that
all of FMC's contracts with HMO's provides for stop-loss coverage by the HMO's.
Any determination of material noncompliance with insurance regulations or any
change in the stop-loss coverage by the HMO's could adversely affect the
operations of FMC.
REDUCTION IN GOVERNMENTAL REIMBURSEMENT. FMC assumes the financial
risks related to changes in patient volume, payer mix and rates the governmental
establishes for offering reimbursements for various services. There are
increasing public and private sector pressures to restrain health care costs and
to restrict reimbursement rates for medical services. During the past decade,
federal and state governments have implemented legislation designed to slow the
rise of health care costs and it is anticipated that such legislative
initiatives will continue. Any such legislation could result in reductions in
reimbursement for the care of patients in governmental programs such as
Medicare, Medicaid and workers' compensation. A large percentage of the
capitated fee revenue described above is also derived indirectly from a Medicare
funded program with Humana. Any change in reimbursement policies, practices,
interpretations or regulations, or legislation that limits reimbursement amounts
or practices, could have a material adverse effect on FMC's operating results.
See "Business--FMC--Government Regulation."
While FMC believes it is in material compliance with applicable
Medicare and Medicaid reimbursement regulations, all Medicare and Medicaid
providers and practitioners are subject to claims review and audits. There can
be no assurance that FMC would be found to be in compliance in all respects with
such regulations. A determination that FMC is in violation of such regulations
could result in retroactive adjustments and recoupments and have a material
adverse effect on FMC.
DEPENDENCE ON KEY PERSONNEL. FMC is dependent upon the services of
certain of its executive officers, including Dennis A. Sokol, Valdimir Checklin
and Dr. Ken Burhart for the management of FMC and the implementation of its
strategy. FMC maintains key man life insurance for Dennis A. Sokol. The loss to
FMC of the services of any of these executive officers could adversely affect
FMC's operations.
INTERNATIONAL OPERATIONS
First Medical Group Inc. ("FMG") through its subsidiaries is subject to
numerous factors relating to the business environments of those developing
countries in which FMG conducts business operations. In particular,
-7-
fundamental economic and political changes occurring in Eastern Europe and the
CIS could have a material impact on FMG's international operations and on FMG's
ability to continue the development of its international businesses. There can
be no assurance that such developments in Eastern Europe and the CIS will not
have a material adverse effect on FMG's business operations.
POTENTIAL POLITICAL AND ECONOMIC INSTABILITY IN EASTERN EUROPE AND THE
CIS. Eastern Europe and the CIS are undergoing fundamental political and
economic changes, including the introduction of market economies. Consequently,
such countries have only recently begun the process of developing the necessary
framework and infrastructure to support this transition. Laws and regulations
are sometimes adopted without widespread notification, which can delay full
knowledge of their scope and impact, and the enforcement and administration
thereof are often inconsistent and without precedents. Governments will continue
to exercise influence over their country's economy. Uncertainties will continue
to exist with respect to the future governance of, and economic policies in,
such countries. Such involvement could include, but not be limited to,
expropriation, confiscatory taxation, foreign exchange restrictions or
nationalization, all of which could materially effect FMG's international
operations.
FOREIGN GOVERNMENT REGULATION. FMG's operations in Eastern Europe and
the CIS are subject to diverse laws and regulations primarily relating to
foreign investment (as well as numerous national and local laws and regulations
concerning the provision of medical services). Failure to comply with such laws
or regulations could have a material adverse effect on FMG. At the present time,
FMG is unaware of any restrictions on foreign investment that could materially
affect FMG's business. FMG believes it is in compliance with foreign government
regulations.
YEAR 2000. The Company has conducted a comprehensive review of its
computer systems to identify the systems that could be affected by the "Year
2000" issue and is developing an implementation plan to resolve the issue. The
Year 2000 problem is the result of computer programs being written using two
digits rather than four to define the applicable year. Any of the Company's
programs that have time-sensitive software may recognize a date using "00" as
the year 1900 rather than the year 2000. This could result in a major system
failure or miscalculations. The Company presently believes that, with
modifications to existing software and converting to new software, the Year 2000
problem will not pose significant operational problems for the Company's
computer systems as so modified and converted. However, if such modifications
and conversions are not completed timely, the Year 2000 problem may have a
material impact on the operations of the Company.
DISCLOSURES RELATING TO LOW PRICES STOCKS; POSSIBLE RESTRICTIONS
ON RESALES OF LOW PRICED STOCKS AND ON BROKER-DEALER SALES; POSSIBLE ADVERSE
EFFECT OF "PENNY STOCK" RULES ON LIQUIDITY FOR THE COMPANY'S SECURITIES. The
Company's securities may be subject to Rule 15g-9 (the "Rule") promulgated under
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), which
imposes additional sales practice requirements on broker-dealers that sell
securities governed by the Rule to persons other than established customers and
"accredited investors" (generally, individuals with a net worth in excess of
$1,000,000 or annual individual income exceeding $200,000 or $300,000 jointly
with their spouses). For transactions covered by the Rule, the broker-dealer
must make a special suitability determination for the purchaser and have
received the purchaser's written consent to the transaction prior to sale.
Consequently, the Rule may have an adverse effect on the ability of
broker-dealers to sell the Company's securities and may affect the ability of
purchasers in the Offering to sell the Company's securities in the secondary
market and otherwise affect the trading market in the Company's securities.
The Commission has adopted resolutions which generally define a "penny
stock" to be any non-Nasdaq equity security that has a market price (as therein
defined) less than $5.00 per share or with an exercise price of less than $5.00
per share, subject to certain exceptions. For any transactions by broker-dealers
involving a penny stock (unless exempt), rules promulgated under the Exchange
Act require delivery, prior to a transaction in a penny stock, of a risk
disclosure document relating to the penny stock market. Disclosure is also
required to be made about compensation payable to both the broker-dealer and the
registered representative and current quotations for the securities. Finally,
monthly statements are required to be sent disclosing recent price information
for the penny stocks. If the Company's securities were subject to the rules on
penny stock, the market liquidity for the Company's securities could be
materially adversely affected.
-8-
USE OF PROCEEDS
There is no conversion price for converting shares of Preferred Stock
and consequently the Company will receive no compensation upon their conversion.
The Company will not receive any of the proceeds from the reoffer and resale of
the Shares by the Selling Stockholders.
PRICE RANGE OF COMMON STOCK
The following table reflects the range of the reported high and low
closing prices of Common Stock on the NYSE for the calendar quarters indicated.
The information in the table and in the following paragraph has been adjusted to
reflect retroactively all applicable stock splits and stock dividends but not
the Reverse Split, except for the fourth quarter for the period commencing
November 13, 1997.
Common Stock
High Low
---- ---
1995:
First quarter........................... $ 3/4 $ 5/8
Second quarter.......................... 5/8 3/8
Third quarter........................... 1/2 5/8
Fourth quarter.......................... 33/64 13/16
-9-
Common Stock
High Low
---- ---
1996:
First quarter........................... $11/16 $7/16
Second quarter.......................... 9/16 3/8
Third quarter........................... 11/16 1/4
Fourth quarter.......................... 15/32 1/8
1997:
First quarter........................... $1/4 $13/32
Second quarter.......................... $14/32 $1/8
Third quarter........................... $15/32 $3/32
Fourth quarter from October 1,
1997 through November 12, 1997.......... $1/4 $1/8
Fourth quarter from November 13,
1997 through December 31, 1997.......... $4-1/4 $1-1/4
The prices above reflect trading of the Common Stock on the NYSE
through November 12, 1997. See "Risk Factors--Delisting by the NYSE." Subsequent
to the delisting of the Common Stock from the NYSE, the prices above for the
period from November 13, 1997 through December 31, 1997 reflect trading of the
Common Stock on the OTC Bulletin Board. On February 17, 1998, the price for the
Common Stock was $1.875. On November 7, 1997, there were approximately 8,000
holders of the Common Stock.
The Company has not paid any cash dividends since prior to January 1,
1995.
CAPITALIZATION
THE COMPANY
The following table sets forth the capitalization of the Company at
September 30, 1997.
September 30, 1997
----------------------
(Dollars in Thousands)
Long-term debt................................................ $4,893
Stockholder's equity:
Common Stock, $.001 par value, 100,000,000 shares 9
authorized 9,397,292 outstanding, as adjusted(1)........
Additional paid-in capital............................... 7,801
Retained earnings........................................ (1,945)
-----
Total stockholders' equity............................... 5,865
-----
Total capitalization................................ $10,758
======
(1) Reflects retroactive adjustment for the 1-for-30 stock split.
DIVIDEND POLICY
The Company has paid no cash dividends on its Common Stock since prior
to 1995 and does not intend to pay cash dividends on its Common Stock for the
foreseeable future. The payment of cash dividends will depend upon, among other
things, future earnings, the operating results and financial condition of the
Company, its capital requirements, general business considerations and other
pertinent factors and is subject to the discretion of the Board of Directors. In
addition, the Board is authorized to issue up to 5,000,000 shares of preferred
stock of which 1,037,461 shares of Preferred Stock were issued in connection
with the Merger. Each share of Preferred Stock is entitled to dividends, pari
passu with dividends declared and paid with respect to the Common Stock, equal
to 250 times the amount declared and paid with respect to each share of Common
Stock.
-10-
MANAGEMENT'S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion should be read in conjunction with the
consolidated financial statements, including the notes thereto, contained
elsewhere in this Prospectus.
GENERAL
On July 9, 1997 at a Special Meeting (the "Special Meeting") of
stockholders of the Lehigh Group, Inc. ("Lehigh"), the stockholders of Lehigh
approved the merger (the "Merger") pursuant to the terms of the Agreement and
Plan of Merger dated as of October 29, 1996 (the "Merger Agreement") among
Lehigh, First Medical Corporation ("FMC") and Lehigh Management Corp., a
wholly-owned subsidiary of Lehigh ("Merger Sub"). On the same day, Merger Sub
was merged with and into FMC and each outstanding share of common stock of FMC
(the "FMC Common Stock"), was exchanged for (i) 1,127.675 shares of Lehigh's
Common Stock, par value $.001 per share ("Lehigh Common Stock"), and (ii)
103.7461 shares of Lehigh's Series A Convertible Preferred Stock, par value
$.001 per share (the "Lehigh Preferred Stock"), each of which is convertible
into 250 shares of Lehigh Common Stock and has a like number of votes per
shares, voting together with the Lehigh Common Stock. As a result of such
merger, legally FMC became a wholly-owned subsidiary of the Company. See
"Business - Merger with FMC." The financial statements presented reflect First
Medical Corporation's acquisition of Lehigh since the acquisition date of July
9, 1997. Although legally The Lehigh Group acquired First Medical Corporation,
for accounting purposes First Medical Corporation is considered the accounting
acquirer (i.e., the reverse acquisition). Therefore, the operating results of
Lehigh are included in the statement of operation since the acquisition date
(July 9, 1997) and the September 30, 1997 balance sheet reflects the effect of
the acquisition of Lehigh. The acquisition of Lehigh's business has no material
effect on First Medical's business since they are completely separate
industries.
RECENT EVENTS
As a result of the Company experiencing operating losses in its physician
practice management business, the Company undertook an evaluation of the
carrying value of its assets pursuant to SFAS #121. At the present time, the
Company anticipates that it will recognize an impairment loss of approximately
$1.5 million in the fourth quarter. In addition, the Company has reevaluated the
carrying value of certain intangible assets relating to the merger with The
Lehigh Group which it believes will result in a writedown in the fourth quarter
of approximately $3.0 million. These charges in addition to a fourth quarter
expected operating loss will result in the Company reporting a significant loss
in the fourth quarter and for the year ended December 31, 1997. Based on
unaudited results, the Company anticipates a fourth quarter operating loss (in
addition to losses discussed above) of approximately $1 million. These losses
primarily occurred in the Company's physician practice medical segment and
includes the writeoff of certain uncollectible receivables in its electrical
segment and severance costs paid to former employees. The Company has made
significant improvements in the end of the third quarter in its reduction of
medical expenses specifically related to utilization and in a number of its
primary operations its bed days per thousand has been reduced significantly.
Because of these improvements, Management does not anticipate losses to continue
in the future.
The Company does not believe the fourth quarter Lehigh impairment loss will
impact First Medical's continuing operations due to the fact that it will be a
non-cash charge.
RESULTS OF OPERATIONS - FMG
NINE MONTHS ENDED SEPTEMBER 30, 1997
COMPARED WITH NINE MONTHS ENDED
SEPTEMBER 30, 1996
REVENUE. Total revenue of FMG for the nine months ended September 30,
1997 and 1996 were $52.0 million and $39.5 million, respectively, of which 76%
and 85%, respectively, was derived from prepaid contractual agreements with
Humana pursuant to which Humana pays FMG a capitated fee ("HMO revenue"). During
the nine months ended September 30, 1997, $41.5 million or 80% of FMG's revenue
were derived from the physician practice management division , $6.8 million or
13% was derived from the international medical clinics division, and $3.8
million or 7% was derived from the electrical supply division (as a result of
the merger in July 1997). During the nine months ended September 30, 1996,
revenue derived from the physician practice management division was $34.6
million, or 88% of FMG's revenue and $4.9 million or 12% was derived from the
international medical clinics division. The HMO revenue growth was primarily a
result of new provider agreements, as of September 1996, to manage a center in
New Port Richey, Florida and as of October 1996, to manage additional centers in
Lutz, Florida and South Dale Mabry, Florida. Revenue related to these centers
represent an increase of $11.8 million and the revenue related to the other
centers decreased by $4.9 million, due to a decrease in membership in the South
Florida market.
-11-
The approximately $1.5 million loss pertains to the Company's physician practice
management segment and includes write-off's of certain receivables and deferred
costs previously capitalized, the recoverability of which was not assured
because of operating losses at this segment.
Subsequent to the Company's merger with The Lehigh Group, Inc., the Company was
delisted from the New York Stock Exchange. In addition, the Company considered
the sale of Lehigh's only wholly owned subsidiary (Hallmark Electric Supply
Corp.) and had obtained an appraisal. Based upon the appraisal and the fact that
the Company lost its New York Stock Exchange listing, the intangible assets
recorded at the date of acquisition were considered impaired and the Company
expects an impairment loss of approximately $3.0 million dollars.
At the present time, the amounts of impairment losses disclosed on page 11 are
preliminary estimates and thus subject to change with a possible range of
$500,000 - $1.0 million in additional losses.
The impairment losses disclosed are primarily non-cash charges and do not
directly impact the Company's future liquidity. However, as a result of the
significance of the write-off's and the impact on net worth, future financing
alternatives may be limited. The operating results will not be affected.
The impairment loss is a non-cash charge and will not have any effects on future
costs and revenues.
This loss occurred in 1997. The Company believes it will still have enough
liquidity to operate and further believes the Company will be profitable in
1998. The Company is contemplating selling one or more of its operations to
increase its liquidity. At this point the Company does not know what the
operating loss for the fourth quarter will be.
MEDICAL EXPENSE/COST OF SALES. Medical expenses increased $11.5
million, or 35.6%, to $43.8 million for the nine months ended September 30, 1997
from $32.3 million for the same period in 1996. The entire increase ($11.5
million or 100%) resulted from medical services provided under the New Port
Richey, Lutz and South Dale Mabry agreements. Medical expenses as a percentage
of HMO and fee for service revenue ("medical loss ratios") were 94.3% and 83.2%,
respectively, for the nine months ended September 30, 1997 and 1996. The
increase in medical expenses was due to changes in the program benefits provided
Humana. FMG has recently implemented controls to monitor expenses in the future.
The recently implemented controls to monitor expenses
-12-
relate to a more diligent review of utilization and the hiring of a Vice
President of Finance to monitor expenses. Cost of sales for the electrical
supply business was 67.1%
OPERATING EXPENSES. Operating expenses increased by $1.5 million, or
24%, to $7.5 million, for the nine months ended September 30, 1997 from $6.0
million for the same period in 1996. The increase was primarily due to the
electrical supply division for $1.2 million and remaining increase was due to
the additional three centers. As a percent of revenue, operating expenses were
14.4% as compared to 15.3% for the same period in 1996.
NET INCOME. Net loss for the nine months ended September 30, 1997 was
$2.3 million compared to net income of $.7 million for the same period in 1996.
YEAR ENDED DECEMBER 31, 1996 COMPARED TO
YEAR ENDED DECEMBER 31, 1995
Revenue. The total revenues of FMC for the year ended December 31, 1996
and 1995 were $53.0 million and $22.7 million, respectively, of which 85% and
96%, respectively, was derived from prepaid contractual agreements with Humana
pursuant to which Humana pays FMC a capitated fee ("HMO revenue"). HMO Revenue
is derived primarily from the predetermined prepaid contractual arrangements
paid per member per month by Humana to the primary care centers which are owned
and operated by the Company. Under the capitated fee arrangements, FMC assumes
the risk of providing medical services for each managed care member. To the
extent that members require more frequent or extensive care, the revenue to FMC
may be insufficient to cover the cost of the care that was provided. During the
year ended December 31, 1996, $46.4 million or 88% of FMC's revenues were
derived from the physician practice management division and $6.7 million or 12%
was derived from the international medical clinics division. As of December 31,
1996 the FMC Healthcare Services division had not obtained any definitive
management consulting service agreements. Revenue increased by $30.3 million or
133% to $53.0 million for the year ended December 31, 1996, from $22.7 million
for the same period in 1995. The HMO revenue growth was primarily a result of
FMC's acquisition during January 1996 of controlling ownership of Broward
Managed Care, Inc. (the "Broward acquisition"), which has Humana affiliated
provider agreements ("provider agreement") to operate and manage two primary
care centers in Broward County, Florida ("Broward"), and new provider
agreements, as of September 1996, to manage a center in New Port Richey, Florida
("New Port Richey") and as of October 1996, to manage additional centers in
Lutz, Florida and South Dale Mabry, Florida. Revenue related to the Broward, New
Port Richey, Lutz, and South Dale Mabry centers represents $20.3 million or 87%
of the increase in HMO revenue. As discussed in Note 1 of the audited
consolidated financial statements, FMC (through the transaction between MedExec
and AMC) has a management services agreement with three clinics in the CIS.
During the year ended December 31, 1996, revenues generated by this
international division accounted for $6.7 million of the $30.3 million increase
discussed above. FMC intends to finance the growth of the clinics in Eastern
Europe primarily with the capital contribution from GDS. The $30.3 million
increase in FMC's revenue is also net of the decrease resulting from the
termination in August 1995 of the provider agreement to manage the center in
Brandon, Florida. The Brandon center generated $3.5 million in revenue during
the year ended December 31, 1995.
Medical Expenses. Medical expenses increased $25.1 million, or 136%, to
$43.5 million for the year ended December 31, 1996 from $18.4 million for the
same period in 1995. The majority of the increase ($21.6 million or 86%)
resulted from medical services provided under the Broward, New Port Richey, Lutz
and South Dale Mabry provider agreements. Medical expenses related to the AMC
clinics accounted for $5.4 million or 22% of the increase. The increase in
medical expense is net of the decrease related to the termination of the Brandon
provider agreement in 1995. Medical expenses for Brandon were $3.3 million in
1995. Medical expenses as a percentage of HMO and fee for service revenue
("medical loss ratio") were 84% for the years ended December 31, 1996 and 1995.
-13-
Operating Expenses. Operating expenses increased by $3.1 million, or
89%, to $8.7 million, for the year ended December 31, 1996 from $4.6 million for
the same period in 1995. The increase was primarily due to new employees to
staff the primary care centers in Broward, New Port Richey, Lutz, and South Dale
Mabry and $.8 million in expenses incurred by FMC in connection with the
development and opening of two international centers. As a percentage of
revenue, however, operating expenses decreased to 15% from 20% for the same
period in 1995.
Net Income. Net income for the year ended December 31, 1996 was $.3
compared to a net loss of $(.4) for the year ended December 31, 1995.
YEAR ENDED DECEMBER 31, 1995 COMPARED TO
YEAR ENDED DECEMBER 31, 1994
Revenue. Revenue increased by $1.4 million, or 7%, to $22.7 million in
1995, from $21.3 million in 1994 due to increased revenue from existing provider
agreements offset by the termination during August 1995 of the provider
agreement to manage the center in Brandon, Florida.
Medical Expenses. Medical expenses increased $1.8 million, or 11%, to
$18.4 million in 1995 from $16.6 million in 1994 primarily as a result of an
increase in medical services rendered. The medical loss ratio was 81% for the
year ended December 31, 1995 compared to 78% for the year ended December 31,
1994.
Operating Expenses. Operating expenses increased $1.2 million, or 35%,
to $4.6 million in 1995 from $3.4 million in 1994 due mainly to the additional
$1.1 million of expenses incurred by FMC during 1995. These expenses relate
primarily to additional compensation to former officers of FMC under employment
agreements, development cost incurred relating to the Chicago market, repricing
adjustments from Humana related to previous years and legal and professional
fees incurred in connection with a proposed merger with another company. Humana
from time to time renegotiates certain contracts which results in retroactive
adjustments to the financial statements. In 1995, Humana renegotiated certain
hospital contracts in the Tampa market retroactive to the beginning of 1994. As
a result, hospitals rebilled FMC for previously billed claims in order to
recover additional funds from FMC for 1994 and 1995. The ongoing impact, as with
any price increase is higher medical costs. The repricing is noted because 1995
in effect included two years of price increases instead of one. As per FAS No.
5, FMC records retroactive adjustments when they are probable and estimable. As
a percentage of revenue, operating expenses for the year ended December 31, 1995
increased to 20% from 16% for the year ended December 31, 1994.
Net Income (Loss). Net loss for 1995 was $(.4) million compared to net
income in 1994 of $1.4 million, a decrease of $1.8 million, which is primarily
due to the increase in medical services rendered, the write-off of certain
accounts receivables and additional compensation to shareholders under
employment agreements. The accounts receivable balances which were written-off
because they were uncollectible related to certain management services provided
by FMC totaling $.47 million. The amount was reversed out of revenues where it
was originally recorded during the year rather than written off in operating
expenses as a bad debt. The remaining accounts receivable balances were deemed
to be collectible.
YEAR ENDED DECEMBER 31, 1994 COMPARED TO
YEAR ENDED DECEMBER 31, 1993
Revenue. Revenue increased by $10.2 million, or 92%, to $21.3 million
in 1994, from $11.1 million in 1993 primarily due to two new full-risk Humana
affiliated provider agreements to manage primary care centers in Brandon and
Plant City, Florida.
Medical Expenses. Medical expenses increased $8.2 million, or 98%, to
$16.6 million in 1994 from $8.4 million in 1993 primarily as a result of medical
services provided under the new Brandon and Plant City provider agreements. The
medical loss ratio was 78% for the year ended December 31, 1994 compared to 76%
for the year ended December 31, 1993.
-14-
Operating Expenses. Operating expenses increased $1.7 million, or 100%,
to $3.4 million in 1994 from $1.7 million in 1993 primarily as a result of new
employees to staff the primary care centers in Brandon and Plant City, Florida.
As a percentage of revenue, operating expenses for the year ended December 31,
1994 increased to 16% from 15% for the year ended December 31, 1993.
Other Expenses. Other expenses in 1993 were $.2 million relating
primarily to losses incurred on certain equity investments.
Net Income. Net income increased $.6 million, or 75%, to $1.4 million
from $.8 million in 1993 due to the factors discussed above.
LIQUIDITY AND CAPITAL RESOURCES
At September 30, 1997, FMG had cash of $2.8 million compared to $63,014
at December 31, 1996. As of September 30, 1997, FMG had fully utilized its $2.5
million credit facility. The increase in cash was due to FMG receiving
approximately $4,500,000 as a result of the merger. FMC received $4.5 million
dollars from Generale De Sante International, Plc ("GDS") as a result of an
investment GDS made in FMC. To date $2,000,000 has been used to fund development
and operating losses of MedExec, Inc., $500,000 was used to pay professional
fees in connection wit the Merger and the remaining $2,000,000 will be used for
general working capital requirements.
FMG had cash of $63,014 at December 31, 1996 compared to $198,763 at
December 31, 1995.
Net cash used in operating activities was ($.568) million for the year
ended December 31, 1996.
Net cash used in investing activities of ($.448) million was primarily
the result of ($.119) in capital expenditures, organizational costs of ($.478)
million, acquisition of additional ownership in various subsidiaries of ($.151)
million, net of $.3 million for the proceeds from the sale of MedExec's
investment in HCO Networks.
Net cash provided by financing activities of $.880 million was the
result of $1.350 million in proceeds received from loans payable to Humana,
banks, and certain shareholders, respectively, a $.152 million capital
contribution to AMCD, and ($.622) million repayment on notes due to shareholders
and banks.
FMG believes that cash from operations and borrowings under existing
credit facilities will be sufficient to satisfy its contemplated cash
requirements for at least the next twelve months.
To date, FMG's principal uses of cash have been to support its
operating activities . FMG has met its cash requirements in recent years
primarily from its operating activities, advances from Humana and bank
borrowings.
FMG also maintains a secured line of credit with a domestic bank for
$0.4 million bearing interest at prime. The $0.4 million drawn under this line
of credit at September 30, 1997 has been used by FMG in connection with the
satisfaction of development costs relating to FMG's Midwest operations.
Amortization of $5,000 per month will commence as to the first $200,000 in
November, 1997 and as to the remaining $200,000, in May, 1998.
FMG believes that funds generated from operations, availability under
its credit facilities, and lease financing will be sufficient to finance its
current and anticipated operations and planned capital expenditures at least
through 1997. FMG's long term capital requirements beyond 1997 will depend on
many factors, including, but not limited to, the rate at which FMG expands its
business. To the extent that the funds generated from the sources described
above are insufficient to fund FMG's activities in the short or long term, FMG
would need to raise additional funds through public or private financing. No
assurance can be given that additional financing will be available or that, if
available, it will be available on terms favorable to FMG.
As of September 30, 1997, FMG also has a credit facility for $2.5
million bearing interest at 1/2% above prime, of which $500,000 is guaranteed by
certain current and former officers of FMG. The expiration date for the
-15-
$2.5 million facility is July 31, 1998. FMG also borrowed an additional $537,000
to purchase Lehigh stock in connection with the merger. FMC purchased this block
of stock to increase its voting power at the Special Shareholders meeting that
was held July 9, 1997, to vote in favor of the Merger. The expiration date for
the $537,000 facility is October 1998.
FMG, is in default in the payment of interest (approximately $744,000
interest was past due as of September 30, 1997) on the $390,000 aggregate
principal amount of its 13 1/2% Senior Subordinated Notes due May 15, 1998 ("13
1/2% Notes") and 14 7/8% Subordinated Debentures due October 15, 1995 "14 7/8%
Debentures") that remain outstanding and were not surrendered to the Company in
connection with its financial restructuring consummated in 1991. The Company has
been unable to locate the holders of the 13 1/2% Notes and 14 7/8% Debentures
(with the exception of certain of the 14 7/8% Debentures, which were retired
during 1996).
Management expects a sizable loss for the fourth quarter and the year.
This loss occurred in 1997. The Company believes it will still have enough
liquidity to operate. The Company is contemplating selling one or more of its
operations to increase its liquidity. At this point the Company does not know
what the operating loss for the fourth quarter will be.
-16-
SUMMARY FINANCIAL DATA
(DOLLARS IN THOUSANDS, EXCEPT SHARE DATA)
The summary financial data for the years ended December 31, 1992, 1993,
1994, 1995 and 1996 set forth below has been derived from the audited financial
statements of FMG (1992-1996 is FMC). The summary financial data for the nine
month period ended September 30, 1997 is unaudited.
Nine Month
Year Ended December 31, Ended
------------------------------------------------------------------------- -------------
September
30,
1992(1) 1993(1) 1994(1) 1995(1) 1996(1) 1997(4)
------- ------- ------- ------- ------- ----
STATEMENT OF OPERATIONS:
Revenues:
Capitated revenue $5,406 $10,563 $20,253 $21,744 $45,070 39,768
Fee-for-service 53 96 200 182 7,075 6,727
Other 398 428 865 746 869 5,514
------- ------- ------- ------- ------- ------
Total revenue 5,857 11,087 21,318 22,672 53,014 52,009
Medical expenses/Cost of Sales 4,480 8,405 16,568 18,444 43,526 46,486
------- ------- ------- ------- ------- ------
Gross profit 1,377 2,682 4,750 4,228 9,488 5,523
Operating expenses:
Salaries and related benefits 561 670 1,651 2,434 3,503 2,540
Other operating expenses 573 991 1,771 2,200 5,194 4,965
------ ------ ------ ------ ------ ------
Total operating expenses 1,134 1,661 3,422 4,634 8,697 7,504
Income (loss) from operations 243 1,021 1,328 (406) 791 (1,981)
Other expenses (income) 4 218 (35) (42) 55 288
Net income (loss) before taxes 247 803 1,364 (364) 736 (2,269)
Pro forma adjustments for income
taxes(2) 99 321 545 ---- 413 0
------- ------ ------ ------- ------ ------
Pro forma net income (loss) from
continuing operations $ 148 $ 482 $ 818 ($ 364) $ 323 $(2,269)
======= ====== ======= ======== ======= ========
Pro forma net income (loss) from
continuing operations per share $ .02 $ .05 $ .09 $( .04) $ .04 $ .25
Pro forma weighted average number
of FMG shares
currently outstanding (3) 9,021 9,021 9,021 9,021 9,021 9,136
Cash Dividends as Declared 12 17 117 38 ---- ----
BALANCE SHEET DATA:
Working Capital $ 83 $ 279 $272 $(302) $(2,047) $(2,124)
Total Assets 840 2,739 4,128 3,045 12,323 29,337
Current Liabilities 657 1,341 3,157 2,817 10,596 18,564
Stockholder's Equity 183 1,398 972 227 703 (5,879)
Book Value per share - fully diluted $ .02 $ .15 $ .11 $ .03 $ .08 $(.64)
(1) The summary financial data for the years ended December 31, 1992, 1993,
1994 and 1995 has been derived from the audited combined financial
statements of MedExec, Inc. and subsidiaries; SPI Managed Care, Inc.;
and SPI Managed Care of Hillsborough County, Inc. (collectively,
"MedExec"). The data for 1996 has been derived from the 1996
consolidated financial statements of FMC.
(2) Prior to December 31, 1995, MedExec. Inc., and prior to May, 1994, SPI
Managed Care, Inc. were S corporations and not subject to Federal and
Florida corporate income taxes. The Statement of Operations data
reflects a proforma provision for income taxes as if the Company was
subject to Federal and Florida corporate income taxes for all periods.
This proforma provision for income taxes is computed using a combined
effective Federal and State tax rate of 40%.
-17-
(3) The amount of FMC stock issued and outstanding has been adjusted to
reflect the exchange of 10,000 shares for 11,276,750 shares of the
Lehigh Group, plus the conversion of the Preferred Stock to Common Stock
and the 1-for-30 reverse stock split.
(4) The nine months ended September 30, 1997 reflect FMC's acquisition of
Lehigh as of 7/9/97 and include the operating results and balance sheet
of Lehigh as of 7/9/97.
(5) On July 9, 1997 at a Special Meeting (the "Special Meeting") of
stockholders of the Lehigh Group, Inc. ("Lehigh"), the stockholders of
Lehigh approved the merger (the "Merger") pursuant to the terms of the
Agreement and Plan of Merger dated as of October 29, 1996 (the "Merger
Agreement") among Lehigh, First Medical Corporation ("FMC") and Lehigh
Management Corp., a wholly-owned subsidiary of Lehigh ("Merger Sub"). On
the same day, Merger Sub was merged with and into FMC and each
outstanding share of common stock of FMC (the "FMC Common Stock"), was
exchanged for (i) 1,127.675 shares of Lehigh's Common Stock, par value
$.001 per share ("Lehigh Common Stock"), and (ii) 103.7461 shares of
Lehigh's Series A Convertible Preferred Stock, par value $.001 per share
(the "Lehigh Preferred Stock"), each of which is convertible into 250
shares of Lehigh Common Stock and has a like number of votes per share,
voting together with the Lehigh Common Stock.
-18-
SELECTED AND PRO FORMA
FINANCIAL DATA
(DOLLARS IN THOUSANDS, EXCEPT SHARE DATA)
The selected financial data for the years ended December 31, 1992,
1993, 1994, 1995 and 1996 set forth below has been derived from the audited
financial statements of FMG (1992-1996 is FMC). The selected financial data for
the nine month period ended September 30, 1997 is unaudited.
Nine Month
Year Ended December 31, Ended
---------------------------------------------------------------- -----------
September
30,
1992(1) 1993(1) 1994(1) 1995(1) 1996(1) 1997(4)
------- ------- ------- ------- ------- ----
STATEMENT OF OPERATIONS:
Revenues:
Capitated revenue $5,406 $10,563 $20,253 $21,744 $45,070 39,768
Fee-for-service 53 96 200 182 7,075 6,727
Other 398 428 865 746 869 5,514
------- ------- ------- ------- ------- ------
Total revenue 5,857 11,087 21,318 22,672 53,014 52,009
Medical expenses/Cost of Sales 4,480 8,405 16,568 18,444 43,526 46,486
------- ------- ------- ------- ------- ------
Gross profit 1,377 2,682 4,750 4,228 9,488 5,523
Operating expenses:
Salaries and related benefits 561 670 1,651 2,434 3,503 2,540
Other operating expenses 573 991 1,771 2,200 5,194 4,965
------ ------ ------ ------ ------ ------
Total operating expenses 1,134 1,661 3,422 4,634 8,697 7,504
Income (loss) from operations 243 1,021 1,328 (406) 791 (1,981)
Other expenses (income) 4 218 (35) (42) 55 288
Net income (loss) before taxes 247 803 1,364 (364) 736 (2,269)
Pro forma adjustments for income
taxes(2) 99 321 545 ---- 413 0
------- ------ ------ ------- ------ ------
Pro forma net income (loss) from
continuing operations $ 148 $ 482 $ 818 ($ 364) $ 323 $(2,269)
======= ====== ======= ======== ======= ========
Pro forma net income (loss) from
continuing operations per share $ .02 $ .05 $ .09 $( .04) $ .04 $( .25)
Pro forma fully diluted weighted
average number of FMG shares
currently outstanding (3) 9,021 9,021 9,021 9,021 9,021 9,136
Cash Dividends as Declared 12 17 117 38 ---- ----
BALANCE SHEET DATA:
Working Capital $ 83 $ 279 $272 $(302) $(2,047) $(2,124)
Total Assets 840 2,739 4,128 3,045 12,323 29,337
Current Liabilities 657 1,341 3,157 2,817 10,596 18,564
Stockholder's Equity 183 1,398 972 227 703 (5,879)
Book Value per share - fully diluted $ .02 $ .15 $ .11 $ .03 $ .08 $(.64)
- ------------------
(1) The selected financial data for the years ended December 31, 1992, 1993,
1994 and 1995 has been derived from the audited combined financial
statements of MedExec, Inc. and subsidiaries; SPI Managed Care, Inc.;
and SPI Managed Care of Hillsborough County, Inc. (collectively,
"MedExec"). The data for 1996 has been derived from the 1996
consolidated financial statements of FMC.
(2) Prior to December 31, 1995, MedExec. Inc., and prior to May, 1994, SPI
Managed Care, Inc. were S corporations and not subject to Federal and
Florida corporate income taxes. The Statement of Operations data
reflects a proforma provision for income taxes as if the Company was
subject to Federal and Florida corporate income taxes for all periods.
This proforma provision for income taxes is computed using a combined
effective Federal and State tax rate of 40%.
(3) The amount of FMC stock issued and outstanding has been adjusted to
reflect the exchange of 10,000 shares for 11,276,750 shares of the
Lehigh Group, plus the conversion of the Preferred Stock and the
1-for-30 reverse stock split.
(4) The nine months ended September 30, 1997 reflect FMC's acquisition of
Lehigh as of 7/9/97 and include the operating results and balance sheet
of Lehigh as of 7/9/97.
-19-
(5) On July 9, 1997 at a Special Meeting (the "Special Meeting") of
stockholders of the Lehigh Group, Inc. ("Lehigh"), the stockholders of
Lehigh approved the merger (the "Merger") pursuant to the terms of the
Agreement and Plan of Merger dated as of October 29, 1996 (the "Merger
Agreement") among Lehigh, First Medical Corporation ("FMC") and Lehigh
Management Corp., a wholly-owned subsidiary of Lehigh ("Merger Sub"). On
the same day, Merger Sub was merged with and into FMC and each
outstanding share of common stock of FMC (the "FMC Common Stock"), was
exchanged for (i) 1,127.675 shares of Lehigh's Common Stock, par value
$.001 per share ("Lehigh Common Stock"), and (ii) 103.7461 shares of
Lehigh's Series A Convertible Preferred Stock, par value $.001 per share
(the "Lehigh Preferred Stock"), each of which is convertible into 250
shares of Lehigh Common Stock and has a like number of votes per share,
voting together with the Lehigh Common Stock.
-20-
BUSINESS
MERGER WITH FMC
On July 9, 1997 at a Special Meeting (the "July Meeting") of
stockholders of the Company, the stockholders of the Company approved the Merger
pursuant to the terms of the Agreement and Plan of Merger dated as of October
29, 1996, as amended (the "Merger Agreement") among the Company, First Medical
Corporation ("FMC") and Lehigh Management Corp., a wholly-owned subsidiary of
the Company ("Merger Sub"). On the same day, Merger Sub was merged with and into
FMC and each outstanding share of common stock of FMC (the "FMC Common Stock"),
was exchanged for (i) 1,127.675 shares of the Company's Common Stock, par value
$.001 per share ("Common Stock"), and (ii) 103.7461 shares of the Company's
Series A Convertible Preferred Stock, par value $.001 per share (the "Preferred
Stock"), each of which, as a result of the Reverse Split, is convertible into
250 shares of Common Stock and has a like number of votes per share, voting
together with the Common Stock. Prior to the Merger, FMC held approximately
25.4% of the outstanding shares of Common Stock which were acquired through two
series of transactions.
There were outstanding 10,000 shares of FMC Common Stock immediately
prior to the Merger. These shares were exchanged for a total of (i) 11,276,750
shares of Common Stock which, as a result of the Reverse Split, is now 375,875
shares of Common Stock, and (ii) 1,037,461 shares of Preferred Stock. As a
result of the Merger, holders of Common Stock immediately prior the Merger and
former FMC stockholders each owned 50% of the issued and outstanding shares of
Common Stock immediately following the Merger. In the event that all of the
shares of Preferred Stock issued to the former FMC stockholders are converted
into Common Stock, holders of Common Stock immediately prior to the Merger and
former FMC stockholders would own approximately 4% and 96%, respectively, of the
outstanding Common Stock.
In addition, under the terms of the Merger Agreement, concurrently with
the implementation of the Reverse Split, the Company will be renamed "First
Medical Group, Inc.," and following the Merger, Dennis Sokol, the Chairman of
the Board and Chief Executive Officer of FMC, became the Chairman and Chief
Executive Officer of the Company, Salvatore Zizza, the Chairman of the Board,
President and Chief Executive Officer of the Company, became Executive Vice
President and Treasurer and Mr. Bruno continued as Vice President and Secretary.
Mr. Bruno, Richard Bready, Charles Gargano, Anthony Amhurst and Salvatore
Salibello, five of the six members of the Board of Directors were not nominated
for re-election, and at the Special Meeting Mr. Sokol, Melvin Levinson, Elliot
Cole and Paul Murphy, four members of FMC's board of directors, were elected to
replace them. On August 11, 1997, Richard Berman was elected to the Board of
Directors.
LEHIGH
GENERAL
Lehigh (formerly The LVI Group Inc.) through its wholly owned
subsidiary, HallMark Electrical Supplies Corp., is engaged in the distribution
of electrical supplies for the construction industry both domestically
(primarily in the New York Metropolitan area) and for export.
Prior to 1994, Lehigh, through its wholly owned subsidiaries, had been
engaged in the following other businesses: (i) through certain of its operating
subsidiaries ("NICO Construction"), interior construction; (ii) through its
wholly owned subsidiary, LVI Environmental Services Group Inc. ("LVI
Environmental"), and subsidiaries thereof, asbestos abatement; (iii) through
Riverside Mfg., Inc. ("Riverside"), the design, production and sale of
electrical products; (iv) through Mobile Pulley and Machine Works, Inc. ("Mobile
Pulley"), the manufacture and sale of dredging equipment and precision machined
castings; and (v) through LVI Energy Recovery Corporation ("LVI Energy"), energy
recovery and power generation and landfill closure services. All of such other
businesses were transferred or sold prior to 1994.
Riverside and Mobile Pulley were transferred to a liquidating trust in
connection with Lehigh's financial restructuring of its outstanding debt and
preferred stock on March 15, 1991 (the "1991 Restructuring"). During the
-21-
third quarter of 1991, Lehigh discontinued its interior construction business
operated through its NICO Construction subsidiaries due to the general economic
slowdown, particularly as it related to the real estate market. In the third
quarter of 1990, Lehigh discontinued its LVI Energy business which was prompted
by technical problems at the LVI Energy power plant facility. Both the NICO
Construction and LVI Energy subsidiaries were sold on December 31, 1991.
The following is a detailed supplemental description of the 1993
restructuring as it appeared in note number 1 to Lehigh's Annual Report on Form
10-K for the year ended December 31, 1993:
FINANCIAL CONDITION AND RESTRUCTURING - Lehigh incurred substantial
losses from operations in 1988, 1989 and 1990 attributable in significant part
to the performance of its NICO Construction and LVI Environmental businesses.
The interior construction segment experienced significant revenue decreases in
each of these years and incurred losses in both 1989 and 1990. The asbestos
abatement segment incurred substantial losses in 1988 and 1989 and experienced a
revenue decrease in 1990. Lehigh also incurred a substantial loss attributable
to its LVI Energy business in 1990. For the three year period ended December 31,
1990, Lehigh incurred a cumulative net loss of $76.7 million. As a consequence,
Lehigh had a consolidated shareholders' deficit at December 31, 1990 of $30.8
million.
At December 31, 1990, Lehigh had outstanding long-term debt (including
the current portion thereof), on a consolidated basis, of approximately $97.8
million (excluding revolving credit facilities of certain subsidiaries and trade
notes payable to subcontractors). This long-term debt had an annual debt service
requirement of $12.2 million, all but $2.5 million of which was payable in cash.
Lehigh had also not paid the eight quarterly dividends on its outstanding
preferred stock due from March 15, 1989 through December 15, 1990, aggregating
$2.5 million ($4.12 per share).
For the foregoing reasons, Lehigh consummated the 1991 Restructuring on
March 15, 1991. The consummation of the 1991 Restructuring followed extensive
negotiations and discussion among Lehigh, and representatives of various of its
creditors and preferred stockholders which began in August 1990.
Pursuant to the 1991 Restructuring, among other things,
(a) The holders of $33.84 million principal amount of Lehigh's 13-1/2%
Senior Subordinated Notes due May 15, 1998 ("13-1/2 Notes") exchanged such
securities, together with accrued but unpaid interest thereon, for $8,642,736
principal amount of new 8% Class B Senior Secured Redeemable Notes due March 15,
1999 issued by NICO Construction ("Class B Notes") and 212,650,560 shares of
Common Stock;
(b) The holders of $8.76 million principal amount of Lehigh's 14-7/8%
Subordinated Debentures due October 15, 1995 ("14-7/8% Debentures") exchanged
such securities, together with the accrued but unpaid interest thereon, for
$2,156,624 principal amount of Class B Notes and 53,646,240 shares of Common
Stock,
(c) each of the 444,068 shares of Lehigh's $2.0625 Cumulative
Convertible Exchangeable Preferred Stock, no par value (the "Cumulative
Preferred Stock"), outstanding on March 15, 1991, together with the accumulated
but unpaid dividends thereon, was converted into 34 shares of Common Stock (an
aggregate of 15,098,312 common shares),
(d) NICO Construction transferred to the Trust all of the stock of
Mobile Pulley and Riverside together with approximately $4 million face amount
of certain debt securities,
(e) a group of related insurance companies, consisting of Executive
Life Insurance Company, Executive Life Insurance Company of New York and First
Stratford Life Insurance Company (collectively, "First Executive"), exchanged
$53.596 million principal amount of NICO Construction's senior secured notes for
(i) $8 million principal amount of new 9.5% Class A Senior Secured Redeemable
Notes due March 15, 1997 issued by NICO Construction ("Class A Notes"), (ii) $6
million principal amount of Class B Notes, (iii) 78,746,690 shares of Common
Stock, and (iv) beneficial ownership of the Trust, and
-22-
(f) prior to the consummation of the 1991 Restructuring, certain
amendments to the indentures, pursuant to which the 13-1/2% Notes and the
14-7/8% Debentures were issued, were adopted to eliminate substantially all of
the restrictive covenants set forth therein.
In sum, pursuant to the 1991 Restructuring, a total of 360,141,802
shares of Common Stock, $16,799,360 principal amount of Class B Notes and $8
million principal amount of Class A Notes were issued. The total shares of
Common Stock issued pursuant to the 1991 Restructuring was reduced to 10,289,765
in December, 1991, as a result of a 35 for 1 reverse split approved by Lehigh's
stockholders. Upon consummation of the 1991 Restructuring, the former holders of
the 13-1/2% Notes, 14-7/8% Debentures and First Executive owned approximately
90% of the outstanding shares of Common Stock (exclusive of any Common Stock
owned by them prior thereto), the former holders of Cumulative Preferred Stock
owned approximately 4% of the outstanding shares of Common Stock (exclusive of
any Common Stock owned by them prior thereto) and the holders of Common Stock
immediately prior to the 1991 Restructuring owned approximately 6% of the
outstanding shares of Common Stock.
As intended, the 1991 Restructuring substantially reduced Lehigh's debt
service obligations. However, adverse market conditions in the interior
construction industry continued to negatively impact the sales volume of NICO
Construction. Significant overhead reductions were made to reduce costs to a
level commensurate with reduced sales volume. Notwithstanding these efforts, the
effect of the general economic slowdown, particularly as it related to the real
estate market, prompted management to discontinue Lehigh's interior construction
business during the third quarter of 1991.
In September, 1991, Lehigh sold its registered service mark "NICO" for
use in the interior construction management and consulting business in the
United States. In December, 1991, Lehigh sold all ownership in its NICO
Construction and LVI Energy businesses.
Lehigh was in default of certain covenants to the holders of Class A
Notes and Class B Notes (the "Notes") at December 31, 1992 and 1991 and, as a
consequence, the Notes were classified as current in the 1992 and 1991 Financial
Statements.
Lehigh consummated a restructuring on May 5, 1993 (the "1993
Restructuring"). Pursuant to the 1993 Restructuring, Lehigh, through NICO Inc.,
a wholly owned subsidiary ("NICO"), sold LVI Environmental to LVI Holding
Corporation ("LVI Holding"), a newly formed company organized by the management
of LVI Environmental, which had a minority interest in LVI Holding. The owners
of LVI Holding were certain holders of the Class A Notes and the Class B Notes
and members of the management of LVI Environmental. As a result of the 1993
Restructuring, 100% of the Class A Notes and over 97% of the Class B Notes
(together, the "Notes") were surrendered to Lehigh, together with 3,000,000
shares of its Common Stock (27% of all Common Stock then outstanding), and, in
exchange therefor, participating holders of the Notes acquired, through LVI
Holding, all of the stock of LVI Environmental. Lehigh's consolidated
indebtedness was thereby reduced from approximately $45.9 million to
approximately $3.6 million (excluding approximately $431,217 of indebtedness
under Class B Notes that LVI Holding agreed to pay in connection with the 1993
Restructuring, but for which Lehigh remains liable). LVI Holding paid $1.5
million to Lehigh during 1993 and 1994 in connection with the 1993 Restructuring
to fund operating expenses and working capital requirements.
Beginning in 1994, Lehigh investigated the feasibility of acquiring or
investing in one or more other businesses that management of Lehigh believed
might have a potential for growth and profit. On July 9, 1997, Lehigh acquired
FMC pursuant to the Merger.
ELECTRICAL SUPPLIES
HallMark was acquired by Lehigh in December 1988. HallMark's sales
include electrical conduit, armored cable, switches, outlets, fittings, panels
and wire which are purchased by HallMark from electrical equipment manufacturers
in the United States. Approximately 90% of HallMark's sales are domestic and 10%
are export. All of Lehigh's revenues are attributed to HallMark.
-23-
Domestic sales are made by HallMark employees. Nine customers accounted
for approximately 61%, 72% and 44% (including one customer which accounted for
approximately 25%, 18% and 12%) of HallMark's total domestic sales in 1996, 1995
and 1994, respectively. The loss of any of these customers could have a material
adverse effect on its business. Export sales are made by sales agents retained
by HallMark. Distribution is made in approximately 2 countries. From November 1,
1992 until October 31, 1996, HallMark's export business was conducted primarily
from Miami, Florida. HallMark now conducts its export operation from New York
City.
HallMark customers whose sales exceed 10% of Lehigh's consolidated
revenues (prior to the Merger) are: Adco Electric, Arc Electric or and Forest
Electric. These customers account for an aggregate of approximately 38% of
Lehigh's consolidated revenues (prior to the Merger).
Management believes that many companies (certain of which are
substantially larger and have greater financial resources than HallMark) are in
competition with HallMark. Management believes that the primary factors for
effective competition between HallMark with its competitors are price, in-stock
merchandise and a reliable delivery service. As a result, orders for merchandise
are received daily and shipped daily; hence, backlog is insignificant.
Management believes that HallMark is generally in compliance with
applicable governmental regulations and that these regulations have not had and
will not have a material adverse effect on its business or financial condition.
EMPLOYEES
As of June 30, 1997, Lehigh had 2 employees and HallMark had 35.
Approximately 85% of such employees are compensated on an hourly basis.
Lehigh and HallMark comply with prevailing local contracts in the
respective geographic locations of particular jobs with respect to wages, fringe
benefits and working conditions. Most employees of HallMark are unionized. The
current collective bargaining agreement for HallMark, which is with the
International Brotherhood of Electrical Workers, Local Union #3, expires on
April 30, 1999.
LEGAL PROCEEDINGS
The State of Maine and Bureau of Labor Standards commenced an action in
Maine Superior Court on or about November 29, 1990 against Lehigh and Dori Shoe
Company (an indirect former subsidiary) to recover severance pay under Maine's
plant closing law. The case was tried without a jury in December 1994. Under
that law, an "employer" who shuts down a large factory is liable to the
employees for severance pay at the rate of one week's pay for each year of
employment. Although the law did not apply to Lehigh when the Dori Shoe plant
was closed it was amended so as to arguably apply to Lehigh retroactively. In a
prior case brought against Lehigh (then known as Lehigh Valley Industries) and
its former subsidiary under the Maine severance pay statute prior to its
amendment, Lehigh was successful against the State of Maine. See Curtis v. Loree
Footwear and Lehigh Valley Industries, 516 A. 2d 558 (Me. 1986).
The Superior Court, by decision docketed April 10, 1995, entered
judgement in favor of the former employees of Dori Shoe Company against Dori
Shoe and Lehigh in the amount of $260,969.11 plus prejudgment interest and
reasonable attorneys' fees and costs to the Plaintiff upon their application
pursuant to Maine Rules of Civil Procedure 54(b)(3)(d). Lehigh filed an appeal
appealing that decision and the matter was argued before the Maine Supreme
Judicial Court on December 7, 1995. On February 18, 1997, the Supreme Judicial
Court of Maine affirmed the Superior Court's decision. In July 1997, the Company
agreed to pay the State of Maine $215,000 to satisfy the judgment. On or about
September 30, 1997, the Company made its payment.
Lehigh is involved in other minor litigation, none of which is
considered by management to be material to its business or, if adversely
determined, would have a material adverse effect on Lehigh's financial
condition.
-24-
PROPERTIES
Lehigh, as of October 1, 1997 is currently occupying 2,400 square feet
at 1055 Washington Boulevard, Stamford, CT 06901 pursuant to a 3 year lease that
FMC has with its landlord at annual rental of $65,000.00 (which progressively
escalates to $75,000.00 in 1999). HallMark leases 28,250 square feet of office
and warehouse facilities in Brooklyn, New York, pursuant to a lease expiring on
June 30, 2004, at an annual rental of approximately $78,000 (which progressively
escalates to $106,000 in 2003). In December 1994, HallMark leased 4,500 square
feet of additional warehouse facilities in Brooklyn, New York, pursuant to a
lease expiring on June 30, 2004, at an annual rental of $18,000 (which
progressively escalates to $21,600).
Lehigh believes that all of its facilities are adequate for the
business in which it is engaged.
FMG
FMG is an international provider of management, consulting and
financial services to physicians, hospitals and other health care delivery
organizations and facilities. FMG's diversified operations are currently
conducted through three divisions: (i) a physician practice management division
which provides physician management services including the operation of clinical
facilities and management services to Medical Service Organizations, (ii) an
international division which currently manages western style medical centers in
Eastern Europe and the CIS and (iii) a recently formed hospital services
division which provides a variety of administrative and clinical services to
acute care hospitals and other health care providers.
INDUSTRY BACKGROUND
The role of the primary care physician is changing dramatically.
Historically, the health care services industry was based on a model in which
physician specialists played a predominant role. This model contributed to
over-utilization of specialized health care services and, in turn, increases in
health care costs at rates significantly higher than inflation. In response,
third-party payers have been implementing measures to contain costs and improve
the availability of medical services. These measures, which include managing the
utilization of specialized health care services and alternative methods of
reimbursement, have caused the health care industry to evolve toward models that
contain health care costs more efficiently. In these models, the primary care
physician and physician management organization are playing increasingly
important roles.
FMG believes that two important trends contributing to the evolution of
the health care services industry define its business opportunities. First,
physicians are increasingly abandoning traditional private practices in favor of
affiliations with larger organizations such as FMG that can provide enhanced
management capabilities, information systems and capital resources. This
transformation of physician practice is based on an increasingly competitive
health care environment characterized by intense cost containment pressure,
increased business complexity and uncertainty regarding the impact of health
care reform on physicians.
The second trend is that many payers and their intermediaries,
including HMO's, are increasingly looking to outside providers of physician
services to manage their professional medical requirements and to share the risk
of providing services through capitation arrangements. As these payers seek to
limit their health care costs by reducing the fee-for-service component paid to
their medical service providers, there is additional pressure on smaller
providers to consolidate and realize the efficiencies that can be achieved by
operating in larger practice groups.
DOMESTIC OPERATIONS.
Cost containment, industry consolidation and changes in reimbursement
methods are causing difficulties for health care providers, particularly
not-for-profit hospitals. As a result of intense competition from large
for-profit hospitals, not-for-profit hospitals must develop effective plans for
attracting and retaining patient flow. Such plans may include, among other
things, (i) reducing or changing the services provided in order to better
utilize current facilities, equipment and space, (ii) entering into new
contracts with physician groups, HMO's, and other third party
-25-
payors, and (iii) various cost-cutting measures. Ultimately, a facility's
ability to adapt to changing environments requires access to capital and
management expertise, services which FMG is willing and able to provide.
INTERNATIONAL OPERATIONS.
The American health care delivery system and its related services
remain a valuable export. The internationally recognized level of training,
technology and services associated with the American health care systems and
their professionals continues to enjoy increasing demand among both expatriates
and wealthy nationals in FMC's expanding foreign markets. FMC's value is
reflected in the premium prices which its clients are willing to pay for access
to comprehensive American health care and related services.
STRATEGY OF FMG
FMG's strategy with respect to its physician practice management
division is to develop its business by addressing significant changes in the
role and practice patterns of the primary care physician in the health care
services industry. Elements of this strategy include:
Development of Additional Primary Care Centers and Physician Resources.
A major priority for FMG is the development of additional primary care centers
and physician resources. In furtherance of this goal, FMG will continue to
identify and evaluate potential acquisitions and relationships which complement
its existing business operations and increase its market share and develop a
competitive position in all areas of its business. In addition, FMG believes
that its experienced management team and operational systems will afford FMG the
opportunity to be successful in recruiting and managing physicians, in
integrating new physician practices and in managing the utilization of health
care services.
Expanding Presence in Capitated Medical Services. FMG believes that
managed care will continue to be a rapidly growing segment of the health care
services industry that offers one of the best long-term solutions to controlling
health care costs. FMG plans to develop its physician practice management
services division by expanding the services provided to existing clients and
obtaining new HMO contracts. FMG plans to build on this experience to develop
and enlarge integrated networks of health care providers that will contract with
intermediaries and payers on a capitated basis.
Developing and Expanding Management Consulting and Financial Services.
A priority for FMG is the development of its management consulting and financial
services division by continuing to provide creative solutions to complex
financial and management related health care delivery issues. FMG believes that
there are numerous organizations, including payor-owned physician practices,
hospital owned physician practices and not-for-profit providers, which are
experiencing financial or operational distress which could benefit from FMG's
expertise. FMG believes that its strong management team, which has over 75 years
in managing health care delivery systems, situates and enables FMG to assist
troubled health care providers, including not-for-profit and proprietary acute
care hospitals, long-term care facilities and specialty care facilities, with
direct management services, including "turn key" and departmental or program
management, transitional or turn-around management, strategic planning and
marketing, financial and general business consulting services.
FMG plans to offer health care providers a full array of advanced
management services including, but not limited to: utilization management;
information systems; human resources management; financial control systems;
outcomes measurement and monitoring; customer service programs; training and
education; financial services; strategic planning; network development; and risk
contracting. These services will be offered as a comprehensive package or
individually, but through one point of contact, creating a "one-stop shop" for
management services.
Integration of Domestic Operations. In addition to sharing management
services expertise and resources, FMG anticipates that its physician practice
management and management consulting and financial services divisions will
eventually be consolidated into one division. It is expected that the cross-
selling opportunities will create a relationship between the two divisions
warranting a consolidation. A primary objective of FMG is to provide
-26-
management services on a long-term contractual basis for an entire integrated
delivery system in a number of local markets.
FMG's management believes that nationwide concerns over escalating
health care costs and the possibility of legislated reforms are increasing the
emphasis on managed care, integrated networks of health care providers and
prepaid, capitated arrangements. Increased managed care penetration is
generating more recognition of the benefits of organized physician groups
serving large patient populations as well as reducing the reimbursement rates
for services rendered. In anticipation of such changes in the health care
environment, FMG continues to review and revise its business mix.
Continued Development of the International Division. FMG will continue
the development and expansion of its international division. FMG believes that
through its continuing development efforts, FMG will be positioned to become a
premier owner, operator and manager of international primary care clinics, acute
care hospitals and other health care delivery organizations. FMG expects that it
will benefit from exporting the expertise and capabilities developed by its
domestic operations to its international operations. FMG has entered into an
agreement to open a western-style medical facility in Abu Dhabi, United Arab
Emirates in March 1997 status, and anticipates opening additional facilities
throughout Europe, the Middle East, Latin American and the Pacific Rim as part
of its expansion program.
FMG strives to deliver a comprehensive range of diverse medical
services to meet the specific needs of its clients in each of FMG's unique
markets. In response to demands for western style hospitals in the CIS, FMG
commenced development of the American Hospital of Moscow pursuant to which FMG
will establish the first western-style hospital in the CIS.
An integral part of FMG's strategy is to provide an environment for
medical education and training of local medical professionals and health care
administrators. In this regard, FMG will continue to be active in sponsoring
exchange programs with western facilities and teaching institutions such as the
Baylor College of Medicine in Houston, Texas. FMG has also organized an in-house
mentor program to expose local medical professionals and aspiring physicians to
the western health care system.
DIVISIONS OF FMG
Physician Practice Management Division
FMC's physician practice management operations are currently conducted
through MedExec. MedExec functions in two capacities as a management services
organization: (i) owning and operating nine primary care centers (located in
Florida and Indiana) which have full risk contracts for primary care and part B
services and partial risk (50%) contracts for part A services, and (ii) managing
sixteen multi-specialty groups (located in Florida and Texas) with
fee-for-service and full risk contracts for primary care and part B services and
partial risk (50%) contracts for part A services. Full risk contracts are
contracts with managed care companies where FMC assumes essentially all
responsibility for a managed care members' medical costs and partial risk
contracts are contracts where FMC assumes partial responsibility for a managed
care members' medical costs. Revenue from the primary care centers is derived
primarily from the predetermined amounts paid per member ("capitation") by
Humana. In addition to the payments from Humana, the primary care centers
received copayments from commercial members for each office visit, depending
upon the specific plan and options selected by individual members and receive
payments from non-HMO members on a fee-for-service basis. Revenue from the
multi-specialty practices managed by FMC are determined based on per member per
month fees and/or a percentage of the net profits for Part A and Part B service
funds for such centers.
Revenue from the multi-specialty practices are obtained by FMC through
management agreements. In Texas, pursuant to a five-year management agreement,
FMC is entitled to receive (i) direct expenses incurred by FMC in furnishing all
items and services to the multi-specialty group, (ii) indirect space costs, and
an (iii) administrative fee of $30,000.00 per month. In Florida, FMC is entitled
to receive (i) from Humana Medicare members, an amount equal to $4.50 per member
per month plus a percentage of Part A profits, Part B profits and
-27-
Medicare Membership Conversion fees ranging from 9% down to 4% based upon
Medicare membership, and (ii) for Humana commercial HMO members, an amount equal
to $1.50 per member per month plus 5% of Part A profits and Part B profits. The
members of the practices are patients of the physicians who are enrolled as
Humana members.
FMC is not licensed to practice medicine. FMC employs or manages
licensed physicians to work at the primary care centers in Florida and Indiana
which centers provide the delivery of medicine. In Texas, FMC provides
utilization, billing, human resources, management information systems, senior
executive management, financial consulting and risk evaluation as a management
services organization. In order to better serve its existing markets and
potential markets, FMC is in the process of establishing five geographic
operating regions, to wit, the East Coast of Florida, the West Coast of Florida,
the Midwest, the Southwest and the Northeast.
In connection with the operation of such primary care centers in
Florida and Indiana, FMC employs all of the personnel, including physicians who
agree to provide the necessary clinical skills, required in such centers. FMC
compensates its physician employees bi-weekly pursuant to the terms of written
employment agreements. The written employment agreements are for a term of 2-3
years, provide for termination "with cause", provide for a base salary and a
bonus, which bonus is determined by a formula comprised of quality management,
utilization management, medical records documentation, patient
satisfaction/patient education and time and motion management, contain a
non-competition provision and contain provisions outlining the duties of the
physician and FMC.
FMC currently employs physicians in Florida and Indiana, which states
do not have regulations on the corporate practice of medicine. In Texas, there
are regulations on the corporate practice of medicine, and FMC does not employ
any physicians and has no ownership interest in or control of the entity in
which physicians are employed. In all states other than Texas, FMC retains an
ownership interest or control in the various clinics it operates. FMC operates
an office in Illinois for administrative services only and has employed
physicians in Indiana. FMC maintains a proprietary data base for physicians who
might be available to be employed at FMC's owned and operated clinics in
particular specialties and locations, and expects to create an in-house
recruiting department.
FMC generates fees at its primary care centers on a fee-for-service
basis and/or capitated basis. Under fee-for-service arrangements, FMC bills and
collects the charges for medical services rendered by contracted or employed
health care professionals and also assumes the financial risks related to
patient volume, payor risk, reimbursement and collection rates. Under capitated
arrangements, FMC assumes the risk and receives revenues at a fixed rate from
HMO's at contractually agreed-upon per member per month rates for all the
primary care needs of a patient. Under its HMO contracts, FMC receives a fixed,
prepaid monthly fee for each covered life in exchange for assuming
responsibility for the provision of medical services, subject to certain
limitations. To the extent that enrollees require more frequent or extensive
care than was anticipated by FMC, the revenue to FMC under a contract may be
insufficient to cover the costs of the care that was provided. A substantial
portion of the patients seeking clinical services from the company's primary
care centers are members of HMO's with which FMC maintains contractual
relationships.
Additionally, FMC has entered into contracts with HMO's to manage the
delivery of comprehensive medical services to enrollees at FMC's clinics located
in Florida, Texas and Indiana. A substantial portion of the revenues of FMC's
managed care business are derived from prepaid contractual arrangements with
Humana, pursuant to which Humana pays FMC a capitated fee. FMC employs primary
care physicians to work at FMC clinics in Florida and Indiana. FMC also provides
for other services with hospitals and medical specialists at negotiated prices
for both capitated and non-capitated (i.e. fee-for service) services. Due to
FMC's risk for the cost of providing health care services, it carefully manages
utilization of primary care, hospital and medical specialist services.
In addition, FMC contracts with primary care medical practices pursuant
to which FMC provides a variety of management services. In particular, FMC
provides management services which improve physician practices' operating
efficiencies through standardization of operating processes, including the
installation of information technology and billing systems, and assists such
practices in contracting on a network basis to insurers, HMO's and other payers.
In consideration for such management services, FMC receives an annual management
fee and participates in profits.
-28-
FMC believes that it will have significant opportunities to expand its
managed care business primarily because physician practice management
organizations are better qualified than most third-party payers to recruit,
manage and retain physicians, deliver services on a cost-effective basis and
control medical malpractice costs. FMC believes that physician practice
management organizations are better qualified to perform these functions because
of their ability to provide and guarantee quality control by providing quality
health care while simultaneously providing favorable utilization through the use
of a medical director who manages the physicians in the center. In contrast, an
HMO is generally concerned with utilization and risks which are handled from a
centralized headquarter; while a management service organization is concerned
with providing consistent quality at the site at which healthcare services are
delivered.
Neither FMC, its subsidiary, MedExec, nor its affiliates are licensed
to operate as HMO's.
CEDA CONTRACT
FMC has been awarded an exclusive contract to provide health care
services to organizations operating under the Community Economic Development Act
(CEDA) in Cook County, Illinois and certain areas in northeastern Illinois. CEDA
is an organization designed to provide communities with access to various
government assistance programs by creating places where individuals can receive
assistance directly and conveniently. The CEDA contract, held by Midwest
Management Care, a wholly-owned subsidiary of FMC, is to provide overall
management of primary care centers. Humana, the HMO, provides the insurance
function. The contract designates FMC's clinics as the exclusive referral sites
for recipients of CEDA assistance, although it does not guarantee that all of
the estimated 60,000 recipients will use FMC's clinics for their health care
needs.
As a result of being awarded such agreement, FMC plans to develop eight
to ten clinics on or near CEDA sites. FMC anticipates that certain of such
clinics will be operational by the end of 1997. The CEDA contract requires that
reimbursements must flow through a fully licensed and accredited HMO. FMC will
be reimbursed based on what the HMO has determined the monthly amount necessary
to provide all covered services to Assigned Members. The HMO had established
capitation funding at a specific amount per member per month. The Medicare Part
B capitation rate for the richest benefit plan will be paid at an aggregate of
$140 per member per month. The Medicare Part A richest benefit plan will be paid
at an aggregate of $220 per member per month. Accordingly, FMC has recently
selected Humana Healthcare Plans, a fully accredited HMO to participate with and
is currently finalizing the terms of a partnership agreement.
Hospital Services Division
FMC, through FMC Healthcare Services, Inc. ("FMC Healthcare Services")
will provide management, consulting and financial services to troubled
not-for-profit hospitals and other health care providers. FMC Healthcare
Services, which was incorporated in June 1996, will offer creative solutions to
complex health care delivery issues. To date, FMC is in the process of
negotiating healthcare facility contracts but has not yet entered into any
definitive agreements. FMC Healthcare Services' primary target groups include:
(i) individual hospitals (not-for-profit, municipal and proprietary), (ii)
long-term care facilities, (iii) provider networks and systems, and (iv)
alternate delivery systems (i.e., free standing diagnostic and treatment and
ambulatory surgery centers). The primary target groups have been identified in
order to match FMC's management teams and senior managers with businesses in
which they have experience (e.g. troubled hospitals that need crisis management;
physician groups that need the management experience of a management service
organization; extended care facilities and alternative care providers that
desire to be affiliated with a network).
The scope of services to be provided are determined following an
individualized assessment of the target facility and include, but are not
necessarily limited to, (i) full service and direct management of health care
organizations including (a) "turn-key" management of a facility, (b)
supplemental support to existing management and (c) management of specific
departments, programs or systems; (ii) transitional management or turnaround
services including (a) assisting in the development of a comprehensive
turnaround plan and (b) supporting a restructured management team in reaching
financial and operational objectives through the implementation of turnaround
plan; and (iii) general business and consulting services including the
furnishing of (a) financial services,
-29-
(b) feasibility studies, (c) capital development and (d) necessary capital and
other resources or arranging for the provision of such resources to enable the
facility to restructure existing debt.
The management consulting services to be provided by FMC Healthcare
Services will range from four to 24 months and will involve a minimum of three
health care professionals. Ideally, senior level professionals retained by FMC
Healthcare Services will oversee general operations, medical staff and nursing
at the subject medical facility. These individuals will be situated on site at
the respective facility. Other personnel employed by FMC Healthcare Services
will be furnished as needed or as requested. FMC Healthcare Services will be
paid on a fee for services basis.
International Medical Clinics Division
FMG's international division currently specializes in developing and
managing health care facilities in Eastern Europe, the CIS and other developing
countries. Currently, FMG contracts to provide services in Moscow, St.
Petersburg and Kiev of the CIS; Warsaw, Poland; and Prague, Czech Republic. FMG
has recently entered into an agreement with Bin Barook Trading Company to open
and operate a western- style medical clinic in Abu-Dhabi, United Arab Emirates,
which is expected to commence operations in March 1997. FMG has also entered
into a letter of intent with American International Medical System Inc., which
in turn has an agreement with the Peoples Hospital of Beijing to open the
American Medical Center of Beijing.
Revenues of FMG's international division are primarily derived from
fee-for-service charges and annual non-refundable membership fees charged to
corporations, families and individuals. A variety of diverse membership plans
are available and can be tailored to meet the unique needs of corporate clients.
Based upon its experience, FMG's management believes that a significant and
increasing portion of the international division's revenues will be derived from
local customers who seek medical services on a fee-for-service basis. Local
customers currently account for approximately 25% of the international
division's revenue.
Generally, corporations are required to pay an annual membership fee as
well as placing an advance deposit with FMG for future services rendered based
on the selected membership plan and size of the respective organizations.
Membership plans offer a wide range of benefits including 24-hour emergency
access, monthly medical newsletters and specials, fee discounts and cross
membership with other clinics. FMG also offers an insurance processing service
for corporate members. FMG's corporate membership currently includes
approximately five hundred international corporations.
In order to meet the changing needs of FMG's corporate clients and to
provide expanded access to western health care to potential clients, FMG has
recently developed and implemented a variety of comprehensive managed care
plans. These plans range from individual and family plans to corporate plans
covering up to 2,000 employees in various and sometimes remote locations.
Based upon its experience, FMG's management believes that a significant
and increasing portion of the international division's revenues will be derived
from local customers who seek medical services on a fee-for-service basis.
COMPETITION
The provision of physician management services is a highly competitive
business in which FMC competes for contracts with several national and many
regional and local providers of physician management services. Furthermore, FMC
competes with traditional managers of health care services, such as hospitals,
which directly recruit and manage physicians. Certain of FMC's competitors have
access to substantially greater financial resources than FMC.
Although there exist a number of companies which offer one or more of
the services which are offered by FMC Healthcare Services, FMC believes that
Hospital Services Group is unique in that it offers a variety of management,
consulting and financial services "under one roof." Certain companies which
compete with FMC have access to substantially greater resources than FMC
Healthcare Services.
-30-
Internationally, FMG has relatively little competition on a
multinational scale, but faces strong competition in local markets from small
entrenched and start-up health care providers.
While the bases for competition vary somewhat between business lines,
competition is generally based on cost and quality of care. More particularly,
in the area of managed care, FMC believes the market for developing and
providing management of primary care networks in the United States which
contract with HMO's and employers will increasingly be based on patient access,
quality of care, outcomes management and cost.
MARKETING
FMC's physician practice management division has developed two
marketing methods. The primary method is to conduct joint marketing efforts with
HMO's. These efforts focus on customer service, quality and access programs and
are designed to attract new members to the HMO, retain current members and
enroll members at the company's medical centers. The second method focuses on
development of local market awareness and creating a positive image of FMC among
the physician community in order to create opportunities for additional
physician management contracts.
The management, consulting and financial services division currently
relies on the ability of the management team to leverage their reputations,
experience and network of contacts to develop new clients or arrange for new
contracts with existing clients.
International marketing is done at a local level through traditional
media advertising and promotional activities. The image and status of the
clinics themselves and the medical personnel are carefully cultivated through an
intensive public relations campaign. The network of international clinics is
also collectively marketed to multinational corporations through representatives
who maintain relationships and develop new contracts with the benefits managers.
GOVERNMENT REGULATION OF DOMESTIC OPERATIONS
FMC's domestic operations and relationships are subject to a variety of
governmental and regulatory requirements. A substantial portion of the company's
revenue is derived from payments made by government-sponsored health care
programs (primarily Medicare). These programs are subject to substantial
regulation by the federal and state governments which are continually revising
and reviewing the programs and their regulations. Any determination of material
noncompliance with such regulatory requirements or any change in reimbursement
regulations, policies, practices, interpretations or statutes that places
material limitations on reimbursement amounts or practices could adversely
affect the operations of FMC.
In addition to current regulation, the public and state and federal
governments have recently focused significant attention on reforming the health
care system in the United States. A broad range of health care reform measures
have been introduced in Congress and in certain state legislatures. Among the
proposals under consideration are cost controls on hospitals, insurance market
reforms to increase the availability of group health insurance to small
businesses, requirements that all businesses offer health insurance coverage to
their employees and the creation of a single government health insurance plan
that would cover all citizens. It is not clear at this time what proposals will
be adopted, if any, or, if adopted, what effect, if any, such proposals would
have on FMC's business. Certain proposals, such as cutbacks in Medicare programs
and containment of health care costs that could include a freeze on prices
charged by physicians and other health care providers could adversely affect the
company. There can be no assurance that currently proposed or future health care
legislation or other changes in the administration or interpretation of
governmental health care programs will not have a material adverse effect on
FMC's operating results.
Continuing budgetary constraints at both the federal and state level
and the rapidly escalating costs of health care and reimbursement programs have
led, and may continue to lead, to relatively significant reductions in
government and other third-party reimbursements for certain medical charges. The
company's health care professionals are subject to periodic audits by government
reimbursement programs to determine the adequacy of coding procedures and the
reasonableness of charges.
-31-
All Medicare and Medicaid providers and practitioners are subject to
claims review, audits and retroactive adjustments, recoupments, civil monetary
penalties, criminal fines and penalties, and/or suspension or exclusion from
payment programs for improper billing practices. Federal regulations also
provide for withholding payments to recoup amounts due to the programs. Periodic
audits of health care professionals by government reimbursement programs have
not had any impact on FMC.
Federal law prohibits the offer, payment, solicitation or receipt of
any form of remuneration in return for the referral of Medicare or state health
care program (e.g., Medicaid) patients or patient care opportunities, or in
return for the purchase, lease, order or recommendation of items or services
that are covered by Medicare or state health care programs. Violations of this
law are felonies and may subject violators to penalties and exclusion from
Medicare and all state health care programs. In addition, the Department of
Health and Human Services may exclude individuals and entities from
participation in Medicare and all state health care programs based on a finding
in administrative proceedings that the individual or entity has violated the
antikickback statute. FMC has not violated the antikickback statute; if either
FMC or its employees violated the statute they could be subject to sanctions.
Only one physician holds FMC common stock and this physician does not refer any
patients to FMC, is the medical director of FMC, oversees the medical aspect of
the physician practice management division, and has no bonus arrangement with
FMC; therefore management believes the Federal anti-Kickback statute is not
applicable.
Every state imposes licensing requirements on individual physicians and
on health care facilities. In addition, federal and state laws regulate HMO's
and other managed care organizations with which FMC may have contracts. Many
states require regulatory approval before acquiring or establishing certain
types of health care equipment, facilities or programs. Since FMC is not an
insurer, there is no insurance regulation of FMC's operations. Texas prohibits
the corporate practice of medicine. The business structure that FMC has adopted
in Texas in order to comply with the prohibitions on the corporate practice of
multi-specialty medicine is a full service management agreement wherein FMC
manages an independent group of physicians by providing utilization, billing,
human resources, management information systems, senior executive management,
financial consulting and risk evaluation for a negotiated fee.
The laws of many states prohibit physicians from splitting fees with
nonphysicians and prohibit business corporations from providing or holding
themselves out as providers of medical care. While FMC believes it complies in
all material respects with state fee splitting and corporate practice of
medicine laws, there can be no assurance that, given varying and uncertain
interpretations of such laws, FMC would be found to be in compliance with all
restrictions on fee splitting and the corporate practice of medicine in all
states. FMC currently operates in Texas through professional corporations, and
has recently formed professional corporations or qualified professional
corporations to do business in several other states where corporate practice of
medicine laws may require the company to operate through such a structure. A
determination that FMC is in violation of applicable restrictions on fee
splitting and the corporate practice of medicine in any state in which it has
significant operations could have a material adverse effect on the company.
FMC currently operates in only one state that prohibits the corporate
practice of medicine, which state is Texas. Risks associated with expanding
FMC's business into other states that have this type of prohibition include (i)
the issue of consolidation of revenues and (ii) preventing FMC from exploiting
the physician-patient relationship in pursuit of profits. FMC does not
consolidate the revenues from Texas, but operates as a management services
organization under a management contract. If FMC expands its business into other
states which prohibit the corporate practice of medicine, it will operate as a
management services organization under a management contract.
FMC attempts to mitigate the risk of potentially high medical costs
incurred in catastrophic cases through stop-loss provisions, reinsurance and
other special reserves which limit FMC's financial risk. To date, such
protection has been provided to FMC through its provider agreements with Humana.
There can be no assurances that the agreements which provide such insurance to
FMC will continue. If assumption of capitated payments risk through contracts
with HMO's could be construed as insurance, FMC believes there would be no
effect from state insurance laws due to the circumstance that all of FMC's
contracts with HMO's provides for stop-loss coverage by the HMO's. Any
determination of material noncompliance with insurance regulations or any change
in the stop-loss coverage by the HMO's could adversely affect the operations of
FMC.
-32-
PROFESSIONAL LIABILITY INSURANCE
Over the last twenty years, the health care industry has become subject
to an increasing number of lawsuits alleging medical malpractice and related
legal theories, including the withholding of approval for necessary medical
services. Often, such lawsuits seek large damage awards, forcing health care
professionals to incur substantial defense costs. Due to the nature of its
business, FMC, from time to time, becomes involved as a defendant in medical
malpractice lawsuits, some of which are currently ongoing, and is subject to the
attendant risk of substantial damage awards. The most significant source of
potential liability in this regard is the negligence of health care
professionals employed or contracted by the company.
One part of FMC's management services involves the provision of
professional liability insurance ("PLI") coverage for its physicians. FMC
currently provides this coverage through an umbrella PLI policy with Zurich
American Insurance Group maintained for substantially all of the company's
employees and independent contractors. This PLI policy generally provides
coverage in the amount of $1,000,000 per physician and per claim, subject to an
aggregate per physician limit of $3,000,000 per year. In its insurance policy,
FMC also maintains the right to purchase extended coverage beyond the expiration
of the policy period for an agreed upon premium to cover the costs of claims
asserted after the expiration of the effective policy. In addition, the company
books reserves against those claims in which the amount of coverage provided
could possibly be insufficient in the event of a relatively large award. FMC
maintains professional liability insurance on a claims made basis in amounts
deemed appropriate by management, based upon historical claims and the nature
and risks of its business. However, there can be no assurance that a future
claim or claims will not exceed the limits of available insurance coverage, that
any insurer will remain solvent and able to meet its obligations to provide
coverage for any claim or claims or that coverage will continue to be available
or available with sufficient limits to adequately insure FMC's operations in the
future.
LEGAL PROCEEDINGS
FMC is involved in various legal proceedings incidental to its
business, substantially all of which involve claims related to the alleged
malpractice of employed and contracted medical professionals and to the failure
to render care resulting in a violation or infringement of civil rights and, no
individual item of litigation or group of similar items of litigation, taking
into account the insurance coverage available to FMC, is not likely to have a
material adverse effect on FMC's financial condition.
Additionally, on November 20, 1996, a discharged employee and
shareholder of FMC filed a Demand For Arbitration alleging breach of contract,
defamation and interference with business relationships. No specific monetary
amount of damages was claimed. The employee was terminated by FMC for cause
after having refused to sign a confidentiality agreement, disclosed financial
information to outsiders, violating confidentiality standards. Thereafter, on
November 26, 1996, this same employee filed an action in Dade County, Florida
alleging what is essentially a breach of fiduciary duties by FMC's Board of
Directors arising out of payments made to former partners as part of the
purchase price, which the employee believed was improper. This litigation was
settled for an amount that would be unlikely to have a material adverse effect
on FMC's financial condition.
EMPLOYEES
As of December 23, 1997, FMC had approximately 755 employees.
Approximately 20% of such employees are compensated on an hourly basis.
FMC complies with prevailing local contracts in the respective
geographic locations of particular jobs with respect to wages, fringe benefits
and working conditions.
-33-
PROPERTIES
FMG's principal executive office is located at 1055 Washington
Boulevard, Stamford, Connecticut 06901, and its telephone number is (203)
327-0900.
FMC leases approximately 2,400 square feet in Stamford, Connecticut.
FMC leases approximately 5,000 square feet in Miami, Florida to provide
administrative support pursuant to a lease expiring on December 31, 1998 at an
annual rental of $147,000. FMC leases approximately 1,400 square feet in Tampa,
Florida for use by SPI Hillsborough pursuant to a lease expiring on November 30,
2001 at an annual rental of $26,736. FMC leases approximately 4,100 square feet
in Maywood, Illinois pursuant to a lease expiring on November 30, 2001 at an
annual rental of $48,000.
In addition, FMG through its subsidiaries leases two facilities in
Moscow, and one each in St. Petersberg, Kiev, Warsaw and Prague, which
facilities are used as medical clinics, at monthly rents of $16,780, $4,933,
$10,326, $6,000, $3,110 and $6,700, respectively.
FMC believes that all of its facilities are adequate for the business
in which it is engaged.
MANAGEMENT
The table set forth below sets forth information with respect to the
directors and executive officers of the Company. Information as to age,
occupation and other directorships has been furnished to the Company by the
individual named. Salvatore J. Zizza, Dennis A. Sokol, Melvin Levinson, Elliot
Cole and Richard Berman are currently directors of the Company and will serve as
directors until the next annual meeting of stockholders of the Company (or until
their respective successors are duly elected and qualified or until their
earlier death, resignation or removal).
DIRECTORS AND EXECUTIVE OFFICERS
NAME AGE CURRENT POSITION
---- --- ----------------
Dennis A. Sokol 52 Chairman of the Board, Chief Executive
Officer and Director of the Company and
Chairman of the Board and Chief Executive
Officer of FMC
Salvatore J. Zizza 52 Chief Financial Officer, Executive Vice
President, Treasurer and Director of the
Company
Robert A. Bruno 41 Vice President, General Counsel and
Secretary of the Company
Melvin E. Levinson, M.D. 68 Director of the Company
Elliot H. Cole 65 Vice Chairman of the Board and Director of
the Company
Richard Berman 53 Director of the Company
Mr. Sokol has been a director and Chairman of the Board and Chief
Executive Officer of the Company since the Merger, which was consummated on July
9, 1997. Mr. Sokol has served as the Chairman of the Board and Chief Executive
Officer of FMC since its formation in January 1996. Prior to the formation of
FMC, Mr. Sokol served as the Chairman of the Board and Chief Executive Officer
of Hospital Corporation International, Plc., the former international division
of Hospital Corporation of America, Inc., which entity owned and operated
hospitals and primary care facilities in the United Kingdom, Central and Eastern
Europe, the Middle East and Pacific Rim, and American Medical Clinics, Ltd. Mr.
Sokol was the founder, and from 1984 to 1988 served as Chief Executive Officer
of Medserv Corporation, a multifaceted medical service company. Mr. Sokol was
the founder, and from
-34-
1989 to 1992 served as the Chief Executive Officer, of the American-Soviet
Medical Consortium whose members included Pfizer, Inc., Colgate-Palmolive
Company, Hewlett-Packard Company, MedServ, Amoco Corporation and Federal Express
Corp. In all, Mr. Sokol has over 30 years experience in the medical services
industry.
Mr. Zizza has been a director of the Company since 1985 (except that he
did not serve as a director during the period from March 15, 1991 through April
16, 1991) and Executive Vice President and Treasurer since 1997. He was Chairman
of the Board of the Company from April 16, 1991 until the Merger, and was Chief
Executive Officer of the Company from April 16, 1991 through August 22, 1991 and
President of NICO Inc. ("NICO") from 1983 through August 22, 1991. He also
served as President of the Company from October 1985 until April 16, 1991. He is
also a director of the Gabelli Equity Trust, Inc.; The Gabelli Asset Fund; The
Gabelli Growth Fund; The Gabelli Convertible Securities Funds, Inc., The Gabelli
Global MultiMedia Trust Inc. and Initial Acquisition Corp. (a NASDAQ - listed
company). In 1995, Mr. Zizza became Chairman of the Board of The Bethlehem
Corporation (an AMEX company).
Mr. Bruno has served as Vice President and General Counsel of the
Company since May 5, 1993 and as Secretary since August 22, 1994. He served on
the Board from March 31, 1994 until July 9, 1997. He also has served as General
Counsel to NICO and its subsidiaries since June 1983 (except he did not serve as
General Counsel to NICO during the period of January 1, 1992 through May 31,
1993).
Dr. Levinson has been a director of the Company since July 1997 and has
served as a Co-Vice Chairman of FMC's Board of Directors since its formation in
January 1, 1996. Dr. Levinson was a co-founder of MedExec, Inc., a wholly-owned
subsidiary of FMC ("MedExec"), for which he served as Chairman of the Board and
a director from March 1991 to January 1996. Dr. Levinson was also a co-founder
and former director of HealthInfusion, Inc., a publicly traded company engaged
in the delivery of intravenous home therapy. Dr. Levinson is a founder and since
January 1996 has served as the Chairman of the Board of Scion International,
Inc., a manufacturer of medical devises. Dr. Levinson is currently an Associate
Professor at the University of Miami School of Medicine.
Mr. Cole has been a director of the Company since July 1997 and has
served as the Co-Vice Chairman of FMC's Board of Directors since its formation
in January 1996. Mr. Cole is a senior partner in the law firm of Patton Boggs
LLP, Washington, D.C., a firm of approximately 250 lawyers. Mr. Cole has
practiced corporation law and been engaged in Federal matters for more than
thirty-five years. Mr. Cole has served as a trustee of Boston University since
1977 as well as being a member of numerous corporate and not-for-profit boards.
Mr. Berman has been a director of the Company since August 1997. Since
1995 Mr. Berman has been the President of Manhattanville College. From 1991 to
1994 he was employed by Howe-Lewis International, initially as President of
North America and subsequently as President and Chief Executive Officer. He also
is a director of HCIA, Inc., Health Insurance Plan of Greater New York, the
Independent College Fund and a member of the Special Advisory Panel on Empire
Blue Cross/Blue Shield and the New York State Council on Health Care.
No family relationship exists between any of the directors and
executive officers of the Company.
All directors will serve until the annual meeting of stockholders of
the Company to be held in 1998 and until their respective successors are duly
elected and qualified or until their earlier death, resignation or removal.
Officers are elected annually by the Board of Directors and serve at the
discretion thereof.
BOARD MEETINGS AND COMMITTEES OF THE BOARD
During 1996 the Board of Directors held three meetings which were
attended by all of the directors, except two former directors who each missed
one meeting.
The Board of Directors has a standing Audit Committee, Executive
Committee and Compensation Committee. The Audit Committee did not meet during
1996. The current members of the Audit Committee are Messrs. Zizza and Berman.
The functions of the Audit Committee include recommending to the Board of
Directors the appointment of the independent public accountants for the Company;
reviewing the scope of the audit performed by the independent public accountants
and their compensation therefor; reviewing recommendations to management
-35-
made by the independent public accountants and management's responses thereto;
reviewing internal audit procedures and controls on various aspects of corporate
operations and consulting with the independent public accountants on matters
relating to the financial affairs of the Company. The Executive Committee of the
Board of Directors held no meetings in 1996. The current members of the
Executive Committee are Messrs. Sokol, Zizza and Cole. The Executive Committee
is authorized (except when the Board of Directors is in session) to exercise all
of the powers of the Board of Directors (except as otherwise provided by law).
The Compensation Committee did not meet in 1996. The current members of the
Compensation Committee are Mr. Cole and Dr. Levinson. The Compensation Committee
is responsible for developing the Company's executive compensation policies,
determining the compensation paid to the Company's Chief Executive Officer and
its other executive officers and administering the Stock Option Plan and the
Incentive Compensation Plan. See "Board Report on Executive Compensation."
EXECUTIVE COMPENSATION
The following table sets forth a summary of compensation awarded to,
earned by or paid to the Chief Executive Officer and the other most highly
compensated executive officers of the Company whose total annual salary and
bonus exceeded $100,000 for services rendered in all capacities to the Company
during each of the years ended December 31, 1997, December 31, 1996 and December
31, 1995:
SUMMARY COMPENSATION TABLE+
Long Term
Compensation
Annual Compensation Awards
--------------------------------- -------------------
Securities
Underlying
Options
Other Annual (number of All Other
Name and Principal Position Year Salary Bonus Compensation(1) Shares) Compensation (2)
- ---------------------------------- ------- ----------- ------ ---------------- ----------------- --------------------
Salvatore J. Zizza (3) 1997 $200,000 0 0 0 $ 1,288
Chairman of the Board 1996 $200,000 0 0 0 $ 1,272
1995 $200,000 0 0 0 $ 1,272
Dennis Sokol (4)(6) 1997 $296,800 0 0 0 $57,980
1996 $267,200 0 0 0 $29,790
1995 $250,000 0 0 0 $ 0
Kenneth Banhart (6) 1997 $172,763 0 0 0 $ 0
1996 $ 0 0 0 0 $ 0
1995 0 0 0 0 $ 0
Shannon Slusher (7) 1997 $125,000 0 0 0 $33,000(8)
1996 $ 80,000 0 0 0 $35,000(8)
1995 90,000 0 0 0 $35,000(8)
Vladmir Checklin (7) 1997 $150,000 0 0 0 $12,000(9)
1996 $ 0 0 0 0 $ 0
1995 $ 0 0 0 0 $ 0
Michael Cavanaugh (5)(6) 1997 $236,114 0 0 0 $ 0
1996 $236,725 0 0 0 $ 0
1995 $242,695 0 0 0 $ 0
Stuart Kaufman (5)(6) 1997 $ 0 0 0 0 $ 0
1996 $110,800 0 0 0 $ 0
1995 $199,952 0 0 0 $ 0
Stephanie Schmidt (5)(6) 1997 $ 0 0 0 0 $ 0
1996 $140,421 0 0 0 $ 0
1995 $150,000 0 0 0 $ 0
Mark Kugler (5)(6) 1997 $ 0 0 0 0 $ 0
1996 $205,785 0 0 0 $ 0
1995 $206,329 0 0 0 $ 0
Mel Levinson (5)(6) 1997 $ 0 0 0 0 $ 0
1996 $116,997 0 0 0 $ 0
1995 $200,924 0 0 0 $ 0
Asif Jamal (5)(6) 1997 $ 0 0 0 0 $ 0
1996 $ 84,818 0 0 0 $ 0
1995 $150,000 0 0 0 $ 0
Jeff Fine (5)(6) 1997 $ 0 0 0 0 $ 0
1996 $110,800 0 0 0 $ 0
1995 $200,924 0 0 0 $ 0
- ----------------------
(1) As to each individual named, the aggregate amount of personal benefits
not included in the Summary Compensation Table does not exceed the
lesser of $50,000 or 10% of the total annual salary and bonus reported
for the named executive officer.
(2) Represents premiums paid by the Company with respect to term life
insurance for the benefit of the named executive officer or the
Company.
(3) Until the Merger, Mr. Zizza was Chairman of the Board, President and
Chief Executive Officer of the Company and at present he is the
Executive Vice President and Treasurer. On August 22, 1994, the Company
and Mr. Zizza entered into an employment agreement. Mr. Zizza and the
Company amended the terms of Mr. Zizza's employment agreement effective
as of the time of Merger. In general, as amended, the employment
agreement provides for his employment through December 31, 2000 at an
annual salary
-36-
of $200,000 (subject to increase, in the discretion of the Board of
Directors, if the Company acquires one or more new businesses, to a
level commensurate with the compensation paid to the top executives of
comparable businesses). In addition, Mr. Zizza may be entitled to a
bonus, at the discretion of the Company.
(4) During 1995 these individuals were employed by American Medical
Clinics, Inc.
(5) During 1995 these individuals were employed by MedExec Inc.
(6) During 1996 and 1997 these individuals were employed by FMC as a result
of the reorganization among MedExec Inc., American Medical Clinics,
Inc. and FMC.
(7) These individuals were employed by American Medical Clinics, Inc.
(8) Represents a housing allowance of $30,000, $30,000 and $25,000 for
1995, 1996 and 1997 respectively. Also represented is a travel
allowance of $5,000, $5,000 and $8,000 for 1995, 1996 and 1997
respectively.
(9) Represents a housing allowance.
Dividends paid to shareholders of American Medical Clinics, Inc., MedExec Inc.
and FMC have not been included.
-37-
COMPENSATION OF DIRECTORS
Prior to the Merger, the Company's directors received no compensation
for serving on the Board of Directors other than the reimbursement of reasonable
expenses incurred in attending meetings. Since the consummation of the Merger,
executive directors have continued to receive no compensation; however, each
non- executive director now is entitled to receive annually shares of Common
Stock with a fair market value of $10,000 (pro-rated in 1997 to reflect the
portion of the year following the Merger); as of November 7, 1997, the non-
executive directors had not received any shares for 1997. In April 1996, the
Company granted options to purchase 15,000 shares of Common Stock at an exercise
price of $.50 per share to a former non-executive officer director and options
to purchase 10,000 shares of Common Stock at an exercise price of $.50 per share
to three former non- executive officer directors, two of whom were members of
the Compensation Committee.
INDEMNIFICATION OF OFFICERS AND DIRECTORS
The Certificate of Incorporation and By-laws of the Company contain
provisions permitted by the Delaware General Corporation Law (under which the
Company is organized), that, in essence, provide that directors and officers
shall be indemnified for all losses that may be incurred by them in connection
with any claim or legal action in which they may become involved by reason of
their service as a director or officer of the Company if they meet certain
specified conditions. In addition, the Certificate of Incorporation of the
Company contains provisions that limit the monetary liability of directors of
the Company for certain breaches of their fiduciary duty of care and provide for
the advancement by the Company to directors and officers of expenses incurred by
them in defending suits arising out of their service as such.
Insofar as indemnification for liabilities arising under the Securities
Act of 1933, as amended (the "Securities Act") may be permitted to directors,
officers or persons controlling the Company pursuant to the foregoing
provisions, the Company has been informed that in the opinion of the SEC such
indemnification is against public policy as expressed in the Act and is
therefore unenforceable.
OPTIONS
No options were granted during 1996 to the executive officers of the
Company named in the Summary Compensation Table or to other employees of the
Company. However, four former non-executive officer directors were granted stock
options in 1996. See "Compensation of Directors." In July 1997, the Board of
Directors established, subject to stockholder approval, the Lehigh Group, Inc.
Stock Option Plan (the "Stock Option Plan") and the Incentive Compensation Plan
(the "Incentive Compensation Plan"). In connection with the Reverse Split, the
Company is seeking shareholder approval of the Stock Option Plan and the
Incentive Compensation Plan which are described below.
No options were exercised by the executive officers of the Company
named in the Summary Compensation Table during the fiscal year ended December
31, 1996. The following table sets forth the number and dollar value of options
held by such persons on December 31, 1996, none of which were "in the money" at
December 31, 1996.
AGGREGATED OPTION EXERCISES IN
1996 AND YEAR-END OPTIONS
Number of Unexercised Options and Warrants at
Year-End
-----------------------------------------------
NAME Exercisable Unexercisable
---- ----------------- ------------------------
Salvatore Zizza 6,000,000(1) 12,000,000(1)
Robert Bruno 250,000(2)
-38-
(1) See note 3 of the Summary Compensation Table.
(2) See note 4 of the Summary Compensation Table.
THE STOCK OPTION PLAN
The purpose of the Stock Option Plan is to advance the Company's
interests by providing additional incentive to attract and retain in the employ
of the Company and its subsidiaries, qualified and competent persons to provide
management services, to encourage the sense of proprietorship and to stimulate
the active interest of such persons in the development and financial success of
the Company and its subsidiaries. The Stock Option Plan provides for the grant
of incentive stock options and nonqualified stock options within the meaning of
Section 422 of the Internal Revenue Code of 1986, as amended (the "Code"), as
well as stock appreciation rights ("Rights") with respect to stock options and
restricted stock ("Restricted Stock") awards.
The Stock Option Plan, which is administered by the Compensation
Committee of the Board of Directors (but can also be administered directly by
the Board of Directors), currently authorizes the issuance of a maximum of
500,000 shares of Common Stock (on a post Reverse Split basis), which may be
newly issued shares or previously issued shares held by any subsidiary of the
Company. If any award under the Stock Option Plan terminates, expires
unexercised, or is cancelled, the shares of Common Stock that would otherwise
have been issuable pursuant thereto will be available for issuance pursuant to
the grant of new awards.
The purchase price of each share of Common Stock purchasable under an
incentive option granted under the Stock Option Plan is to be determined by the
Compensation Committee at the time of grant, but is to not be less than 100% of
the fair market value of a share of Common Stock on the date the option is
granted; PROVIDED, HOWEVER, that with respect to an optionee who, at the time
such incentive option is granted, owns more than 10% of the total combined
voting power of all classes of stock of the Company or of any of its
subsidiaries, the purchase price per share is to be at least 110% of the fair
market value per share on the date of grant. The term of each option is to be
fixed by the Compensation Committee, but no option is to be exercisable more
than five years after the date such option is granted.
The aggregate fair market value, determined as of the date the
incentive option is granted, of shares of Common Stock for which incentive
options are exercisable for the first time to any optionee during any calendar
year under the Stock Option Plan (and/or any other stock options plans of the
Company or any of its subsidiaries) shall not exceed $100,000. The aggregate
number of shares of Common Stock subject to options granted under the Stock
Option Plan granted during any calendar year any one director is not to exceed
that number of shares as equals ten percent of the outstanding shares of the
Company for which options may be granted under the Stock Option Plan.
The Compensation Committee shall have the authority to grant Rights
with respect to all or some of the shares of Common Stock covered by any option,
which Rights may be granted together with or subsequent to the grant of the
option. Rights entitle the holder to cash equal to the difference between an
Offer Price Per Share (as defined in the Stock Option Plan) and the exercise
price of the related option if shares of Stock representing 20 percent or more
of the aggregate votes of the Stock voting together as a single class, provided,
however, that each share of Preferred Stock will have the number of votes
provided for such share pursuant to its Certificate of Designation is acquired
pursuant to a tender offer or exchange offer. If a Right is exercised, the
related Option is terminated, and if an option terminates or is exercised, the
corresponding Right terminates.
In addition, the Compensation Committee shall have the authority to
award Restricted Stock which entitles the recipient to acquire, at no cost or
for a purchase price determined by the Compensation Committee, shares of Common
Stock subject to such restrictions and conditions as the Compensation Committee
may determine at the time of grant. Conditions may be based on continuing
employment and/or achievement of pre-established performance goals and
objectives. A recipient of Restricted Stock shall have the rights of a
stockholder with respect to the voting of the Restricted Stock, subject to such
other conditions contained in the written instrument evidencing the Restricted
Stock. However, generally Restricted Stock may not be sold, assigned,
transferred, pledged or otherwise encumbered or disposed of, and, generally,
upon the termination of the recipient's employment with the Company, the Company
shall have the right, at the discretion of the Compensation Committee, to
repurchase such Restricted Stock at its purchase price. Nonetheless, once the
pre-established performance goals, objectives and other conditions have been
-39-
attained, such shares of Restricted Stock shall no longer be Restricted Stock
and shall be deemed "vested" and will be freely transferable.
The Board of Directors may amend, suspend, or terminate the Stock
Option Plan, except that no amendment may be adopted that would impair the
rights of any optionee without his consent. Further, no amendment may be adopted
which, without the approval of the stockholders of the Company, would (i)
materially increase the number of shares issuable under the Stock Option Plan,
except as provided in itself, (ii) materially increase the benefits accruing to
optionees under the Stock Option Plan, (iii) materially modify the eligibility
requirements for participation in the Stock Option Plan, (iv) decrease the
exercise price of an incentive option to less than 100% of the fair market value
per share of Common Stock on the date of grant or the exercise price of a
nonqualified option to less than 80% of the fair market value per share of
Common Stock on the date of grant, or (v) extend the term of any option beyond
that provided for in the Stock Option Plan.
The Compensation Committee may amend the terms of any option previously
granted, prospectively or retroactively, but no such amendment may impair the
rights of any optionee without his consent. The Compensation Committee may also
substitute new options for previously granted options, including options granted
under other plans applicable to the participant and previously granted options
having higher option prices, upon such terms as it may deem appropriate.
The number of shares of Common Stock available under the Stock Option
Plan and the terms of any option or other award granted thereunder are subject
to adjustment in the event of a merger, reorganization, consolidation,
recapitalization, stock dividend, or other change in corporate structure
affecting the shares of Common Stock, if the Compensation Committee determines
that such event equitably requires such an adjustment.
As of November 7, 1997, there were no options outstanding under the
Stock Option Plan and no Restricted Stock had been awarded.
INCENTIVE COMPENSATION PLAN
The purpose of the Incentive Compensation Plan is to advance the
Company's interests by providing additional incentives to those key employees of
the Company who contribute the most to the growth and profitability of the
Company and to encourage such key employees to continue as employees by making
their compensation competitive with compensation opportunities in competing
businesses and industries.
The Incentive Compensation Plan, which is administered by the
Compensation Committee of the Board of Directors (but can also be administered
directly by the Board of Directors), authorizes the Compensation Committee to
determine by March 15 of each year which key employees will be eligible in such
year for incentive compensation pursuant to the Incentive Compensation Plan (the
"Participants") and to establish targets for such fiscal year for the Company's
earnings per share. If the targets are achieved then each Participant will
receive (i) a cash bonus equal to 10% of his base salary for such year, (ii) an
amount of Common Stock (the "Stock Bonus") determined by dividing 30% of his
base salary by fifty percent (50%) of the average of the high and low closing
prices for the Common Stock during such year (or, if lower, 50% of the closing
sales price on the last trading day of such year), and (iii) a cash payment
sufficient to satisfy such participant's income tax liability with respect to
his Stock Bonus. There is no maximum number of shares of Common Stock which may
be awarded under the Incentive Compensation Plan
The Compensation Committee may amend the Incentive Compensation Plan,
except that no amendment may be adopted that would impair the rights of any
Participant with respect to the year in which such amendment has been adopted.
The Plan shall terminate on December 31, 2002 except for the delivery
of shares of Common Stock and/or cash due to Participants with respect to such
year.
If, prior to the end of the any Fiscal Year, a Participant's employment
terminates on account of (i) death, (ii) retirement, (iii) total and permanent
disability, or (iv) the Company's termination of the Participant without
-40-
Cause, the Participant will nonetheless remain eligible to receive amounts under
the Incentive Compensation Plan for such year if the Participant shall have been
an active, full-time employee for a period of at least two years preceding such
termination. In all other cases, the Participant will be ineligible.
No bonuses or stock have been awarded under the Incentive Compensation
Plan.
BOARD REPORT ON EXECUTIVE COMPENSATION
The Compensation Committee is responsible for developing the Company's
executive compensation policies, determining the compensation paid to the
Company's Chief Executive Officer and its other executive officers and
administering the Stock Option Plan and the Incentive Compensation Plan. The
Compensation Committee did not meet in 1996 since all executives are paid
pursuant to previously executed employment agreements and the report is the
report of the entire Board of Directors.
-41-
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
Until the meeting on July 9, 1997 at which the current Board of
Directors was elected, Anthony Amhurst and Charles Gargano were members of the
Compensation Committee and were directors. Currently, Mr. Cole and Dr. Levinson
are members of the Compensation Committee and are directors. There are no
compensation committee interlock relationships to be disclosed pursuant to Item
402 of Regulation S-K.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
FMC and Generale De Sante International, Plc ("GDS") are parties to a
Subscription Agreement, dated June 11, 1996 pursuant to which GDS paid
$5,000,000 in order to acquire a variety of ownership interests in FMC and its
subsidiaries, including (i) 10% of the outstanding shares of FMC's common stock
(the FMC Common Stock"), each share of which was automatically exchanged
pursuant to the Merger for 1,127.675 shares of Common Stock and 103.7461 shares
of Preferred Stock, and (ii) shares of FMC's 9% Series A Convertible Preferred
Stock (the "FMC Preferred Stock") convertible into 10% of the shares of FMC
Common Stock, which Shares of FMC Preferred Stock were converted following the
Merger. Consequently, when GDS converts its shares of FMC Preferred Stock, GDS
received shares of Lehigh Common Stock and Lehigh Preferred Stock. Together with
the shares issued for the FMC Common Stock, these shares would give GDS a total
of approximately 23% ownership interest and voting power of the Company. See
"Security Ownership of Certain Beneficial Owners of the Company."
For information regarding the employment arrangements and options of
Messrs. Zizza and Bruno, see notes 3 and 4 to the Summary Compensation Table and
note 3 to the table regarding Security Ownership of Certain Beneficial Owners of
the Company.
On January 1, 1996, FMC and Dr. Levinson, who is a director of the
Company, entered into an agreement for the period commencing January 1, 1996 and
terminating December 31, 1998 and providing for a payment of $100,000 (subject
to increase in accordance with the consumer price index) annually during the
period. Mr. Levinson's contract was not terminated as a result of the Merger. He
is employed as Vice Chairman of FMC and performs services that are customary to
that office.
FMC and Dennis A. Sokol, the Chairman of the Board, Chief Executive
Officer and Director of the Company and Chairman of the Board and Chief
Executive Officer of FMC, have an oral agreement whereby FMC has agreed to pay
Mr. Sokol an annual salary of $300,000 per year for his services as FMC's
Chairman of the Board and Chief Executive Officer. At the discretion of the
Compensation Committee of the Board of FMC, Mr. Sokol may be awarded an annual
bonus.
The Company and Elliot H. Cole, the Vice Chairman of the Board and
Director of the Company, have an oral agreement whereby the Company has agreed
to pay Mr. Cole a consulting fee of $60,000 per year for his services as the
Company's Vice Chairman of the Board.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS OF THE COMPANY
The following table indicates the number of shares of Common Stock and
Preferred Stock beneficially owned as of November 7, 1997 by (i) each person
(including any "group," as that term is used in Section 13(d)(3) of the Exchange
Act) known to the Company to be the beneficial owner of more than 5% of the
Common Stock or the Preferred Stock, (ii) each director and nominee for director
of the Company, (iii) each of the executive officers named in the Summary
Compensation Table set forth above and (iv) all directors and executive officers
of the Company as a group. Unless otherwise indicated, the address of each
person listed below is the Company's principal executive offices.
-42-
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS OF THE COMPANY
Common Stock(1)(8) Preferred Stock
-----------------------------------------------------------------------------------------------------
Amount and Nature of Amount and Nature of
Name of Beneficial Owner Beneficial Ownership(2) Percent of Class Beneficial Ownership(2) Percent of Class
- ----------------------------- ---------------------------- ------------------ --------------------------- --------------------
Generale De Sante 2,559,822 11.35% 235,504 22.70%
International PLC
4 Cornwall Terrace
London NW1 4QP
ENGLAND
SAJH Partners 2,121,157(3) 9.41% 195,146(3) 18.81%
Salvatore J. Zizza 8,735,630(4) 28.15% -- --
Robert A. Bruno 312,760(5) 1.38% -- --
Dennis A. Sokol 603,306(6) 2.68% 55,504(6) 5 .35%
Melvin E. Levinson 558,199 2.48% 51,354 4.95%
Elliot H. Cole 401,452 1.78% 36,934 3.56%
Richard Berman
All executive officers __ -- -- --
and directors as a group
(7 persons) 15,292,326(7) 57.23% 574,442(6) 55.37%
* Less than 1%.
(1) Does not include shares of Common Stock which are obtainable upon the
conversion of shares of Preferred Stock since the shares are not
convertible until such time as the Company's authorized and unissued
shares of Common Stock exceeds the aggregate number of shares of Common
Stock into which all of the authorized shares of Preferred Stock is
convertible, which will require either an amendment to the Company's
Certificate of Incorporation to increase the number of authorized
shares of Common Stock or a reverse stock split such as the Reverse
Split.
(2) Except as otherwise indicated, each of the persons listed above has
sole voting and investment power with respect to all shares shown in
the table as beneficially owned by such person.
(3) Dennis Sokol is the Managing Partner of SAJH Partners and has a 1%
partnership interest in the partnership and consequently could be
deemed under Rule 13d-3 of the Exchange Act to have beneficial
ownership of such shares. Mr. Sokol disclaims ownership of all such
shares other than as a result of his 1% partnership interest.
(4) Includes options to purchase 8,480,128 shares of Common Stock for $.875
per share, which options were received on July 9, 1997, when (i) Mr.
Zizza's options and warrants to purchase 12,000,000 shares of Common
Stock, half exercisable at $.75 per share and half exercisable at $1.00
per share, were converted into options to purchase three percent of the
total issued and outstanding stock of the Company on a fully diluted
basis immediately after the merger (after giving effect to the issuance
of Common Stock and the issuance and conversion of Preferred Stock
pursuant to the Merger Agreement) and (ii) Mr. Zizza's options and
warrants to purchase 6,000,000 shares of Common Stock at an exercise
price of $.50 per share were cancelled. See note 3 of the Summary
Compensation Table.
(5) Includes options to purchase 250,000 shares of Common Stock at $.50 per
share. See note 4 of the Summary Compensation Table.
-43-
(6) Excludes shares as indicated in note (3) above.
(7) Includes shares as indicated in notes (4) and (5) above. Excludes
shares as indicated in note (3) above.
(8) The Common Stock reported is before giving effect to the Reverse Split.
-44-
SELLING STOCKHOLDERS
The following table sets forth (i) the number of Shares to be offered
for resale by each Selling Stockholder and (ii) the number and percentage of
Shares to be held by each Selling Stockholder after completion of the offering.
Number of Common
Number of Number of Shares Shares/Percentage of Class to
Shares Beneficially Owned to be Sold in the be Owned After Completion
Name and Address(1)(2) Prior to the Offering(3) Offering Resale of the Offering
- ----------------------------------------- ------------------------------- ------------------- -------------------------------
Number Percent
------ -------
Generale de Sante 2,047,860 2,047,860 0 *
Dennis Sokol 482,644 482,644 0 *
Elliot Cole 321,165 321,165 0 *
Shannon Slusher 321,165 321,165 0 *
Myles Druckman 220,084 220,084 0 *
Elena Korchagina 99,235 97,235 0 *
Vladimir Checklin 160,583 160,583 0 *
James C. Gale/Judith S. Haselton 57,109 57,109 0 *
James C. Gale Trustee F/B/O Ariana J. Gale 27,816 27,816 0 *
Jack Weinstein 12,517 12,517 0 *
Robert Weinstein 4,868 4,868 0 *
Doug Kleinberg 3,477 3,477 0 *
Lionel G.H. Hest 35,465 35,465 0 *
Robert Sablowsky 18,776 18,776 0 *
Charles Greenberg 31,247 31,247 0 *
Global Asset Allocation Consultant Inc. 139,080 139,080 0 *
Gruntal & Co. 33,382 33,382 0 *
Mark Kugler 446,557 446,557 0 *
Melvin Levinson, M.D. 471,556 471,556 0 *
Stuart Kaufman 471,556 471,556 0 *
Jeff Fine 471,556 471,556 0 *
Michael Cavanaugh 407,765 407,765 0 *
Asif Jamal 162,883 162,883 0 *
Stephanie Schmidt 162,883 162,883 0 *
SAJH 1,595,021 1,595,021 0 *
Lindsay D. Kugler 221,980 221,980 0 *
Gregg Fine 110,965 110,965 0 *
Kevin Fine 110,965 110,965 0 *
Jamie Kaufman 110,965 110,965 0 *
Debbie Susskind 110,965 110,965 0 *
Mike Levinson 110,965 110,965 0 *
Jill Kaufman 110,965 110,965 0 *
Charles Pendola(4) 54,167 54,167 0 *
Joel Feiss, M.D.(5) 223,333 223,333 0 *
Michael Gironta 8,345 8,345 0 *
- ------------
* Less than 1%
(1) The persons named in the table, to the Company's knowledge, have sole
voting and investment power with respect to all shares shown as
beneficially owned by them, subject to community property laws where
applicable and the footnotes to this table. The calculation of Common
Shares beneficially owned was determined in accordance with Rule 13d-3
of the Exchange Act.
(2) Unless otherwise stated, the address for each Selling Stockholder is
c/o First Medical Corporation, 1055 Washington Boulevard, Stamford,
Connecticut 06901.
(3) Assumes all the shares of Preferred Stock owned by each Selling
Stockholder have been converted into shares of Common Stock.
(4) The address for the selling Stockholder is 18 Guild Ct., Plainview, New
York 11803
(5) The address for the Selling Stockholder is c/o West Broward
Gastroenterology, 201 Northwest 82nd Avenue, Suite 202, Plantation,
Florida 33324
-45-
DESCRIPTION OF SECURITIES
The following is a summary of certain provisions of the Company's
Certificate of Incorporation, the Certificate of Designation and rights accorded
to holders of Common Stock and Preferred Stock generally and as a matter of law,
and does not purport to be complete. It is qualified in its entirety by
reference to the Certificate of Incorporation, the Certificate of Designation,
the Company's By-Laws, and the Delaware General Corporation Law.
COMMON STOCK
GENERAL. As of November 7, 1997, there were 22,553,500 shares of Common
Stock outstanding. Under the Company's Delaware charter and applicable law, the
Board of Directors has broad authority and discretion to issue convertible
preferred stock, options and warrants, which, if issued in the future, may
impact the rights of the holders of the Common Stock. The Company has
100,000,000 shares of common stock authorized and 5,000,000 preferred shares
authorized.
DIVIDENDS. Holders of Common Stock may receive dividends if, as and
when dividends are declared on Common Stock by the Company's Board of Directors.
If the Board of Directors hereafter authorizes the issuance of preferred shares,
and such preferred shares carry any dividend preferences, holders of Common
Stock may have no right to receive dividends unless and until dividends have
been declared and paid. At the present time, there is no preferred stock
outstanding except for the Preferred Stock. The ability of the Company to
lawfully declare and pay dividends on Common Stock is also limited by certain
provisions of applicable state corporation law. It is not expected that
dividends will be declared on the Common Stock in the foreseeable future.
DISTRIBUTIONS IN LIQUIDATION. If the Company is liquidated, dissolved
and wound up for any reason, distribution of the Company's assets upon
liquidation would be made first to the holders of preferred shares, if any, and
then to the holders of Common Stock. If the Company's net assets upon
liquidation were insufficient to permit full payment to the holders of shares of
preferred stock, if any, then all of the assets of the Company would be
distributed pro rata to the holders of shares of preferred stock and no
distribution will be made to the holders of Common Stock. There are no shares of
preferred stock issued or outstanding at this time except for the Preferred
Stock. A consolidation or merger of the Company with or into any other company,
or the sale of all or substantially all of the Company's assets, is not deemed a
liquidation, distribution or winding up for this purpose.
VOTING RIGHTS. The holders of record of Common Stock and Preferred
Stock (collectively, the "Stock"), the Company's only classes or series of
voting stock currently outstanding, are entitled, as a result of the Reverse
Split, to one vote and 8-1/3 votes respectively for each share held, except that
the Certificate of Incorporation provides for cumulative voting in all elections
of directors. Abstentions and broker non-votes with respect to any proposal will
be counted only for purposes of determining whether a quorum is present for the
purpose of voting on that proposal and will not be voted for or against that
proposal. Such outstanding shares of the Stock present in person or by Proxy
representing one third of the votes to which all of the outstanding shares of
Stock are entitled to vote (provided, however, that each share of Preferred
Stock will have 8-1/3 votes) is required for a quorum.
PREFERRED STOCK
GENERAL. The Certificate of Incorporation authorizes the issuance of
5,000,000 shares of preferred stock, $.001 par value of which the Company has
issued 1,037,461 shares of Preferred Stock. The terms of the Preferred Stock are
included in the Certificate of Designation. The Preferred Stock possesses all
those rights and privileges as are afforded to capital stock by applicable law
in the absence of any express grant of rights or privileges in the Certificate
of Designation. The Preferred Stock does not have any preemptive rights. The
Preferred Stock is not listed on any national securities exchange. Set forth
below is a description of the rights and preferences of the Preferred Stock.
DIVIDEND RIGHTS. Each share of Preferred Stock is entitled to
dividends, pari passu with dividends declared and paid with respect to the
Common Stock, equal to, as a result of the Reverse Split, 81/3 times the amount
declared and paid with respect to each share of Common Stock.
VOTING RIGHTS. Each share of Preferred Stock is entitled, as a result
of the Reverse Split, to 81/3 votes, on any matter submitted to a vote of
stockholders, to be voted together with the Common Stock. The Preferred Stock
has no right to vote separately, as a class, except as provided by law.
-46-
CONVERSION RIGHTS. Each share of Preferred Stock is convertible, as a
result of the Reverse Split, at any time into 81/3 shares, of Common Stock,
subject to adjustment in certain circumstances. In order to exercise the
conversion privilege, the holder of a share of Preferred Stock shall surrender
the certificate representing such share at the office of the transfer agent for
the Common Stock and shall give written notice to the Company at said office
that such holder elects to convert the same, specifying the name or names and
denominations in which such holder wishes the certificate or certificates for
the Common Stock to be issued.
The number of shares of Common Stock issuable upon the conversion of
shares of Preferred Stock is subject to adjustment under certain circumstances,
including (a) the distribution of additional shares of Common Stock to all
holders of Common Stock; (b) the subdivision of shares of Common Stock; (c) a
combination of shares of Common Stock into a smaller number of shares of Common
Stock; (d) the issuance of any securities in a reclassification of the Common
Stock; and (e) the distribution to all holders of Common Stock of any shares of
the Company's capital stock (other than Common Stock) or evidence of its
indebtedness, assets (other than certain cash dividends or dividends payable in
Common Stock) or certain rights, options or warrants (and the subsequent
redemption or exchange thereof).
LIQUIDATION, DISSOLUTION OR WINDING UP. Upon any liquidation,
dissolution or winding up of the Company, no distribution will be permitted to
be made to holders of Common Stock unless, prior thereto, the holders of the
Preferred Stock shall have received $.01 per share, plus an amount equal to
unpaid dividends thereon, if any, including accrued dividends, whether or not
declared, to the date of such payment. With regard to rights to receive
dividends and distributions upon dissolution, the Preferred Stock shall rank
prior to the Common Stock and junior to any other preferred stock issued by the
Company, unless the terms of such other preferred stock provide otherwise.
TRANSFER AGENT AND REGISTRAR
The transfer agent, warrant agent and registrar for the Common Stock is
American Stock Transfer & Trust Company, New York, New York.
PLAN OF DISTRIBUTION
Neither the Company nor the Selling Stockholders have employed an
underwriter for the sale of Shares by the Selling Stockholders. The Company will
bear all expenses in connection with the preparation of this Prospectus. The
Selling Stockholders will bear all expenses associated with the sale of the
Shares.
The Shares may be offered for the account of the Selling Stockholders
from time to time on any stock exchange upon which shares of Common Stock are
traded, at fixed prices that may be changed or at negotiated prices. The Selling
Stockholders may effect such transactions by selling shares to or through
broker-dealers, and all such broker-dealers may receive compensation in the form
of discounts, concessions, or commissions from the Selling Stockholders and/or
the purchasers of Shares for whom such broker-dealers may act as agents or to
whom they sell as principals, or both (which compensation as to a particular
broker-dealer might be in excess of customary commissions).
Any broker-dealer acquiring Shares from the Selling Stockholders may
sell the shares either directly, in its normal market-making activities, through
or to other brokers on a principal or agency basis or to its customers. Any such
sales may be at prices then prevailing on the NYSE or at prices related to such
prevailing market prices or at negotiated prices to its customers or a
combination of such methods. The Selling Stockholders and any broker- dealers
that act in connection with the sale of the Shares hereunder might be deemed to
be "underwriters" within the meaning of Section 2(11) of the Securities Act; any
commissions received by them and any profit on the resale of shares as principal
might be deemed to be underwriting discounts and commissions under the
Securities Act. Any such commissions, as well as other expenses incurred by the
Selling Stockholders and applicable transfer taxes, are payable by the Selling
Stockholders.
-47-
EXPERTS
The financial statements and schedule of the Company included in this
Prospectus and the Registration Statement have been audited by BDO Seidman, LLP,
independent certified public accountants, to the extent and for the periods set
forth in their report appearing elsewhere herein and in the Registration
Statement, and are included in reliance upon such report given upon the
authority of said firm as experts in auditing and accounting.
The audited combined financial statements of MedExec Inc. &
Subsidiaries; SPI Managed Care Inc.; & SPI Managed Care of Hillsborough County,
Inc., as of December 31, 1995 and 1994, and for each of the years in the three
year period ended December 31, 1995, which are included in this Prospectus, have
been so included in reliance on the reports in the three year period ended
December 31, 1995 of KPMG Peat Marwick LLP, as independent certified public
accountants, appearing elsewhere herein, and upon the authority of such firm as
experts in auditing and accounting.
The audited consolidated financial statements of First Medical
Corporation, as of December 31, 1996, and for the year then ended, which is
included in this Prospectus, has been so included in reliance on the report in
the year ended December 31, 1996 of KPMG Peat Marwick LLP, as independent
certified public accountants, appearing elsewhere herein, and upon the authority
of such firm as experts in auditing and accounting.
LEGAL MATTERS
The validity of the shares of the Common Stock offered hereby will be
passed upon for the Company by Olshan Grundman Frome & Rosenzweig LLP, New York,
New York.
ADDITIONAL INFORMATION
The Company has filed with the SEC a Registration Statement on Form S-1
(together with all amendments and exhibits thereto, the "Registration
Statement") under the Securities Act covering the securities described herein.
This Prospectus does not contain all of the information set forth in the
Registration Statement, certain parts of which are omitted in accordance with
the rules and regulations of the SEC. Statements contained herein or
incorporated herein by reference concerning the provisions of documents are
summaries of such documents, and each statement is qualified in its entirety by
reference to the applicable document if filed with the SEC or attached as an
appendix hereto. For further information, reference is hereby made to the
Registration Statement and the exhibits filed therewith. The Registration
Statement and any amendments thereto, including exhibits filed as a part
thereof, are available for inspection and copying as set forth above.
The Company hereby undertakes to provide without charge to each person
to whom a copy of this Prospectus has been delivered, on the written or oral
request of any such person, a copy of any or all of the documents referred to
above which have been or may be incorporated in this Prospectus by reference,
other than exhibits to such documents. Requests for such copies should be
directed to Robert A. Bruno, The Lehigh Group, Inc., 1055 Washington Boulevard,
Stamford, CT 06901, (telephone (203) 327-0900).
-48-
INDEX TO FINANCIAL STATEMENTS
FIRST MEDICAL GROUP INC. ("FMG"):
Consolidated Balance Sheets - September 30, 1997
and December 31, 1996 (Unaudited)..................................
Consolidated Statements of Income for the Nine Months Ended
September 30, 1997 and 1996........................................
Consolidated Statements of Stockholders' Equity for the Nine Months
Ended September 30, 1997 and 1996..................................
Consolidated Statements of Cash Flows for the Nine Months Ended
September 30, 1997 and 1996........................................
Notes to Consolidated Financial Statements...........................
FIRST MEDICAL CORPORATION
Independent Auditors' Report.........................................
Consolidated Balance Sheet - December 31, 1996.......................
Consolidated Statement of Income for the Year Ended
December 31, 1996..................................................
Consolidated Statement of Stockholders' Equity for the Year
Ended December 31, 1996............................................
Consolidated Statement of Cash Flows for the Year Ended
December 31, 1996..................................................
Notes to Consolidated Financial Statements...........................
MEDEXEC, INC. AND SUBSIDIARIES; SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.:
Independent Auditors' Report.........................................
Combined Balance Sheets - December 31, 1995 and 1994................
Combined Statements of Operations for Each of The Years in The
Three-Year Period Ended December 31, 1995.........................
Combined Statements of Stockholders' Equity For Each of The
Years in The Three-Year Period Ended December 31, 1995............
Combined Statements of Cash Flows for Each of The Years
in The Three-Year Period Ended December 31, 1995..................
Notes to Combined Financial Statements...............................
BROWARD MANAGED CARE, INC.
Independent Auditors' Report.......................................
Balance Sheet - December 31, 1995..................................
Statement of Operations for the years Ended December 31, 1995......
Statement of Stockholders' Deficit for the year ended
December 31, 1995................................................
Statement of Cash Flows for the year ended Deecmber 31, 1995.......
Notes to Financial Statements......................................
SPI MANAGED CARE OF BROWARD, INC.
Independent Auditors' Report.......................................
Balance Sheets - December 31, 1995 and 1994........................
Statements of Operations for the years ended December 31, 1995
and 1994.........................................................
Statements of Stockholders' Equity (Deficit) for the years
ended December 31, 1995 and 1994.................................
Statements of Cash Flows for the years ended December 31, 1995
and 1994.........................................................
Notes to Financial Statements......................................
THE LEHIGH GROUP INC. ("LEHIGH") AND SUBSIDIARIES:
Report of Independent Certified Public Accountants...................
Consolidated Balance Sheets as of 12/31/96 and 12/31/95..............
Consolidated Statements of Operations for the Years Ended
12/31/96, 12/31/95, and 12/31/94...................................
Consolidated Statements of Changes in Shareholders' Equity
(Deficit) for the Years Ended
12/31/96, 12/31/95, and 12/31/94...................................
Consolidated Statements of Cash Flows for the Years Ended
12/31/96, 12/31/95, and 12/31/94...................................
Notes to Consolidated Financial Statements...........................
Schedule of Valuation and Qualifying Accounts for the
Years Ended 12/31/96, 12/31/95, and 12/31/94.......................
Consolidated Statements of Operations for the Six Months
Ended 6/30/97......................................................
Consolidated Balance Sheets for the Six Months Ended 6/30/97.........
Consolidated Statement of Changes in Shareholder's Equity
(Deficit) for the Six Months Ended 6/30/97.........................
Consolidated Statements of Cash Flowsfor the Six Months
Ended 6/30/97......................................................
Notes to Consolidated Financial Statements...........................
UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS
Introduction.........................................................
Pro Forma Combined Balance Sheet as of June 30, 1997.................
Pro Forma Combined Statement of Operations for First Medical
Corporation, and The Lehigh Group Inc.
for the year ended December 31, 1996...............................
Pro Forma Combined Statement of Operations for the Six Months
Ended June 30, 1997... ............................................
F-1
FIRST MEDICAL GROUP, INC.
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(in thousands)
September 30, December 31,
ASSETS 1997 1996
------ ------------- ------------
Current assets:
Cash and cash equivalents $ 2,827 $ 63
Humana IBNR receivable and claims reserve fund 7,876 7,308
Other receivable, net of allowance for doubtful accounts 6,906 537
of $686 and $50
Due from related parties 975 462
Inventories 1,846 --
Prepaid expenses and other current assets 258 179
-------- --------
Total current assets 20,688 8,549
Property and equipment, net 656 400
Intangible assets, net 7,275 2,864
Other assets 718 638
-------- --------
$ 29,337 $ 12,452
======== ========
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 3,739 $ 1,699
Accrued expenses 2,349 338
Accrued medical claims, including incurred but not reported 6,950 6,071
Corporate deposits 635 806
Loans payable to Humana 168 98
Loans payable to banks 3,830 750
Obligations to certain shareholders 506 422
Deferred income taxes, net 113 300
Income taxes payable 275 113
-------- --------
Total current liabilities 18,564 10,596
Loans payable to Humana, net of current maturities 412 277
Loans payable to banks, net of current maturities 4,227 --
Obligations to certain shareholders, net of current maturities 254 746
-------- --------
Total liabilities 23,458 11,620
Shareholders' Equity:
Capital stock, par value $.001;authorized shares 100,000,000 23 0
shares issued 9,397,292 and 9,021,400 in
1997 and 1996, respectively
Additional paid in capital 7,801 380
(Accumulated deficit) Retained Earnings (1,945) 452
-------- --------
Total shareholders' equity 5,879 832
-------- --------
Commitments and contingencies
-------- --------
TOTAL $ 29,337 $ 12,452
======== ========
See accompanying notes to consolidated financial statements.
F-2
FIRST MEDICAL GROUP, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
(in thousands, except per share data)
NINE MONTHS ENDED
SEPTEMBER 30,
------------------------
1997 1996
----------- ------------
Revenue:
Capitated revenue - Humana $ 39,768 $ 33,694
Fee for service 6,727 5,176
Other revenue 5,514 665
----------- ------------
Total revenue 52,009 39,535
Medical expenses 43,843 32,335
Cost of sales 2,643 -
----------- ------------
Gross profit 5,523 7,200
----------- ------------
Operating Expenses:
Salaries and related benefits 2,540 2,625
General and administrative 4,355 2,999
Depreciation and amortization 610 404
----------- ------------
Total operating expenses 7,504 6,028
(Loss) Income before interest, taxes and other (1,981) 1,172
Other expense:
Interest expense, net (288) (37)
----------- ------------
(288) (37)
----------- ------------
(Loss) Income before taxes (2,269) 1,135
Provision for income taxes - 454
=========== ============
Net (loss) income $ (2,269) $ 681
=========== ============
(Loss) Earnings per share $ (0.25) $ 0.08
=========== ===========
Weighted average number of common shares
outstanding 9,136 9,021
=========== ===========
See accompanying notes to consolidated financial statements.
F-3
FIRST MEDICAL GROUP, INC.
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
(Unaudited)
(in thousands)
Additional Retained Total
COMMON Paid-in Earnings Stockholders'
STOCK capital (Deficit) Equity
---------- ------------- ------------- ---------------
Balance January 1, 1997 $ 0 $ 380 $ 324 $ 703
Issuance of stock to FMC shareholders 23 2,256 -- 2,279
Capital contribution to FMG -- 5,000 -- 5,000
Capital contribution to AMCD -- 165 -- 165
Net loss for nine months ended 9/30/97 -- -- (2,269) (2,269)
------- ------- ------- -------
Balance September 30, 1997 $ 23 $ 7,801 $(1,945) $ 5,879
======= ======= ======= =======
See accompanying notes to consolidated financial statements.
F-4
FIRST MEDICAL GROUP, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1997 AND 1996
(Unaudited)
(in thousands)
1997 1996
------------ ------------
Cash flow from operating activities:
Net income $(2,269) $ 681
Adjustments to reconcile net income to net cash used in
operating activities:
Depreciation and amortization 610 404
Minority interest in net loss of consolidated subsidiaries (218) (175)
(Increase) decrease in assets, net of acquisitions:
Humana IBNR receivable and claims reserve fund (568) 570
Other receivables (1,473) (982)
Due from related parties, net (648) (826)
Inventories (201) --
Prepaid expenses and other current assets 12 27
Other assets (1,512) (152)
Increase (decrease) in assets, net of acquisitions:
Accounts payable and other accrued expenses 212 385
Accrued medical claims, including IBNR 879 (578)
Corporate deposits (172) (64)
Taxes payable (25) --
------- -------
Net cash used in operating activities (5,370) (710)
------- -------
Cash flows used in investing activities:
Capital expenditures (304) (198)
Organizational costs -- (287)
Acquisition of additional ownership interests in BMC, SPI -- 121
Broward, and Midwest, net of cash acquired
Proceeds from sale of investment -- 300
Acquisition of Lehigh, net of cash acquired 463 --
------- -------
Net cash used in investing activities 159 (64)
------- -------
Cash flow provided from financing activities:
Proceeds from loan payable Humana 254 375
Proceeds from loans payable to banks 8,689 200
Repayment of loan payable Humana (49) --
Repayments of loans payable to banks (5,200) (40)
Proceeds from payable to stockholders 132 200
Payment of obligations to stockholders (362) (266)
Contribution to capital of FMG 4,512 --
Contribution to capital of AMCD -- 152
------- -------
Net cash provided by financing activities 7,975 621
------- -------
Increase (Decrease) in cash and cash equivalents 2,764 (153)
Cash and cash equivalents, beginning of the year 63 199
------- -------
Cash and cash equivalents, end of period $ 2,827 $ 46
======= =======
Supplemented disclosure of Non cash flow:
1) The issuance of FMG stock to FMC shareholders, net $ 2,279
2) Capital contributions by GDSI in FMG in lieu of a payable 488
3) Capital contributions by GDSI in AMCD in lieu of a payable 165
See accompanying notes to consolidated financial statements.
F-5
First Medical Group, Inc.
Notes to Financial Statements
September 30, 1997
1. BASIS OF PRESENTATION
The financial statements presented reflect First Medical Corporation's
acquisition of Lehigh since the acquisition date of July 9, 1997. Although
legally the Lehigh Group acquired First Medical Corporation, for accounting
purposes First Medical Corporation is considered the accounting acquirer (i.e.,
the reverse acquisition). Therefore, the operating results of Lehigh are
included in the statement of operation since the acquisition date (July 9, 1997)
and the September 30, 1997 balance sheet reflects the effect of the acquisition
of Lehigh.
The financial information for the nine months ended September 30, 1997
and 1996 is unaudited. However, the information reflects all adjustments
(consisting solely of normal recurring adjustments) which are, in the opinion of
management, necessary for the fair statement of results for the interim periods.
Certain information and footnote disclosures normally included in
financial statements prepared in accordance with generally accepted accounting
principles have been condensed or omitted. These consolidated financial
statements should be read in conjunction with the consolidated financial
statements and related notes included in the Company's December 31, 1996 Report
on Form 10-K.
The results of operations for the nine month period ended September 30,
1997 are not necessarily indicative of the results to be expected for the full
year.
Loss per common share is calculated by dividing net loss by the
weighted average number of common shares and share equivalents outstanding
during each period. For the periods presented, there were no common stock
equivalents included in the calculation, since they would be anti-dilutive.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(a) CASH AND CASH EQUIVALENTS
Cash equivalents consist of demand deposits. For purposes of the
consolidated statement of cash flows, the Company considers all highly
liquid debt instruments with original maturities of three months or
less to be a cash equivalent.
(b) HUMANA IBNR RECEIVABLE AND CLAIMS RESERVE FUNDS
Humana withholds certain amounts each month from the centers' Part A,
Part B, and supplemental funding in order to cover claims incurred but
not reported or paid. The amount is used by Humana to pay the centers'
Part A, Part B and supplemental costs. The amounts withheld by Humana
to cover incurred but not reported or paid claims varies by center
based on the history of the respective center and is determined solely
by Humana.
Humana also withholds a certain amount each month from the centers'
Part A capitation funding. This amount represents a "catastrophic
reserve fund" to be utilized for the payment of a center's Part A
costs in the event a center ceases operations and the incurred but not
reported reserves are not adequate to reimburse providers for Part A
services rendered. This amount is calculated monthly by Humana.
The withholdings are used to pay the centers' medical claims, which
Humana pays on the centers' behalf. The remaining amount after claims
have been paid is remitted to the company.
(c) PROPERTY AND EQUIPMENT
Property and equipment are stated at cost. Depreciation on property
and equipment is calculated on the straight-line method over the
estimated useful lives. (Medical and office equipment - 5 years and
Furniture and fixtures - 7 years)
(d) INTANGIBLE ASSETS
Goodwill, which represents the excess of purchase price over fair
value of net assets acquired, is amortized on a straight-line basis
over the expected periods to be benefited, 15 years. The Company
assesses the recoverability of this intangible asset by determining
whether the amortization of the goodwill balance over its remaining
life can be recovered through undiscounted future operating cash flows
of the acquired operation. The amount of goodwill impairment, if any,
is measured based on projected discounted future operating cash flows
using a discount rate reflecting the Company's average cost of funds.
F-6
The assessment of the recoverability of goodwill will be impacted if
estimated future operating cash flows are not achieved.
The Company entered into a non-compete agreement with a former
employee and shareholder. This non-compete agreement is being
amortized on a straight-line basis over the life of the agreement
which is two years.
The Company entered into three employment/non-compete agreements with
three shareholders. The agreements consist of guaranteed payments
regardless if any services are rendered. These agreements are being
amortized on a straight line basis over 5 years which is the life of
the agreement (3 years) plus the subsequent non-compete period (2
years).
Deferred organization costs consist principally of legal, consulting
and investment banking fees which were incurred strictly in connection
with the incorporation of FMC and proposed merger with Lehigh. The
costs related to the FMC transaction are being amortized over five
years. The costs related to the Lehigh merger will begin amortizing
when the merger is complete.
(e) IMPAIRMENT OF LONG-LIVED ASSETS
The Company adopted the provisions of SFAS No. 121, Accounting for the
Impairment of Long-Lived Assets and for Long-Lived Assets to Be
Disposed Of, on January 1, 1996. This Statement required that
long-lived assets and certain identifiable intangibles be reviewed for
impairment whenever events change in circumstances indicate that the
carrying amount of an asset may not be recoverable. Recoverability of
assets to be held and used in measured by a comparison of the carrying
amount of an asset of future net cash flows expected to be generated
by the asset. If such assets are considered to be impaired, the
impairment to be recognized is measured by the amount by which the
carrying amount of the assets exceed the fair value of the assets.
Assets to be disposed of are reported at the lower of the carrying
amount or fair values less costs to sell. The Company has no impaired
assets at September 30, 1997.
(f) INCOME TAXES
Income taxes are accounted for under the asset and liability method.
Deferred tax assets and liabilities are recognized for the future tax
consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities and
their respective tax bases and operating loss and tax credit
carryforwards. Deferred tax assets are measured using enacted tax
rates expected to apply to taxable income in the years in which those
temporary differences are expected to be recovered or settled. The
effect on deferred tax assets and liabilities of a change in tax rates
is recognized in income in the period that includes the enactment due.
(g) REVENUE AND MEDICAL COST RECOGNITION
Revenue from Humana for primary care, Part A, Part B and supplemental
funds is recognized monthly on the basis of the number of Humana
members assigned to the primary care centers and the contractually
agreed-upon rates. The primary care centers receive monthly payments
from Humana after all expenses paid by Humana on behalf of the
centers, estimated claims incurred but not reported and claims reserve
fund balances have been determined. In addition to Humana payments,
the primary care centers receive copayments from commercial members
from each office visit, depending upon the specific plan and options
selected and receive payments from non-Humana members on a
fee-for-services basis.
Medical services are recorded as expenses in the period in which they
are incurred. Accrued medical claims are reflected in the consolidated
balance sheet and are based upon costs incurred for services rendered
prior to and up to September 30, 1997. Included are services
F-7
incurred but not reported as of September 30, 1997, based upon actual
costs reported subsequent to September 30, 1997 and a reasonable
estimate of additional costs.
AMCMC and AMCD revenues are derived from medical services rendered to
patients and annual membership fees charged to individuals, families
and corporate members. Membership fees are non-refundable and are
recognized as revenue over the term of the membership. Corporate
members are also required to make advance deposits based upon plan
type, number of employees and dependents. The advance deposits are
initially recorded as deferred income and then recognized as revenue
when service is provided. As the advance deposits are utilized,
additional advance deposits are required to be made by corporate
members.
FMC-HS will recognize revenue under the management consulting service
agreements on a fee-for-service basis as services are rendered by
FMC-HS personnel.
Fee-for-service revenue is reported at the estimated net realizable
amounts from patients and third-party payors as services are rendered.
(h) USE OF ESTIMATES
Management of the Company has made a number of estimates and
assumptions relating to the reporting of assets and liabilities and
the disclosure of contingent assets and liabilities to prepare these
consolidated financial statements in conformity with generally
accepted accounting principles. Actual results could differ from those
estimates.
(i) FAIR VALUE OF FINANCIAL INSTRUMENTS
The carrying amount of financial instruments including cash and cash
equivalents, Humana IBNR receivable claims reserve funds, other
receivables, prepaid expenses and other current assets, accounts
payable and other accrued expenses, accrued medical claims, loan
payable to Humana, loans payable to bank and obligations to certain
stockholders approximate fair value at September 30, 1997 because of
the short term maturity of these instruments.
(j) FOREIGN CURRENCY
The financial statements of the Company's foreign subsidiaries are
remeasured into the US dollar functional currency for consolidation
and reporting purposes. Current rates of exchange are used to
remeasure assets and liabilities and revenue and expense are
remeasured at average monthly exchange rates prevailing during the
year.
(k) STOP-LOSS FUNDING
The primary care centers are charged a stop-loss funding fee by Humana
for the purpose of limiting a center's exposure to Part A costs and
certain Part B costs associated with a member's health services.
For the nine months ended September 30, 1997, the stop-loss threshold
for both Part A and Part B costs for Medicare members was $40,000 per
member per calendar year for both SPI and SPI Hillsborough. For
commercial members, the stop-loss threshold for both Part A and Part B
costs was $20,000 and $15,000 for SPI Hillsborough, respectively.
Since the SPI and SPI Hillsborough centers are not responsible for
claims in excess of the threshold, income and the corresponding
expense, both equal to the stop-loss funding are recognized by SPI and
SPI Hillsborough. These amounts are included in revenue and medical
expenses, respectively, in the accompanying consolidated statement of
income.
F-8
For Midwest, the stop-loss thresholds for Part A and for Part B costs
for Medicare members were $45,000 and $15,000, respectively, per
member per calendar year and the stop-loss thresholds for Part A and
for Part B commercial members were $60,000 and $15,000 respectively,
per member per calendar year.
(l) MATERNITY FUNDING
The primary care centers are charged a maternity funding fee on
commercial membership for the purpose of limiting the center's
exposure to Part A and Part B costs associated with a commercial
member's pregnancy or related illness. Since the SPI and SPI
Hillsborough centers are not responsible for claims in excess of the
amount contributed to the maternity fund, income and expenses both
equal to the maternity fund are recognized by SPI Hillsborough and are
included in revenue and medical expenses, respectively in the
accompanying consolidated statement of operations.
3. INVESTMENT IN LEHIGH
In February, 1997, the Company elected to convert its $300,000 convertible
debenture into 937,500 shares of Lehigh. In addition, the Company purchased
1,920,000 shares in Lehigh for $539,000. As a result of these purchases of
stock, the Company owns 25.4% of Lehigh.
4. SUBSEQUENT EVENTS
On July 9, 1997 at a Special Meeting (the "Special Meeting") of stockholders of
the Lehigh Group, Inc. ("Lehigh"), the stockholders of Lehigh approved the
merger (the "Merger") pursuant to the terms of the Agreement and Plan of Merger
dated as of October 29, 1996 (the "Merger Agreement") among Lehigh, First
Medical Corporation ("FMC") and Lehigh Management Corp., a wholly-owned
subsidiary of Lehigh ("Merger Sub"). On the same day, Merger Sub was merged with
and into FMC and each outstanding share of common stock of FMC the "FMC Common
Stock"), was exchanged for (i) 1,127.675 shares of Lehigh's Common Stock, par
value $.001 per share ("Lehigh Common Stock") and (ii) 103.7461 shares of
Lehigh's Series A Convertible Preferred Stock, par value $.001 per share (the
"Lehigh Preferred Stock"), each of which is convertible into 250 shares of
Lehigh Common Stock. Prior to the Merger, FMC held apporximately 25.4% of the
outstanding shares of Lehigh Common Stock which were acquired through two series
of transactions.
There were outstanding 10,000 shares of FMC Common Stock immediately prior to
the Merger. These share were exchanged for a total of (i) 11,276,750 shares of
Lehigh Common Stock and (ii) 1,037,461 shares of Lehigh Preferred Stock. As of
July 9, 1997 all preferred stock was converted to common stock
On November 12, 1997 the shareholders authorized a 1-for-30 reverse stock split
of the common stock effective November 12, 1997. All calculations pertaining to
the earnings per share have been retroactively adjusted to give effect to the
reverse stock split.
FMC and Generale De Sante International, plc ("GDS") are parties to a
Subscription Agreement, dated June 11, 1996, pursuant to which GDS paid
approximately $4,500,000 in order to acquire a variety of ownership interests in
FMC and its subsidiaries, including 10% of the shares of FMC Common Stock (which
were automatically exchanged pursuant to the Merger for shares of Lehigh Common
Stock and Lehigh Preferred Stock) and shares of FMC's 9% Series A
F-9
Convertible Preferred Stock (the "FMC Preferred Stock") convertible into 10% of
the shares of FMC Common Stock, which shares of FMC Preferred Stock remained
outstanding and convertible following the Merger.
F-10
Independent Auditors' Report
The Board of Directors
First Medical Corporation:
We have audited the accompanying consolidated balance sheet of First Medical
Corporation as of December 31, 1996, and the related consolidated statements of
income, stockholders' equity and cash flows for the year then ended. These
consolidated financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these consolidated
financial statements based on our audit.
We conducted our audit in accordance with generally accepted auditing standards.
Those standards require that we plan and perform the audit to obtain reasonable
assurance about whether the consolidated financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the consolidated financial statements.
An audit also includes assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall consolidated
financial statement presentation. We believe that our audit provides a
reasonable basis for our opinion.
In our opinion, such consolidated financial statements referred to above present
fairly, in all material respects, the consolidated financial position of First
Medical Corporation as of December 31, 1996, and the results of their operations
and their cash flows for the year then ended, in conformity with generally
accepted accounting principles.
/S/ KPMG PEAT MARWICK LLP
Miami, Florida
March 25, 1997, except as to note 2(M)
which is as of November 12, 1997
F-11
FIRST MEDICAL CORPORATION
CONSOLIDATED BALANCE SHEET
December 31, 1996
ASSETS
Current assets:
Cash and cash equivalents $63,014
Humana IBNR receivable and claims reserve funds (note 10) 7,308,482
Other receivables, net of $50,000 reserve for uncollectible accounts 536,506
Due from related parties, net (note 7) 462,329
Prepaid expenses and other current assets (note 1(d)) 179,125
------------
Total current assets 8,549,456
Property and equipment, net (note 3) 399,841
Intangible assets, net (note 4) 2,735,848
Minority interest 338,077
Other assets (note 1(d)) 300,000
------------
$12,323,222
=============
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable and other accrued expenses $2,037,447
Accrued medical claims, including amounts incurred but not reported 6,070,506
Corporate deposits 806,476
Loans payable to Humana (note 5) 97,628
Loans payable to banks (note 6) 750,000
Obligations to certain stockholders (note 7) 421,600
Deferred income taxes, net (note 8) 112,500
Income taxes payable (note 8) 300,000
------------
Total current liabilities 10,596,157
Loans payable to Humana, net of current maturities (note 5) 277,372
Obligations to certain stockholders, net of current maturities (note 7) 746,196
-----------
Total liabilities 11,619,725
-----------
Stockholders' equity:
Capital stock 15,000 shares authorized; 10,000 shares issued and outstanding at 100
par value, $.01 per share
Additional paid-in capital 379,685
Retained earnings 323,712
-----------
Total stockholders' equity 703,497
-----------
Commitments and contingencies (note 12)
$12,323,222
===========
See accompanying notes to consolidated financial statements.
F-12
FIRST MEDICAL CORPORATION
CONSOLIDATED STATEMENT OF INCOME
Year ended December 31, 1996
Revenues:
Capitated revenue - Humana (note 10) $ 45,069,743
Fee for service 7,075,458
Other revenue 869,124
----------
Total revenue 53,014,325
-----------
Medical expenses 43,526,181
-----------
Gross profit 9,488,144
Operating expenses:
Salaries and related benefits (note 7) 3,502,860
General and administrative 4,172,568
Depreciation and amortization 530,490
Minority interest in net loss of consolidated subsidiaries (338,077)
Preopening and development costs related to international clinics 828,568
-----------
Total operating expenses 8,696,409
Income before interest, taxes, and other 791,735
-----------
Other expense:
Interest expense, net (55,523)
Other expense (55,523)
-------
Income before taxes 736,212
Provision for income taxes (note 8) 412,500
-----------
Net income $ 323,712
===========
Supplemental Earnings per share after giving effect to
the merger and the 1-for-30 reverse stock split
with Lehigh Group, Inc. on July 9, 1997 (see note 2(M)) $ .04
==========
See accompanying notes to consolidated financial statements
F-13
FIRST MEDICAL CORPORATION
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
Year ended December 31, 1996
Additional Total
Capital paid- Retained stockholders'
Stock in capital earnings equity
----- ---------- -------- ------
Balance, December 31, 1995 $1,500 $1,200 $224,595 $227,295
FMC Corporate transaction (1,400) 225,995 (224,595) --
Capital contribution to AMCD -- 152,490 -- 152,490
Net income -- -- 323,712 323,712
------ -------- -------- --------
Balance, December 31, 1996 $ 100 $379,685 $323,712 $703,497
====== ======= ======= =======
See accompanying notes to consolidated financial statements.
F-14
FIRST MEDICAL CORPORATION
CONSOLIDATED STATEMENT OF CASH FLOWS
For the year ended December 31, 1996
Cash flows from operating activities:
Net income $323,712
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization 530,490
Gain on equity investments (78,259)
Minority interest in net loss of consolidated subsidiaries (338,077)
Change in assets and liabilities, net of acquisitions :
Increase in Humana IBNR receivable and claims reserve funds (2,343,563)
Increase in other receivables (536,506)
Increase in due from related parties, net (457,447)
Increase in prepaid expenses and other current assets (94,438)
Increase in other assets (300,000)
Increase in accounts payable and other accrued expenses 450,634
Increase in accrued medical claims, including amounts incurred but not reported 1,858,086
Increase in corporate deposits 56,201
Increase in income taxes payable 278,272
Increase in deferred income taxes liability, net 83,027
--------
Net cash used in operating activities (567,868)
-----------
Cash flows used in investing activities:
Capital expenditures (119,328)
Organizational costs (477,790)
Acquisition of additional ownership interests in BMC, SPI Broward, and Midwest, net (151,249)
of cash acquired
Proceeds from sale of investment 300,000
---------
Net cash used in investing activities (448,367)
----------
Cash flows provided by financing activities:
Proceeds from loan payable to Humana 325,000
Proceeds from loans payable to banks 650,000
Repayment of loans payable to banks (250,000)
Proceeds from payable to stockholders 374,596
Payment of obligation to stockholders (371,600)
Contribution to capital of AMCD 152,490
---------
Net cash provided by financing activities 880,486
---------
Decrease in cash and cash equivalents (135,749)
Cash and cash equivalents, beginning of year 198,763
---------
Cash and cash equivalents, end of year $ 63,014
========
Supplemental disclosure cash flow information: Cash paid during the year for:
Interest $ 48,748
========
Income taxes $ 33,291
========
F-15
FIRST MEDICAL CORPORATION
CONSOLIDATED STATEMENT OF CASH FLOWS (CONTINUED)
Supplemental disclosure of noncash flow:
(1) As described in note (1), AMCMC purchased certain assets and assumed
certain liabilities in the amount of $1,020,275 which is included in
goodwill at December 31, 1996 (note 4).
(2) The Company entered into a noncompete agreement with a shareholder and
former employee in the amount of $200,000.
(3) Effective January 1, 1996, the Company acquired a controlling interest in
two of its equity investments (see note 1(a)). The fair value of the assets
acquired and liabilities assumed were:
Assets Liabilities Net Assets
------ ----------- ----------
SPI Broward $ 117,085 55,558 61,527
Broward $3,082,464 3,242,579 (160,155)
(4) The Company entered into employment/non-compete agreements with three
executives in the amount of $964,800.
See accompanying notes to consolidated financial statements.
F-16
FIRST MEDICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1996
(1) ORGANIZATION AND OPERATION
First Medical Corporation ("FMC" or the "Company") is an international provider
of management, consulting, and financial services to physicians, hospitals and
other health care delivery organizations and facilities. FMC's operations are
conducted through three divisions: (a) a physician practice management division
which provides physician management services including the operation of clinical
facilities and management services to medical groups, (b) an international
division which manages medical centers in Eastern Europe and the Commonwealth of
Independent States (the former Soviet Union) ("CIS"), and (c) a recently formed
hospital services division which will provide a variety of administrative and
clinical services to proprietary acute care hospitals and other health care
providers.
The consolidated financial statements include the accounts of FMC and its
majority owned subsidiaries: MedExec, Inc. and subsidiaries ("MedExec");
American Medical Clinics Management Company, Inc. ("AMCMC"); American Medical
Clinics Development Corporation, Limited ("AMCD") and FMC Healthcare Services,
Inc. ("FMC-HS"). All significant intercompany balances and transactions have
been eliminated in consolidation.
MedExec, Inc. ("MedExec") was incorporated on March 14, 1991.
On January 1, 1996 MedExec and American Medical Clinics, Inc. (AMC) entered into
a transaction which consisted of the following:
* AMC and MedExec incorporated FMC;
* All of the outstanding shares of MedExec and AMC were converted into shares
of FMC;
* The shareholders of MedExec and AMC received 48% and 52% of the shares of
FMC, respectively;
* 100% of the AMC shares were distributed to the shareholders of FMC (former
shareholders of MedExec received 48% of the distributed shares of AMC);
* In connection with the above transaction, FMC entered into separate
employment contracts with three executives of MedExec whereby the
respective executives are guaranteed payments regardless if any services
are rendered. The agreements are for a three year period and when the
contracts expire they include an additional two year covenant not to
compete. The employment/non-compete agreements have been classified as
intangible assets in the financial statements and are being authorized over
five years. (See Note 4).
The above transaction was accounted for under the purchase method of accounting
with MedExec being deemed the accounting acquirer despite the fact that AMC
received 52% of the shares of FMC. This result was reached due to among other
factors the fact that immediately after this transaction, the FMC Board of
Directors was comprised of four former shareholders of MedExec and three former
shareholders of AMC and the fact that MedExec constituted the larger share of
operations. Because of the short term monetary nature of AMC's assets and
liabilities, historical book values constituted fair value on the transaction
date resulting in no purchase price adjustments under Accounting Principles
Board No. 16.
F-17
On January 2, 1996, AMCMC, a newly formed subsidiary of FMC, acquired from AMC a
membership list (contracts to provide medical services to customers) and assumed
certain liabilities of AMC. The transaction was accounted for under the purchase
method of accounting because, in essence, the purchase of the membership list
represented the acquisition. AMCMC acquired the income stream of an operating
enterprise. Goodwill was recorded in the amount of $1,020,275 related to this
transaction.
AMCMC, a wholly owned subsidiary of the Company, has entered into a management
services agreement with the AMC clinics located in the CIS, whereby the AMC
clinics provide medical services to AMCMC customers (see note 7). AMCMC collects
all of the revenues directly from its members, which it is legally entitled to
collect. AMCMC also pays all of AMC's expenses, including but not limited to the
salaries of the physicians, which it is legally obligated to pay.
On January 20, 1996, the Company entered into an agreement with Generale de
Sante International, plc ("GDS") to form AMCD, an Irish company. AMCD was
established to develop and operate medical clinics throughout the world with the
exception of within the CIS. The Company and GDS's shareholderings in AMCD
Common Stock, as revised, are 51% and 49%, respectively. The authorized share
capital of AMCD is comprised of 1,000 shares of Common Stock, $1.00 par value.
As consideration for the shares, the Company agreed to contribute certain assets
at historical cost in the amount of $300,001. GDS agreed to contribute $299,999
to AMCD and provide a credit facility of up to $1.2 million to be used for the
development of new clinics. These contributions resulted in total capital of
AMCD of $600,000. Included in the statement of cash flows for the year ended
December 31, 1996 is $152,490 for GDS's capital contribution of $299,999. GDS
has an option to purchase up to 51% of the AMCD's Common stock in the event
certain changes in management control occur. The additional consideration will
be determined by the Company and GDS.
(A) PHYSICIAN PRACTICE MANAGEMENT DIVISION - MEDEXEC
The Company's physician practice management operations are currently conducted
through MedExec. MedExec functions in two capacities as a management services
organization: (i) owning and operating nine primary care centers (located in
Florida and Indiana) which have full risk contracts for primary care and part B
services and partial risk (50%) for part A services, and (ii) managing sixteen
multi-specialty groups (located in Florida and Texas) with fee-for service and
full risk contracts for primary care and part B services and partial risk (50%)
for part A services. Full risk contracts are contracts with managed care
companies where FMC assumes essentially all responsibility for a managed care
members' medical costs and partial risk contracts are contracts where FMC
assumes partial responsibility for a managed care members' medical costs.
Ownership and operation of primary care centers ("centers") with full risk
contracts are achieved through MedExec's subsidiaries: SPI Managed Care, Inc.
("SPI"), incorporated on February 19, 1988, SPI Managed Care of Hillsborough
County, Inc. ("SPI Hillsborough"), incorporated on April 20, 1993, Broward
Managed Care, Inc. ("BMC"), incorporated on January 21, 1994, and Midwest
Managed Care, Inc. ("Midwest"), incorporated on March 29, 1995.
F-18
FIRST MEDICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1996
SPI, SPI Hillsborough, and BMC provide health care services subject to
affiliated provider agreements entered into with Humana Medical Plan, Inc.;
Humana Health Plan of Florida, Inc.; and Humana Health Insurance Company of
Florida, Inc. and their affiliates. Midwest provides health care services
subject to affiliated provider agreements entered into with Humana Health Plan,
Inc., Humana Health Chicago, Inc.; and Humana Health Chicago Insurance Company,
Humana Insurance Company and their affiliates. All of the Humana entities will
collectively be known as "Humana". The Company is dependent on Humana for the
majority of its operations. For the year ended December 31, 1996, 85 percent of
the Company's revenue is from such agreements with Humana.
SPI operates two centers in Dade County, Florida located in Kendall and Cutler
Ridge.
SPI Hillsborough operates four centers in the west coast of Florida located in
Plant City, New Port Richey, Lutz, and South Dale Mabry. The affiliated provider
agreements to operate the centers in New Port Richey, Lutz and South Dale Mabry
were entered into in 1996.
BMC operates two centers in Broward County, Florida located in Plantation and
Sunrise.
During 1996, Midwest operated one center in Hammond, Indiana. In February 1997,
Midwest also began to operate an additional center in Gary, Indiana.
Health services are provided to Humana members through the centers and their
networks of physicians and health care specialists. Services to be provided by
the centers include medical and surgical services, including all procedures
furnished in a physician's office such as X-rays, nursing services, blood work
and other incidental, drugs and medical supplies. The centers are responsible
for providing all such services and for directing and authorizing all other care
for Humana members. The centers are financially responsible for all out-of-area
care rendered to a member and provide direct care as soon as the member is able
to return to the designated medical center.
Humana has agreed to pay the centers monthly for services provided to members
based on a predetermined amount per member ("capitation") comprised of
in-hospital services and other services defined by contract ("Part A"),
in-office ("Primary") and other medical services defined by the agreements
("Part B"). For new or start-up centers like the Gary center, Humana has
guaranteed a monthly amount to cover the costs of providing primary care
services and other operating costs. The guaranteed payments are made until the
earlier of the date on which the center achieves a certain membership level or
six months to one calendar year from the commencement date of the agreement at
which point Humana will pay the center a capitation.
SPI Managed Care of Broward, Inc. ("SPI Broward"), incorporated in the State of
Florida on July 15, 1992, manages the full risk managed care segment of a
nonaffiliated multi-specialty group practice in Broward County, Florida.
Effective February 1, 1996, First Medical Corporation-Texas Division
("FMC-Texas") began managing a multi-specialty medical practice in Houston,
Texas ("Houston medical practice") that has a full risk contract with Humana and
fee-for-service.
On December 31, 1995, FMC had a 23.75% and 50% investment, respectively, in BMC
and SPI Broward. Effective January 1, 1996 the Company acquired 71.25% and 50%
interest, respectively, in BMC and SPI Broward, respectively for $50,000 plus a
multiple of the average earnings before income taxes of these two entities
during the years ending December 31, 1996 and 1997. The multiple is three for
cash consideration, and 3.5 times for a combination of stock and cash. Based
upon the earnings of BMC for the year ended December 31, 1996 and assuming that
the multiple used is 3.5 times, the purchase price for the acquisition would
F-19
FIRST MEDICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1996
approximate $1.7 million. This acquisition gives the Company a 95% and 100%
investment in BMC and SPI Broward, respectively. The final value of the
consideration is not yet determinable as the seller has the option of obtaining
cash and/or stock and as the price is based on the average of 1996 and 1997
earnings. Additional goodwill will be recorded at the time the transaction is
finalized in accordance with the purchase method of accounting. Goodwill at
December 31, 1996 amounted to $327,778.
On December 31, 1995, the Company had a 66 2/3% investment in Midwest. Effective
January 1, 1996, the Company acquired the remaining investment and recorded
goodwill of $150,855 as a result of the purchase method of accounting. Book
value constituted fair value on the transaction date.
(B) HOSPITAL SERVICES DIVISION- FMC-HS
FMC-HS was incorporated on June 13, 1996 and is 51% owned by the Company and 49%
owned by General de Sante International, PLC ("GDS"). The Company commenced
operations in August 1996 and plans to provide management, consulting, and
financial services to troubled not-for-profits and other health care providers.
(C) PROPOSED LEHIGH MERGER
On October 29, 1996, the Company entered into a proposed merger agreement with
the Lehigh Group, Inc. ("Lehigh") whereby upon merger, FMC would control
approximately 96% of Lehigh. The proposed merger is subject to stockholder
approval of Lehigh and the Company. Under the terms of the proposed merger, each
share of the FMC Common Stock would be exchanged for (i) 1,127.675 shares of
Lehigh Common Stock and (ii) 103.7461 shares of Lehigh Preferred Stock. Each
share of Lehigh Preferred Stock will be convertible into 250 shares of Lehigh
Common Stock and will have a like number of votes per share, voting together
with the Lehigh Common Stock. Currently, there are outstanding 10,000 shares of
FMC Stock. As a result of these actions, immediately following the merger,
current Lehigh stockholders and FMC stockholders will each own 50% of the issued
F-20
FIRST MEDICAL CORPORATION NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS DECEMBER 31, 1996
and outstanding shares of Lehigh Common Stock. In the event that all of the
shares of Lehigh Preferred Stock issued to the Company's stockholders are
converted into Lehigh Stock, Lehigh stockholders will own approximately 4% and
the Company's stockholders will own approximately 96% of the issued and
outstanding shares of Lehigh Common Stock. In addition, under the terms of the
proposed merger agreement, Lehigh will be renamed "First Medical Group, Inc."
In connection with the proposed merger, Lehigh issued a convertible debenture to
the Company in the amount of $300,000 with interest at two percent per annum
over the prime lending rate. The debenture is recorded in other assets. In
addition, the Company advanced $50,000 to Lehigh. The advance is included in
prepaid expenses and other current assets.
On February 12, 1997, the Company purchased 1,920,757 shares of Lehigh stock for
$.281 per share.
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(A) CASH AND CASH EQUIVALENTS
Cash equivalents consist of demand deposits. For purposes of the consolidated
statement of cash flows, the Company considers all highly liquid debt
instruments with original maturities of three months or less to be a cash
equivalent.
(B) HUMANA IBNR RECEIVABLE AND CLAIMS RESERVE FUNDS (63)
Humana withholds certain amounts each month from the centers' Part A, Part B,
and supplemental funding in order to cover claims incurred but not reported or
paid. The amount is used by Humana to pay the centers' Part A, Part B and
supplemental costs. The amounts withheld by Humana to cover incurred but not
reported or paid claims varies by center based on the history of the respective
center and is determined solely by Humana.
Humana also withholds a certain amount each month from the centers' Part A
capitation funding. This amount represents a "catastrophic reserve fund" to be
utilized for the payment of a center's Part A costs in the event a center ceases
operations and the incurred but not reported reserves are not adequate to
reimburse providers for Part A services rendered. This amount is calculated
monthly by Humana.
The withholdings are used to pay the centers' medical claims, which Humana pays
on the centers' behalf. The remaining amount after claims have been paid is
remitted to the company.
(C) PROPERTY AND EQUIPMENT
Property and equipment are stated at cost. Depreciation on property and
equipment is calculated on the straight line method over the estimated useful
lives. (Medical and office equipment - 5 years and Furniture and fixtures - 7
years)
(D) INTANGIBLE ASSETS
Goodwill, which represents the excess of purchase price over fair value of net
assets acquired, is amortized on a straight-line basis over the expected periods
to be benefited, 15 years. The Company assesses the recoverability of this
intangible asset by determining whether the amortization of the goodwill balance
over its remaining life can be recovered through undiscounted future operating
cash flows of the acquired operation. The amount of goodwill impairment, if any,
is measured based on projected discounted future operating cash flows using a
discount rate reflecting the Company's average cost of funds. The assessment of
F-21
FIRST MEDICAL CORPORATION NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS DECEMBER 31, 1996
the recoverability of goodwill will be impacted if estimated future operating
cash flows are not achieved.
The Company entered into a non-compete agreement with a former employee and
shareholder. This non-compete agreement is being amortized on a straight line
basis over the life of the agreement which is two years.
The Company entered into three employment/non-compete agreements with three
shareholders. The agreements consist of guaranteed payments regardless if any
services are rendreed. These agreements are being amortized on a straight line
basis over 5 years which is the life of the agreement (3 years) plus the
subsequent non-compete period (2 years).
Deferred organization costs consist principally of legal, consulting and
investment banking fees which were incurred strictly in connection with the
incorporation of FMC and proposed merger with Lehigh. The costs related to the
FMC transaction are being amortized over five years. The costs related to the
subsequent Lehigh merger will begin amortizing when the merger is complete.
(E) IMPAIRMENT OF LONG-LIVED ASSETS
The Company adopted the provisions of SFAS No. 121, Accounting for the
Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of, on
January 1, 1996. This Statement required that long-lived assets and certain
identifiable intangibles be reviewed for impairment whenever events change in
circumstances indicate that the carrying amount of an asset may not be
recoverable. Recoverability of assets to be held and used is measured by a
comparison of the carrying amount of an asset of future net cash flows expected
to be generated by the asset. If such assets are considered to be impaired, the
impairment to be recognized is measured by the amount by which the carrying
amount of the assets exceed the fair value of the assets. Assets to be disposed
of are reported at the lower of the carrying amount or fair values less costs to
sell. Adoption of this Statement did not have a material impact on the Company's
financial position, results of operations, or liquidity. The Company has no
impaired assets at December 31, 1996.
(F) INCOME TAXES
Income taxes are accounted for under the asset and liability method. Deferred
tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of
existing assets and liabilities and their respective tax bases and operating
loss and tax credit carryforwards. Deferred tax assets are measured using
enacted tax rates expected to apply to taxable income in the years in which
those temporary differences are expected to be recovered or settled. The effect
on deferred tax assets and liabilities of a change in tax rates is recognized in
income in the period that includes the enactment date.
(G) REVENUE AND MEDICAL COST RECOGNITION
Revenue from Humana for primary care, Part A, Part B and supplemental funds is
recognized monthly on the basis of the number of Humana members assigned to the
primary care centers and the contractually agreed-upon rates. The primary care
centers receive monthly payments from Humana after all expenses paid by Humana
on behalf of the centers, estimated claims incurred but not reported and claims
reserve fund balances have been determined. In addition to Humana payments, the
primary care centers receive copayments from commercial members from each office
visit, depending upon the specific plan and options selected and receive
payments from non-Humana members on a fee-for-service basis.
F-22
FIRST MEDICAL CORPORATION NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS DECEMBER 31, 1996
Medical services are recorded as expenses in the period in which they are
incurred. Accrued medical claims are reflected in the consolidated balance sheet
and are based upon costs incurred for services rendered prior to and up to
December 31, 1996. Included are services incurred but not reported as of
December 31, 1996, based upon actual costs reported subsequent to December 31,
1996 and a reasonable estimate of additional costs.
AMCMC and AMCD revenues are derived from medical services rendered to patients
and annual membership fees charged to individuals, families and corporate
members. Membership fees are non-refundable and are recognized as revenue over
the term of the membership. Corporate members are also required to make advance
deposits based upon plan type, number of employees and dependents. The advance
deposits are initially recorded as deferred income and then recognized as
revenue when service is provided. As the advance deposits are utilized,
additional advance deposits are required to be made by corporate members.
FMC-HS will recognize revenue under the management consulting service agreements
on a fee-for-service basis as services are rendered by FMC-HS personnel.
Fee-for-service revenue is reported at the estimated net realizable amounts from
patients and third-party payors as services are rendered.
(H) USE OF ESTIMATES
Management of the Company has made a number of estimates and assumptions
relating to the reporting of assets and liabilities and the disclosure of
contingent assets and liabilities to prepare these consolidated financial
statements in conformity with generally accepted accounting principles. Actual
results could differ from those estimates.
(I) FAIR VALUE OF FINANCIAL INSTRUMENTS
The carrying amount of financial instruments including cash and cash
equivalents, Humana IBNR receivable and claims reserve funds, other receivables,
prepaid expenses and other current assets, accounts payable and other accrued
expenses, accrued medical claims, loan payable to Humana, loans payable to bank
and obligations to certain stockholders approximate fair value at December 31,
1996 because of the short term maturity of these instruments.
(J) FOREIGN CURRENCY
The financial statements of the Company's foreign subsidiaries are remeasured
into the US dollar functional currency for consolidation and reporting purposes.
Current rates of exchange are used to remeasure assets and liabilities and
revenue and expense are remeasured at average monthly exchange rates prevailing
during the year.
(K) STOP-LOSS FUNDING
The primary care centers are charged a stop-loss funding fee by Humana for the
purpose of limiting a center's exposure to Part A costs and certain Part B costs
associated with a member's heath services.
F-23
FIRST MEDICAL CORPORATION NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS DECEMBER 31, 1996
For the year ended December 31, 1996, the stop-loss threshold for both part A
and Part B costs for Medicare members was $40,000 per member per calendar year
for both SPI and SPI Hillsborough. For commercial members, the stop-loss
threshold for both Part A and part B costs was $20,000 and $15,000 for SPI and
SPI Hillsborough, respectively.
Since the SPI and SPI Hillsborough centers are not responsible for claims in
excess of the threshold, income and the corresponding expense, both equal to the
stop-loss funding are recognized by SPI and SPI Hillsborough. These amounts are
included in revenue and medical expenses, respectively, in the accompanying
consolidated statement of income. Stop-loss funding for the SPI and SPI
Hillsborough centers for the year ended December 31, 1996 was approximately
$4,733,000.
For Midwest, the stop-loss thresholds for Part A and for Part B costs for
Medicare members were $45,000 and $15,000, respectively, per member per calendar
year and the stop-loss thresholds for Part A and for Part B for commercial
members were $60,000 and $15,000 respectively, per member per calendar year.
(L) MATERNITY FUNDING
The primary care centers are charged a maternity funding fee on commercial
membership for the purpose of limiting the center's exposure to Part A and Part
B costs associated with a commercial member's pregnancy or related illness.
Since the SPI and SPI Hillsborough centers are not responsible for claims in
excess of the amount contributed to the maternity fund, income and expenses both
equal to the maternity fund are recognized by SPI and SPI Hillsborough and are
included in revenue and medical expenses, respectively in the accompanying
consolidated statement of operations. Maternity funding for the SPI and SPI
Hillsborough centers for the year ended December 31, 1996 was approximately
$1,403,000.
(M) SUPPLEMENTAL EARNINGS PER SHARE
On July 9, 1997 the Company merged with Lehigh Group, Inc. As a result of this
merger and the conversion of Preferred Stock and the 1-for-30 reverse stock
split on November 12, 1997, the Company had shares outstanding of 9,021,400
resulting in a net earnings per share of $.04 per share.
(3) PROPERTY AND EQUIPMENT, NET
Property and equipment at December 31, 1996 consists of the following:
Medical, computer and office equipment $703,793
Furniture and fixtures 37,986
--------
741,779
Less: accumulated depreciation 341,938
---------
Property and equipment, net $399,841
=========
F-24
FIRST MEDICAL CORPORATION NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS DECEMBER 31, 1996
(4) INTANGIBLE ASSETS
Intangible assets at December 31, 1996 consist of:
Goodwill $1,498,908
Employment/non-compete agreements
with executives 964,800
Organization costs 480,337
Noncompete agreement with former
shareholder 200,000
----------
3,144,045
Less: accumulated amortization 408,197
----------
$2,735,848
==========
As stated in note 1, the following transactions created goodwill at December 31,
1996:
AMCMC $1,020,275
BMC and SPI Broward 327,778
Midwest Managed Care 150,855
----------
$1,498,908
==========
The Company continually reevaluates the propriety of the carrying amount of
goodwill and other intangible assets as well as the amortization period to
determine whether current events and circumstances warrant adjustments to the
carrying value and estimates of useful lives. At this time, the Company believes
that no significant impairment of goodwill or other intangible assets has
occurred and that no reduction of the amortization periods is warranted.
(5) LOANS PAYABLE TO HUMANA
Loans payable to Humana at December 31, 1996 consist of the following:
Secured loan for $250,000 bearing interest at 9.5%. Payable in 48 monthly
installments beginning in February 1997 of $6,850 which includes principal
and interest. The loan is secured by the Company's equipment and
furnishings at the Houston Medical Practice. Proceeds from the loan were
used primarily for the purchase of equipment at the Houston medical
practice. $ 250,000
F-25
FIRST MEDICAL CORPORATION NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS DECEMBER 31, 1996
Secured loan for $75,000 bearing interest at 9.5%. Payable in twelve
monthly installments beginning in February 1997 which includes principal
and interest of $7,172. The loan is secured by the Company's equipment and
furnishings at the Houston Medical Practice. Proceeds from the loan were
used primarily for working capital needs of the Houston medical practice. 75,000
Advance of $50,000 bearing interest at 10% per year for the purchase and
installation of a computer system and related training at the Midwest
locations. The loan is due by September 30, 2000. Monthly installments to
Humana will be a minimum of 10% of any positive balance in Midwest's Part A
Fund. In the event no positive balance exists in the Part A fund, Midwest
will make a minimum monthly payment of $1,268 until the loan is repaid.
50,000
--------
Total long-term loans payable to Humana 375,000
Less current installments 97,628
--------
Loans payable to Humana, excluding current installments $ 277,372
===========
The aggregate maturities of loans payable to Humana for each of the five years
subsequent to December 31, 1996 are as follows:
1997 $ 97,628
1998 81,751
1999 82,688
2000 106,097
2001 6,836
--------
$375,000
========
(6) LOANS PAYABLE TO BANKS
Loans payable to banks at December 31, 1996 consists of the following:
Unsecured line of credit for $200,000 bearing interest at prime (8.25% at
December 31, 1996). The line of credit is personally guaranteed by several
stockholders of the Company and other individuals. The principal balance is
due on June 2, 1997. Interest is due monthly. The $200,000 drawn under this
line of credit was used primarily for development costs relating to
Midwest. $ 200,000
F-26
FIRST MEDICAL CORPORATION NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS DECEMBER 31, 1996
Line of credit for $1,500,000 bearing interest at 1/2% above prime (8.75%
at December 31, 1996). $900,000 of the line is secured by MedExec's cash
and certain net assets of the Company. Secured assets total $1,237,976 at
December 31, 1996. The principal balance is due on May 31, 1997 and
interest is due monthly. In order to borrow the additional $600,000
(unsecured portion of line), the bank would require the personal guarantee
of a stockholder of the Company. The $550,000 drawn under this line of
credit was used primarily for working capital requirements. 550,000
---------
$ 750,000
=========
FMC recently obtained a loan commitment in the amount of $3,300,000 from the
same bank which provided the $1,500,000 line of credit. The commitment is for a
120 day loan bearing interest at the prime plus 1/2% (8.75% at December 31,
1996). The purpose of the loan is to provide financing for the Lehigh merger.
The loan is secured by all of the assets of FMC, 50% of the shares of FMC Common
Stock owned by FMC's Chairman and Chief Executive Officer and any and all shares
of Lehigh Common Stock are issuable to FMC.
The various debt agreements contain certain covenants. Under the most
restrictive of these provisions, certain stockholders of the Company must
personally guarantee $600,000 for the $1,500,000 line of credit as well as the
additional $3,300,000 line of credit.
(7) RELATED PARTY TRANSACTIONS
At December 31, 1996, obligations to certain shareholders includes the
following:
Obligation to pay consulting fees to three stockholders in connection with
the transaction between MedExec and AMC. Obligations have been recorded as
a liability due to the stockholders not having to provide any services for
this consideration to be paid. Payable monthly in the amount of $26,800.
Obligations will be repaid by December 31, 1998. The amount of
consideration paid in 1996 related to these agreements was $321,600. $ 643,200
Credit facility bearing interest at 4.5% from General de Sante
International, plc of up to $1,200,000 to be used for the development of
the clinics of AMCD. $100,000 is to be repaid on demand at any time after
July 10, 2001, $100,000 is to be repaid on demand at any time after August
9, 2001 and $174,596 on demand any time after January 17, 2002, or on the
date GDS subscribes for shares in FMC under the subscription agreement (see
note 12). 374,596
F-27
FIRST MEDICAL CORPORATION NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS DECEMBER 31, 1996
Obligation under non compete agreement with a former employee and
stockholder payable in monthly installments of $8,333 until June 1998 (note
4). 150,000
-------
Total obligations to stockholders 1,167,796
Less current installments 421,600
----------
Total obligations to stockholders, excluding current installments $ 746,196
==========
The aggregate maturities of obligations to stockholders for each of the five
years subsequent to December 31, 1996 are as follows:
1997 $421,600
1998 371,600
1999 --
2000 --
2001 200,000
Thereafter 174,596
----------
Total $1,167,796
==========
The Company paid salaries or consulting fees to stockholders of approximately
$1,520,700 which is included in the consolidated statement of income for the
year ended December 31, 1996.
Certain stockholders have guaranteed the $200,000 outstanding loan with the
financial institution which is described in note 6. In addition, a stockholder
will guarantee any amount in excess of $900,000 which becomes outstanding
related to the $1,500,000 line of credit described in note 6.
On January 24, 1997 the Company acquired director and officer liability
insurance in the amount of $3,000,000 with coverage expiring on December 5,
1997. Coverage under this policy extends to all duly elected or appointed
directors and officers (past, present and future).
At December 31, 1996, the Company has amounts outstanding from the AMC clinics
under its management agreement with AMCMC which total $462,329.
(8) INCOME TAXES
CURRENT DEFERRED TOTAL
US Federal $256,000 $112,500 $368,500
State and Local 44,000 -- 44,000
-------- -------- --------
$300,000 $112,500 $412,500
======== ======== ========
F-28
FIRST MEDICAL CORPORATION NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS DECEMBER 31, 1996
Income tax expense differed from the amounts computed by applying the US
federal income tax rate of 34% to pretax income as a result of the following:
Income tax expense at the statutory rate $250,300
Reduction in valuation allowance (29,300)
Unutilized net operating losses of AMCD 122,000
State taxes, net of federal benefit 31,500
Nondeductible merger costs and meals and entertainment 38,000
--------
Income tax expense recorded in financial statements $412,500
========
The tax effects that give rise to a significant portion of the deferred income
tax assets for the year ended December 31, 1996 are as follows:
Deferred tax assets:
Executive compensation $250,616
Net loss carryforward 58,703
--------
Deferred tax asset 309,319
Valuation allowance (102,403)
--------
Net deferred tax asset 206,916
Deferred tax liabilities:
Goodwill asset 319,416
--------
Net deferred tax liability $112,500
========
The Company has provided a valuation allowance for deferred tax assets as of
December 31, 1996 for $102,403. In assessing the realizability of deferred
tax assets, management considers whether it is more likely than not that some
or a portion of the deferred assets will be realized in the near future.
(9) LEASES
The Company has several noncancelable operating leases primarily for
office space and equipment that expire throughout 2001. Future minimum
lease payments required under noncancelable operating leases at
December 31, 1996 are as follows:
F-29
FIRST MEDICAL CORPORATION NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS DECEMBER 31, 1996
Year ending
December 31,
------------
1997 $ 349,327
1998 339,834
1999 120,487
2000 55,204
2001 49,656
--------
Total minimum lease payments $914,508
========
Rental expense during 1996 amounted to approximately $259,000.
(10) BUSINESS AND CREDIT CONCENTRATIONS
The Company derives the majority of its revenue from its affiliated
provider agreements with Humana 85% or approximately $45,070,000 of the
revenue of the Company for the year ended December 31, 1996 was derived
from such agreements with Humana. The amount of revenue is based on the
number of members assigned to each of the centers. Humana members
include 10,287 Medicare members and 10,420 commercial members at
December 31, 1996. The fluctuation of the number of members
significantly affects the Company's business. The receivable from
Humana at December 31, 1996 is $7,308,482.
Revenue generated by services provided by the AMC clinics in the CIS
represents 12% or approximately $6,534,000 of the revenue of the
Company for the year ended December 31, 1996.
(11) RETIREMENT PLANS
The Company sponsors 401(k) plans (the "Plans") for its domestic
operations. Employees who have worked a minimum of six months or 1000
hours and are at least 21 years of age may participate in the Plans.
Employees may contribute to the Plans up to 14 percent of their annual
salary, not to exceed $9,500 in 1996. The Company's matching
contribution is 25 cents for each dollar of the employee's elected
contribution, up to four percent of the employee's annual salary. The
Company's matching contribution was approximately $35,000 for the year
ended December 31, 1996.
(12) COMMITMENTS AND CONTINGENCIES
LEGAL PROCEEDINGS
The Company and certain stockholders are defendants in a lawsuit
brought on by a stockholder and former employee. The plaintiff is
seeking damages in excess of $1 million. Management, stockholders and
legal counsel for the Company intends to vigorously defend this action.
They are not able to determine the extent of damages, if any, at this
time. Therefore, no accrual has been recorded in the financial
statements at December 31, 1996.
To the best of the Company's knowledge, there are no material claims,
disputes or other unsettled matters (including retroactive adjustments)
concerning third party reimbursements that would have a material effect
on the consolidated financial statements of the Company.
F-30
FIRST MEDICAL CORPORATION NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS DECEMBER 31, 1996
GOVERNMENTAL REGULATIONS
The Company's operations have been and may be affected by various forms
of governmental regulation and other actions. It is presently not
possible to predict the likelihood of any such actions, the form which
such actions may take, or the effect such actions may have on the
Company.
PHYSICIAN CONTRACTS
The Company has entered into employment agreements of two to three
years with its primary care physicians and into contracts with various
independent physicians to provide specialty and other referral services
both on a prepaid and a negotiated fee-for-service basis. Such costs
are included in the consolidated statement of income as medical
expense.
SUBSCRIPTION AGREEMENT
In June 1996, FMC entered into a subscription agreement with GDS by
which GDS has the right to purchase various percentages of interest in
both FMC and its subsidiaries.
MALPRACTICE AND PROFESSIONAL LIABILITY INSURANCE
The Company maintains professional liability insurance on a claims-made
basis through November 1, 1997 including retrospective coverage for
acts occurring since inception of its operations. Incidents and claims
reported during the policy period are anticipated to be covered by the
malpractice carrier. The Company intends to keep such insurance in
force throughout the foreseeable future. At December 31, 1996, there
are no asserted claims made against the Company that were not covered
by the policy.
Physicians providing medical services to members are provided
malpractice insurance coverage (claim-made basis), including
retrospective coverage for acts occurring since their affiliation with
the Company.
F-31
Independent Auditors' Report
The Board of Directors
MedExec, Inc.;
SPI Managed Care, Inc.; and
SPI Managed Care of Hillsborough County, Inc.:
We have audited the accompanying combined balance sheets of MedExec, Inc. and
subsidiaries; SPI Managed Care, Inc.; and SPI Managed Care of Hillsborough
County, Inc. as of December 31, 1995 and 1994, and the related combined
statements of operations, stockholders' equity and cash flows for each of the
years in the three-year period ended December 31, 1995. These combined financial
statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these combined financial statements
based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the combined financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the combined financial statements. An
audit also includes assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall combined
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, such combined financial statements referred to above present
fairly, in all material respects, the combined financial position of MedExec,
Inc. and subsidiaries; and SPI Managed Care, Inc.; and SPI Managed Care of
Hillsborough County, Inc. as of December 31, 1995 and 1994, and the results of
their operations and their cash flows for each of the years in the three-year
period ended December 31, 1995, in conformity with generally accepted accounting
principles.
/S/ KPMG PEAT MARWICK LLP
Miami, Florida
May 17, 1996, except as to note 15,
which is as of December 23, 1996
F-32
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
Combined Balance Sheets
December 31, 1995 and 1994
ASSETS 1995 1994
------ ---- ----
Current assets:
Cash and cash equivalents $ 198,763 468,528
Humana IBNR receivable 2,062,924 2,848,518
Due from affiliates and related parties, net 54,565 196,745
Claims reserve funds 116,212 126,357
Prepaid expenses and other current assets 82,413 37,269
Deferred income taxes (note 12) -- 51,713
--------------------- -----------------------
Total current assets 2,514,877 3,729,130
Property and equipment, net (note 4) 298,060 207,199
Deferred income taxes (note 12) -- 8,287
Investments in other affiliated entities (note 3) 229,094 178,968
Intangible assets, net 2,547 4,896
--------------------- -----------------------
$ 3,044,578 4 ,128,480
===================== =======================
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and other accrued expenses 594,822 556,366
Accrued medical claims, including amounts incurred
but not reported 1,880,318 2,484,258
Due to Humana 192,143 56,152
Loan payable to Humana 50,000 --
Loan payable to bank 100,000 --
Income taxes payable -- 60,000
--------------------- -----------------------
Total current liabilities 2,817,283 3,156,776
--------------------- -----------------------
Commitments and contingencies (note 13)
Stockholders' equity (notes 8 and 9):
Capital stock 1,500 1,500
Additional paid-in capital 1,200 1,200
Retained earnings 224,595 969,004
--------------------- -----------------------
Total stockholders' equity 227,295 971,704
---------------- -----------------------
$ 3,044,578 4,128,480
===================== =======================
See accompanying notes to combined financial statements.
F-33
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
COMBINED STATEMENTS OF OPERATIONS
For each of the years in the three year period ended December 31, 1995
1995 1994 1993
-------------- ---------------------- --------------
Revenue (note 9) $22,671,902 21,317,887 11,086,690
Medical expenses 18,443,943 16,567,554 8,404,521
-------------- ---------------------- --------------
Gross profit 4,227,959 4,750,333 2,682,169
-------------- ---------------------- --------------
Operating expenses (note 9):
Salaries and related benefits 2,434,241 1,650,970 670,536
Depreciation and amortization 68,499 50,408 46,676
Other 2,131,639 1,720,198 944,237
-------------- ---------------------- --------------
Total operating expenses 4,634,379 3,421,576 1,661,449
-------------- ---------------------- --------------
Operating income (loss) (406,420) 1,328,757 1,020,720
-------------- ---------------------- --------------
Other (expense) income:
Gain (loss) on equity investments (note 3) 50,126 28,260 (149,295)
Interest income 11,310 9,593 4,071
Loss on Dominion Healthnet, Inc. (note 3) -- -- (80,009)
Other, net (19,425) (2,948) 7,356
-------------- ---------------------- --------------
Other income (expense), net 42,011 34,905 (217,877)
-------------- ---------------------- --------------
Net income (loss) $ (364,409) 1,363,662 802,843
============== ====================== ==============
(56)
See accompanying notes to combined financial statements.
F-34
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
COMBINED STATEMENTS OF STOCKHOLDERS' EQUITY
For each of the years in the three year period ended December 31, 1995
Capital Additional paid- Total
stock in capital Retained Due to stockholders'
(NOTE 8) (NOTE 8) EARNINGS STOCKHOLDERS EQUITY
------ ------ -------- ------------ ------
Balance, December 31, 1992 $ 900 1,200 143,701 37,000 182,801
Net income -- -- 802,843 -- 802,843
Dividend distributions -- -- (170,745) -- (170,745)
Issuance of stock 100 -- -- -- 100
Proceeds from due to stockholders -- -- -- 583,112 583,112
----- -------- ---------- -------- ------------
Balance, December 31, 1993 1,000 1,200 775,799 620,112 1,398,111
Net income -- -- 1,363,662 -- 1,363,662
Distribution of Midway Airlines stock, at cost -- -- (200,444) (599,556) (800,000)
Dividend distributions -- -- (970,013) -- (970,013)
Issuance of stock 500 -- -- -- 500
Repayment of due to stockholders, net -- -- -- (20,556) (20 ,556)
----- -------- -------- -------- ------------
Balance, December 31, 1994 1,500 1,200 969,004 -- 971,704
Net loss -- -- (364,409) -- (364,409)
Dividend distributions -- -- (380,000) -- (380,000)
----- ------- ---------- -------- -------------
Balance, December 31, 1995 $1,500 1,200 224,595 -- 227,295
===== ===== ========== ======== ============
See accompanying notes to combined financial statements.
F-35
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
COMBINED STATEMENTS OF CASH FLOWS
For each of the years in the three year period ended December 31, 1995
1995 1994 1993
---- ---- ----
Cash flows from operating activities:
Net income (loss) $(364,409) 1,363,662 802,843
Adjustments to reconcile net income (loss) to net cash
provided by operating activities:
Depreciation and amortization 68,499 50,408 46,676
Deferred income taxes -- (60,000) --
Loss on disposal of fixed assets -- -- 801
(Gain) loss on equity investments (50,126) (28,260) 149,295
Write-off of investments -- 597 --
(Increase) decrease in assets:
Humana IBNR receivable 785,594 (1,547,044) (764,831)
Due from affiliates and related parties 142,180 (177,572) 53,369
Claims reserve funds 10,145 13,217 (115,742)
Prepaid expenses and other current assets 14,856 (33,076) (3,653)
Increase (decrease) in liabilities:
Accounts payable and other accrued expenses 38,456 393,636 85,077
Accrued medical claims, including amounts incurred
but not reported (603,940) 1,359,770 583,266
Due to Humana 135,991 2,822 14,779
Income taxes payable (60,000) 60,000 --
-------- ----------- --------
Net cash provided by operating activities 117,246 1,398,160 851,880
-------- ----------- --------
Cash flows from investing activities:
Capital expenditures (157,011) (95,559) (133,922)
Proceeds from sale of fixed assets -- -- 19,900
Purchase of investments -- -- (1,100,600)
------- ---------- ----------
Net cash used in investing activities (157,011) (95,559) (1,214,622)
------- ---------- ----------
Cash flows from financing activities:
Proceeds from issuance of stock -- 500 100
Proceeds from loan payable to Humana 50,000 -- --
Proceeds from loan payable to bank 100,000 -- --
Dividend distributions (380,000) (970,013) (170,745)
Due to stockholders -- (20,556) 583,112
-------- -------- --------
Net cash (used in) provided by financing activities (230,000) (990,069) 412,467
------- ---------- --------
(Decrease) increase in cash and cash equivalents (269,765) 312,532 49,725
Cash and cash equivalents, beginning of year 468,528 155,996 106,271
------- ------- -------
Cash and cash equivalents, end of year $198,763 468,528 155,996
======= ======= =======
Supplemental disclosure of cash flow information:
Cash paid during the year for income taxes $ 60,000 -- --
======== ======= =======
Supplemental schedule of noncash investing and operating activities:
MedExec, Inc. distributed its $800,000 investment in Midway Airlines stock
as a dividend to its shareholders during the year ended December 31, 1994.
See accompanying notes to combined financial statements.
F-36
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
December 31, 1995 and 1994
(1) ORGANIZATION AND OPERATIONS
(A) ORGANIZATION
The accompanying combined financial statements include the
accounts of MedExec, Inc. and subsidiaries ("MedExec"); SPI
Managed Care, Inc. ("SPI"); and SPI Managed Care of
Hillsborough County, Inc. ("SPI Hillsborough") (collectively,
the "Company"), which are affiliated through common
stockholders and the same management. SPI and SPI Hillsborough
are 100%-owned by MedExec stockholders. (55)
MedExec was incorporated on March 14, 1991.
Dominion Healthnet, Inc. ("Dominion") was incorporated on
September 13, 1991. MedExec owned 55 percent of Dominion at
December 31, 1995, and 1994.
HCO Miami, Inc. ("HCO Miami") was incorporated on June 18,
1993. MedExec owned 70 percent and SPI owned 20 percent of HCO
Miami at December 31, 1995 and 1994.
Midwest Managed Care, Inc. ("Midwest") was incorporated on
March 29, 1995. MedExec owned 66.67 percent of Midwest at
December 31, 1995.
SPI, formerly known as Surgical Park, Inc. was incorporated on
February 19, 1988. Surgical Park, Inc. changed its name
pursuant to an amendment to its Articles of
Incorporation on May 7, 1990.
SPI Hillsborough was incorporated on April 20, 1993.
(B) NATURE OF OPERATIONS (57-61)
SPI and SPI Hillsborough operate in the state of Florida and
Midwest (which commenced operations during 1995) operates in
the states of Illinois and Indiana. SPI and SPI Hillsborough
provide health care services subject to affiliated provider
agreements entered into with Humana Medical Plan, Inc.; Humana
Health Plan of Florida, Inc.; Humana Health Insurance Company
of Florida, Inc. and their affiliates. Midwest provides health
care services subject to affiliated provider agreements
entered into with Humana Health Plan, Inc.; Humana Health
Chicago, Inc.; Humana Health Chicago Insurance Company; Humana
Insurance Company and their affiliates. All of the Humana
entities will collectively be known as "Humana". The Company
is dependent on Humana for the majority of its operations. For
the years ended December 31, 1995, 1994 and 1993, 96 percent,
95 percent, and 95 percent, respectively of the Company's
revenue are from such
F-37
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
agreements with Humana. Health services are provided to Humana
members through SPI, SPI Hillsborough and Midwest's primary
care medical centers and its network of physicians and health
care specialists.
SPI operates two centers in Dade County, Florida: in Kendall
("Kendall") and Cutler Ridge ("Cutler Ridge") at December 31,
1995 and 1994.
At December 31, 1994, SPI Hillsborough operated two centers in
Hillsborough County, Florida: in Brandon ("Brandon") and Plant
City ("Plant City"). Effective August 31, 1995, Humana
terminated its Brandon contract with SPI Hillsborough.
Included in accrued medical claims at December 31, 1995, is
approximately $103,000 pertaining to Brandon's open claims
through the termination date. The Brandon center had revenue
of approximately $3,521,000, $3,943,000, and $208,000 for the
years ended December 31, 1995, 1994 and 1993, respectively.
Midwest operates one center in Hammond, Indiana ("Hammond").
Dominion provides networks of hospitals and doctors to
international travel assistance companies outside the United
States. At December 31, 1995, Dominion had one contract with a
Canadian insurance company to care for its insured traveling
to the United States.
HCO Miami provides utilization review and case management
services for HMO and PPO members of affiliated companies.
(C) AFFILIATED PROVIDER AGREEMENTS
Effective April 1, 1990 and September 1, 1990, SPI through the
Cutler Ridge and Kendall centers, respectively, entered into
provider agreements with Humana, which will continue
indefinitely unless terminated according to certain provisions
of the agreements. Such agreements specify that either party
may elect to terminate the agreements, with or without cause,
at any time upon giving 60 days written notice. In addition,
these agreements may be terminated by mutual written consent
of both parties at any time. Amendments to the original
provider agreements with Humana were entered into effective
September 1, 1991 and January 1, 1993 for the Cutler Ridge and
Kendall centers, respectively under full-risk agreements.
The Brandon and Plant City centers entered into five-year
non-risk provider agreements with Humana effective June 1,
1993 and January 1, 1994, respectively. Under these
agreements, the Brandon and Plant City centers are responsible
only for primary (in- office) medical services. These
agreements allow for similar termination provisions to the
agreements for the other centers, except that either party may
elect to terminate the
F-38
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
agreements without cause after the first two years upon giving
six months written notice. Amendments to the aforementioned
provider agreements with Humana were entered into effective
May 1, 1994 under full-risk agreements. The Brandon agreement
with Humana was terminated effective August 31, 1995.
The Hammond center entered into a three-year risk provider
agreement with Humana effective October 1, 1995 with an
automatic three-year renewal. However, the Hammond center is
operating under a non-risk amendment ("Amendment") to this
agreement and is responsible only for primary (in-office)
medical services. The Hammond center will continue to operate
under the Amendment until the earlier of the date on which
Midwest achieves a certain membership level or one calendar
year from the commencement date of the agreement, October 1,
1996. This agreement allows for similar termination provisions
to the agreements for the other centers, except that either
party may elect to terminate the agreement at any anniversary
date of the agreement upon giving at least six months written
notice.
Services to be provided by the SPI, SPI Hillsborough and
Midwest centers include medical and surgical services,
including all procedures furnished in a physician's office
such as X-rays, nursing services, blood work and other
incidentals, drugs and medical supplies. SPI, SPI Hillsborough
and Midwest centers are responsible for providing all such
services and for directing and authorizing all other care,
including emergency and inpatient care for Humana members. The
SPI and SPI Hillsborough centers are financially responsible
for all out-of-area care rendered to a member and provides
direct care as soon as the member is able to return to the
designated medical center.
Humana has agreed to pay the SPI and SPI Hillsborough centers
monthly for services provided to members based on a
predetermined amount per member ("capitation"), comprised of
in-hospital services and other services defined by contract
("Part A"), in- office ("Primary") and other medical services
defined by the agreements ("Part B"). Humana has agreed to pay
the Midwest center a guaranteed monthly amount ("guaranteed
payment") to cover the costs of providing primary care
services and to cover Midwest's other operating costs. The
guaranteed payments will be made until the earlier of the date
on which the Midwest center achieves a certain membership
level or one calendar year from the commencement date of the
agreement at which point Humana will pay Midwest capitation.
Midwest shall not be at risk for Parts A and B until Midwest
has been assigned certain membership.
(D) HUMANA IBNR RECEIVABLE (63)
Humana withholds a certain amount each month from the SPI and
SPI Hillsborough centers' Part A, Part B and supplemental
funding in order to cover claims incurred but
F-39
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
not reported or paid. This amount is to be used by Humana to
pay the centers Part A, Part B and supplemental costs. The
amounts withheld by Humana to cover incurred but not reported
or paid claims varies by center based on the history of the
respective center and is determined solely by Humana. The
amounts withheld are used to pay the centers' medical claims
which Humana pays on the centers' behalf. The remaining amount
after claims have been paid is remitted to the Company. (See
note 1(f))
Management does not believe it has a significant exposure to
effects related to third-party reimbursement programs and the
related revenue recognition policy because they generally
apply to hospitals. Furthermore, FMC has Medicare and Medicaid
contracts only in regard to one facility and fee-for-service
in only one facility. There is a risk, however, even though
FMC is not a direct recipient of third-party payor
arrangements because Medicare and Medicaid may change its
payments.
(E) DUE FROM AFFILIATES AND RELATED PARTIES
Due from affiliates and related parties represents current
amounts receivable from affiliates to cover their operating
expenses.
(F) CLAIMS RESERVE FUNDS
Humana withholds a certain amount each month from the SPI and
SPI Hillsborough centers' Part A capitation funding. This
amount represents a "catastrophic reserve fund" to be utilized
for the payment of the center's Part A costs in the event a
center ceases operations and the incurred but not reported
reserves are not adequate to reimburse providers for Part A
services rendered. This amount is calculated monthly by
Humana.
(G) DUE TO HUMANA
Due to Humana represents amounts advanced to SPI and SPI
Hillsborough by Humana to cover certain operating expenses. No
interest is charged by Humana. No due date is specified on the
amounts advanced.
(H) PHYSICIAN CONTRACTS
SPI, SPI Hillsborough and Midwest have entered into employment
agreements with its primary care physicians and into contracts
with various independent physicians to provide specialty and
other referral services both on a prepaid and a negotiated
fee-for-service basis. Midwest has also entered into a
consulting agreement with a physician. Prepaid physicians'
service costs are based upon a fixed fee per member, payable
on a monthly
F-40
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
basis. Such costs are included in the accompanying combined
statements of income as salaries and related benefits.
(I) MALPRACTICE AND PROFESSIONAL LIABILITY INSURANCE
The Company maintains professional liability insurance on a
claims-made basis through July 1996, including retrospective
coverage for acts occurring since inception of its operations.
Incidents and claims reported during the policy period are
anticipated to be covered by the malpractice carrier. The
Company intends to keep such insurance in force throughout the
foreseeable future.
At December 31, 1995, there are no asserted claims against the
Company that were not covered by the policy. Management of the
Company has accrued approximately $181,100 for incidents which
may have occurred but have yet to be identified under its
incident reporting system, based on industry experience.
Physicians providing medical services to members are provided
malpractice insurance coverage (claims-made basis), including
retrospective coverage for acts occurring since their
affiliation with the Company.
(J) MEMBERSHIP
Humana members assigned to SPI and SPI Hillsborough centers
include approximately 3,100, and 4,200 Medicare members,
respectively, and 3,400, and 5,300 commercial members,
respectively, at December 31, 1995 and 1994. At December 31,
1995, Humana members assigned to the Midwest center include
approximately 60 commercial and 200 Medicare members.
(K) STOP-LOSS FUNDING
The SPI and SPI Hillsborough centers are charged a stop-loss
funding fee by Humana for the purpose of limiting a center's
exposure to Part A costs and certain Part B costs associated
with a member's health services. At December 31, 1995, Midwest
was under a non-risk agreement with Humana, and as such no
stop-loss funding fees were charged to the Midwest center.
For the year ended December 31, 1993, the stop-loss threshold
which applies to Part A costs only, for Medicare members of
SPI and SPI Hillsborough, was $20,000 and $25,000,
respectively, per hospital stay within certain admitting-time
criteria. For commercial members, the threshold is $15,000 for
SPI and SPI Hillsborough per calendar year for both Part A and
Part B costs. For the year ended December 31, 1994, the stop-
F-41
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
loss threshold, which applies to Part A costs only, for
Medicare members was $28,000 for SPI and $32,600 for SPI
Hillsborough per calendar year. For commercial members, the
threshold is $20,000 for SPI and $28,000 for SPI Hillsborough
per calendar year for both Part A and Part B costs. For the
year ended December 31, 1995, the stop-loss threshold for both
Part A and Part B costs for Medicare members was $40,000 per
member per calendar year for both SPI and SPI Hillsborough.
For commercial members, the stop-loss threshold for both Part
A and Part B costs was $20,000 and $15,000 for SPI and SPI
Hillsborough, respectively.
Since the SPI and SPI Hillsborough centers are not responsible
for claims in excess of the threshold, income and the
corresponding expense, both equal to the stop-loss funding are
recognized by SPI and SPI Hillsborough. These amounts are
included in revenue and medical expenses, respectively, in the
accompanying combined statements of income. Stop-loss funding
for the SPI and SPI Hillsborough centers for the years ended
December 31, 1995, 1994 and 1993 was approximately $2,115,000,
$1,919,000, and $956,000, respectively.
The Company is responsible for payment of medical servicers
provided to is members by third party providers. As a result
of its agreements with Humana, which limits the Company's
exposure as to certain catastrophic and maternity claims, the
Company is reimbursed for the amounts in excess of certain
thresholds. Therefore, these amounts are shown as both
revenues and expenses.
(L) MATERNITY FUNDING
The SPI and SPI Hillsborough centers are charged a maternity
funding fee on commercial membership for the purpose of
limiting the centers' exposure to Part A and Part B costs
associated with a commercial member's pregnancy or related
illness. Since the SPI and SPI Hillsborough centers are not
responsible for claims in excess of the amount contributed to
the maternity fund, income and expenses both equal to the
maternity funding are recognized by SPI and SPI Hillsborough
and are included in revenue and medical expenses,
respectively, in the accompanying combined statements of
income. Maternity funding for the SPI and SPI Hillsborough
centers for the years ended December 31, 1995, 1994 and 1993
was approximately $825,000, $917,000, and $499,000,
respectively. At December 31, 1995, Midwest was under a
non-risk agreement with Humana and as such no maternity
funding fees were charged to the Midwest center.
F-42
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(A) PRINCIPLES OF CONSOLIDATION AND COMBINATION
The accompanying combined financial statements include the
accounts of the companies listed in note 1(a) which are
related through common ownership and management. All
significant intercompany balances and transactions have been
eliminated in the consolidation of MedExec, Inc. and
subsidiaries, and the subsequent combination of MedExec, SPI
and SPI Hillsborough.
(B) CASH AND CASH EQUIVALENTS
Cash and cash equivalents consist of demand deposits. For
purposes of the combined statements of cash flows, the Company
considers all highly liquid debt instruments with original
maturities of three months or less to be cash equivalents.
(C) PROPERTY AND EQUIPMENT
Property and equipment are stated at cost. Depreciation on
property and equipment is calculated on the straight-line
method over the estimated useful lives of the assets.
(D) INVESTMENTS IN OTHER AFFILIATED ENTITIES
The Company accounts for equity investments with a percentage
of ownership between 20 percent and 50 percent under the
equity method of accounting, which requires the recognition by
the Company of its pro rata share of the investee's income or
loss. Equity investments of less than 20 percent are carried
at cost.
(E) INTANGIBLE ASSETS
Intangible assets arose in business acquisitions. These
intangibles are being amortized on a straight-line basis over
five years. At December 31, 1995 and 1994, accumulated
amortization was approximately $9,200 and $6,600,
respectively.
(F) INCOME TAXES
MedExec, Inc. qualified as an S corporation for income tax
purposes at December 31, 1995, and 1994. MedExec, Inc. uses
accelerated depreciation methods for reporting
F-43
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
taxable income or losses which are passed through to
stockholders under the Company's S Corporation status. As
stated in footnote 14 to these combined financial statements,
effective January 1, 1996 MedExec's tax status automatically
changed from an S Corporation to a C Corporation. The effect
of this change will result in additional state and federal
deferred income taxes attributable to the temporary
differences at the time of change to be recorded as a deferred
tax liability with a corresponding reduction in income. The
deferred tax liabilities at December 31, 1995 and 1994 were
approximately $13,500 and $126,000. The amount of the
liability at December 31, 1995 would be payable in future
years as the net cumulative temporary differences reverse.
SPI qualified as an S corporation for income tax purposes at
December 31, 1993. In May 1994, the stockholders of SPI
voluntarily revoked SPI's election to be treated as an S
corporation pursuant to the Internal Revenue Code Section
1362(d).
Effective January 1, 1993, SPI Hillsborough and Dominion
adopted the provisions of Statement of Financial Accounting
Standards No. 109, "Accounting for Income Taxes" ("SFAS No.
109"). Effective May 1994, SPI adopted the provisions of SFAS
No. 109. The adoption of SFAS No. 109 had no cumulative effect
on the combined statements of income for the years ended
December 31, 1994 and 1993. Under the asset and liability
method of SFAS No. 109, deferred tax assets and liabilities
are recognized for the future tax consequences attributable to
differences between the financial statement carrying amounts
of existing assets and liabilities and their respective tax
bases and operating loss and tax credit carryforwards.
Deferred tax assets and liabilities are measured using enacted
tax rates expected to be applied to taxable income in the
years in which those temporary differences are expected to be
recovered or settled. Under SFAS No. 109, the effect on
deferred tax assets and liabilities of a change in tax rates
is recognized in income in the period that includes the
enactment date.
Under federal income tax principles, the Company cannot file a
consolidated income tax return. Thus, losses of one entity may
not offset income of another entity within the controlled
group.
(G) REVENUE AND MEDICAL COST RECOGNITION
Revenue from Humana for primary care, Part A, Part B and
supplemental funds are recognized monthly on the basis of the
number of Humana members assigned to the SPI and SPI
Hillsborough centers and the contractually agreed-upon rates.
The SPI and SPI Hillsborough centers receive monthly payments
from Humana after all medical expenses paid by Humana on
behalf of the SPI and SPI Hillsborough centers, estimated
claims incurred but not reported and claims reserve fund
balances have been determined. Medical expenses paid by Humana
on behalf of the Company, accordingly, are included in the
F-44
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
combined statements of operations. During 1995, Midwest
recognizes revenue based on the gross monthly guaranteed
payment amount. The Midwest center receives a net monthly
payment from Humana after all expenses paid by Humana on
behalf of the Midwest center have been determined. In addition
to Humana payments, the SPI, SPI Hillsborough and Midwest
centers receive copayments from commercial members for each
office visit, depending upon the specific plan and options
selected and receive payments from non-Humana members on a
fee-for-service basis.
Medical services are recorded as expenses in the period in
which they are incurred. Accrued medical claims for SPI and
SPI Hillsborough as reflected in the combined balance sheets
are based upon costs incurred for services rendered prior to
and up to the combined balance sheet date. Included are
services incurred but not reported as of the combined balance
sheet date based upon actual costs reported subsequent to the
combined balance sheet date and a reasonable estimate of
additional costs.
In the accompanying combined statements of operations, medical
expenses include amounts paid to hospitals, nursing care and
rehabilitative facilities, home health services, diagnostic
services, pharmacy costs, physician referral fees, and
hospital based physician costs.
(H) USE OF ESTIMATES
Management of the Company has made a number of estimates and
assumptions relating to the reporting of assets and
liabilities and the disclosure of contingent assets and
liabilities to prepare these consolidated financial statements
in conformity with generally accepted accounting principles.
Actual results could differ from those estimates.
(I) RECLASSIFICATIONS
Certain amounts in the 1994 and 1993 financial statements have
been reclassified to conform with the 1995 presentation.
(3) INVESTMENTS IN OTHER AFFILIATED ENTITIES
At December 31, 1993, MedExec had a 30 percent investment in HCO
Networks, Inc. ("HCON"), a claims management company. MedExec has
accounted for its initial investment of $300,000 under the equity
method. For the years ended December 31, 1995, 1994 and 1993, MedExec's
equity interest in the net income (loss) of HCON was approximately
$50,000, $28,000 and ($150,000), respectively.
F-45
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
At December 31, 1993, MedExec had an $800,000 investment in Midway
Airlines ("Midway"), which represented approximately 16 percent
ownership in Midway. The Company has accounted for its investment in
Midway under the cost method. During the year ended December 31, 1994,
the Company distributed as a dividend to its stockholders its
investment in Midway. The recorded value of the investment approximated
the fair value at the time of distribution.
At December 31, 1995 and 1994, MedExec had a 55 percent interest in
Dominion. Dominion has been consolidated in the accompanying combined
financial statements.
MedExec also has a 50 percent investment in SPI Managed Care of
Broward, Inc. ("SPI Broward"), a health care management company, and a
23.75 percent investment in Broward Managed Care, Inc. ("BMC"), which
operates two Humana primary care health centers. At December 31, 1995
and 1994, MedExec's investment in SPI Broward and BMC is $0 under the
equity method of accounting.
F-46
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
(4) PROPERTY AND EQUIPMENT, NET
Property and equipment, net consists of the following:
Estimated
1995 1994 Useful Lives
---- ---- ------------
Medical and office equipment $453,035 267,578 5 years
Furniture and fixtures 32,276 68,426 7 years
------- -------
485,311 336,004
Less accumulated depreciation 187,251 128,805
------- -------
Property and equipment, net $298,060 207,199
======= =======
(5) LOAN PAYABLE TO HUMANA
Loan payable to Humana represents funds advanced to Midwest for the
purchase and installation of a computer system and related training.
The loan is due by September 30, 2000 and is payable in monthly
installments beginning the first month during which Midwest is at full
risk under the terms of the Humana provider agreement. Monthly
installments to Humana will be a minimum of 10 percent of any positive
balance in Midwest's Part A fund. In the event no positive balance
exists in the Part A fund on or at any time after September 30, 1996,
Midwest shall make a minimum monthly payment of $1,268 until the loan
is repaid. Interest is payable at 10 percent per year unless the note
is paid in full by Midwest by September 30, 1996 at which point any
interest owed to Humana will be waived. Management believes that it
will repay the loan before September 30, 1996 and as such has not
accrued any interest at December 31, 1995. The loan is secured by the
computer equipment which has a book value of approximately $55,000 at
December 31, 1995.
(6) LOAN PAYABLE TO BANK
At December 31, 1995, Midwest had a $200,000 unsecured line of credit
bearing interest at prime. The line of credit is personally guaranteed
by all of the stockholders of MedExec at December 31, 1995. The
principal balance is due October 1, 1996, and interest is due monthly.
At December 31, 1995, $100,000 was drawn under this line of credit and
was used primarily for development costs relating to Midwest.
F-47
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
(7) LEASES
Future minimum lease payments required under non cancelable operating
leases at December 31, 1995 are as follows:
Year ended Operating
DECEMBER 31, LEASES
1996 $182,327
1997 188,584
1998 193,875
1999 3,968
Thereafter --
--------
Total minimum lease payments $568,754
========
Rent expense incurred under an assigned office lease agreement for the
years ended December 31, 1995, 1994 and 1993 amounted to approximately
$186,000, $70,000, and $54,000, respectively.
(8) Capital Stock
The shares' authorized, issued, related par value and additional
paid-in capital for each of the combined companies at December 31, 1995
and 1994 are as follows:
Stock Stock Stock total Additional
Authorized Issued par value paid-in capital
---------- ------ --------- ---------------
MedExec, Inc. 500 500 $ 500 700
SPI Managed Care, Inc. 500 500 500 500
SPI Managed Care of Hillsborough
County, Inc. 1,000 500 500 --
------ -----
$ 1,500 1,200
===== =====
(9) RELATED PARTY TRANSACTIONS
The Company paid salaries to stockholders of approximately $1,389,000,
$772,600, and $652,000 which are included in the combined statements of
income for the years ended December 31, 1995, 1994 and 1993,
respectively.
F-48
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
The Company recorded $111,459 and $225,288 in administration fee
revenue from SPI Broward during the years ended December 31, 1995 and
1994, respectively.
The Company recorded approximately $162,000 and $116,050 in utilization
revenue from BMC during the years ended December 31, 1995 and 1994,
respectively.
The Company had receivables from affiliates and related parties of
$59,023 and $196,745 at December 31, 1995 and 1994, respectively, and a
payable to related parties of $4,458 at December 31, 1995.
(10) FAIR VALUE OF FINANCIAL INSTRUMENTS
The carrying amount of financial instruments including cash, accounts
receivable, prepaid expenses and other current assets, accounts payable
and other accrued expenses, loan payable to Humana and loan payable to
bank approximate fair value at December 31, 1995 because of the short
maturity of these instruments.
(11) RETIREMENT PLANS
The Company sponsors 401(k) plans (the "Plans"). Employees who have
worked a minimum of six months or 1,000 hours and are at least 21 years
of age may participate in the Plans. Employees may contribute up to 14
percent of their annual salary, not to exceed $9,240 in 1995 and 1994,
and $8,994 in 1993, to the Plans. The Company's matching contribution
is 25 cents for each dollar of the employee's elected contribution, up
to four percent of the employee's annual salary. The Company's matching
contribution was approximately $21,000, $14,000, and $8,000 in 1995,
1994 and 1993, respectively.
(12) INCOME TAXES
Income tax expense consists of the following:
1995 1994 1993
---- ---- ----
Current expense (benefit):
federal and state $(120,279) 60,000 --
Deferred expense (benefit) 120,279 (60,000) --
------- ------- ------
$ -- -- --
========= ======== ======
F-49
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
A reconciliation of income tax expense and the amount that would be computed
using the statutory federal income tax rate is as follows:
1995 1994 1993
---------------------- -------------------- --------------
Amount Percent Amount Percent Amount Percent
------ ------- ------ ------- ------ -------
Tax expense (benefit)at the
statutory rate (137,839) (34%) 463,645 34% 272,967 34%
S corporation income taxed
at the stockholder level 95,277 23% (532,270) (39)% (292,767) (37)%
Change in the beginning-
of-the year balance of the
valuation allowance for
deferred tax assets
allocated to income tax
expense 42,562 11% 68,625 5% 19,800 3%
-------- --- --------- ----- --------- ----
$ -- -- -- -- -- --
======== === ========= ====== ========= =====
The tax effects of temporary differences that give rise to a significant portion
of the deferred tax assets and deferred tax liabilities of those entities for
which no Subchapter S election is in effect at December 31, 1995 and 1994, are
presented as follows:
1995 1994
---- ----
Deferred tax assets:
Revenue and expenses recognized for financial
reporting purposes in a different period than
for income tax purposes $ 7,646 127,925
Net loss carryforward 123,341 20,500
------- -------
Total deferred tax assets 130,987 148,425
Less valuation allowance (130,987) (88,425)
-------- --------
Net deferred tax asset -- 60,000
Deferred tax liabilities -- --
======= ======
Net deferred tax asset $ -- 60,000
======= ======
F-50
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
The valuation allowance for deferred tax assets as of January 1, 1994
was $19,800. The net change in the valuation allowance for the years
ended December 31, 1995 and 1994 is $42,562 and $68,625, respectively.
The Company reclassed $60,000 of its deferred tax asset as of December
31, 1995 to current tax receivable upon utilization of its net
operating loss.
At December 31, 1995, the companies not qualifying as S corporations,
collectively had a net operating loss carryforward of approximately
$486,000 for tax purposes, which expire in 2009.
(13) COMMITMENTS AND CONTINGENCIES
(A) GOVERNMENTAL REGULATION
The Company's operations have been and may continue to be
affected by various forms of governmental regulation and other
actions. It is presently not possible to predict the
likelihood of any such actions, the form which such actions
may take, or the effect such actions may have on the Company.
(B) STOCKHOLDER AGREEMENTS
The Company entered into employment agreements and change in
control severance agreements with the stockholders during
1994. Such agreements are in effect through April 1, 1999.
(14) SUBSEQUENT EVENTS
Effective January 1, 1996, the Company entered into an agreement with
First Medical Corporation ("FMC"). All of the outstanding shares of the
Company were converted into shares of FMC. In exchange for and in
conversion of all of the issued and outstanding shares of the Company,
FMC has issued and delivered common shares of FMC to the stockholders
of the Company.
Effective January 2, 1996, the Company acquired an additional one
percent interest in SPI Broward from Broward Medical Management ("BMM")
for $1.00 and an equal split of the profits of SPI Broward. Effective
January 2, 1996, the Company acquired an additional 27.25 percent
interest in Broward Managed Care from BMM for $100,000.
Effective January 1, 1996, the MedExec tax status automatically changed
from an S Corporation to a C Corporation as a result of its merger into
FMC. See Note 2(f) above.
On April 4, 1996, the Company sold its investment in HCON for $300,000,
resulting in a gain of $40,967.
F-51
MEDEXEC, INC. AND SUBSIDIARIES;
SPI MANAGED CARE, INC.; AND
SPI MANAGED CARE OF HILLSBOROUGH COUNTY, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
Effective February 1, 1996, the Company began operations in its Durham
center located in Houston, Texas.
The Company has entered into various employment and management services
agreements throughout 1996.
(15) OTHER MATTERS
In October, 1996 FMC entered into a merger agreement with The Lehigh
Group, Inc. ("Lehigh") whereby upon merger FMC would control
approximately 96 percent of the merged company. In connection with the
proposed merger, which is subject to stockholder approval of both
companies, FMC and Lehigh have been named in a lawsuit. In the opinion
of FMC and its legal counsel, such suit will not have a material effect
on the financial statements of FMC, if not resolved favorably.
In June, 1996 FMC entered into a subscription agreement with Generale
De Sante International, PLC ("GDS") by which GDS has the right to
purchase various percentages of interest in both FMC and its
subsidiaries.
F-52
INDEPENDENT AUDITORS' REPORT
The Board of Directors
Broward Managed Care, Inc.:
We have audited the accompanying balance sheets of Broward Managed Care, Inc. as
of December 31, 1995, and the related statements of operations, stockholders'
deficit and cash flows for the year then ended. These financial statements are
the responsibility of the Company's management. Our responsibility is to express
an opinion on these financial statements based on our audits.
We conducted our audit in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audit provides a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Broward Managed Care, Inc. as
of December 31, 1995, and the results of its operations and its cash flows for
the year then ended, in conformity with generally accepted accounting
principles.
/s/ KPMG PEAT MARWICK LLP
Miami, Florida
May 17, 1996
F-53
BROWARD MANAGED CARE, INC.
BALANCE SHEET
December 31, 1995
ASSETS
Current assets:
Cash and cash equivalents $ 201,324
Humana IBNR receivable 2,610,941
Claims reserve funds 174,842
Other receivable 1,514
---------
Total current assets 2,988,621
Property and equipment, net 93,843
----------
$3,082,464
=========
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable and other accrued expenses 666,169
Accrued medical claims, including amounts incurred but not reported 2,332,102
Due to Humana 99,237
Due to related parties 134,986
Income taxes payable 10,085
---------
Total current liabilities 3,242,579
---------
Commitments and contingencies
Stockholders' deficit:
Capital stock, $.01 par value. Authorized 1,000 shares; issued
and outstanding 500 shares
5
Accumulated deficit (160,120)
-----------
Total stockholders' deficit (160,115)
----------
$3,082,464
==========
See accompanying notes to financial statements.
F-54
BROWARD MANAGED CARE, INC.
STATEMENT OF OPERATIONS
Year ended December 31, 1995
Revenue $26,234,531
Medical expenses 23,632,301
----------
Gross profit 2,602,230
Operating expenses:
Salaries and related benefits 894,456
Depreciation and amortization 17,909
Other 1,515,054
----------
Total operating expenses 2,427,419
----------
Income before income taxes 174,811
Income tax expense 10,085
-----------
Net income $ 164,726
==========
See accompanying notes to financial statements.
F-55
BROWARD MANAGED CARE, INC.
STATEMENT OF STOCKHOLDERS' DEFICIT
Year ended December 31, 1995
Total
Capital Accumulated stockholder's
stock deficit deficit
Balance, December 31, 1994 $ 5 (324,846) (324,841)
Net income - 164,726 164,726
- ------- -------
Balance, December 31, 1995 $ 5 (160,120) (160,115)
= ======= =======
See accompanying notes to financial statements.
F-56
BROWARD MANAGED CARE, INC.
STATEMENT OF CASH FLOWS
Year ended December 31, 1995
Cash flows from operating activities:
Net income $ 164,726
Adjustments to reconcile net income to net cash used in operating
activities:
Depreciation and amortization 17,909
Decrease (increase) in assets:
Humana IBNR receivable 1,104,052
Claims reserve funds (174,842)
Other receivable (1,514)
Decrease in liabilities:
Accounts payable and other accrued expenses (2,298)
Accrued medical claims, including amounts incurred but not
reported (949,597)
Due to Humana (141,303)
Due to related parties (73,676)
------------
Net cash used in operating activities (56,543)
------------
Cash flows from investing activities:
Capital expenditures (69,250)
-----------
Net cash used in investing activities (69,250)
----------
Decrease in cash and cash equivalents (125,793)
Cash and cash equivalents, beginning of year 327,117
----------
Cash and cash equivalents, end of year $ 201,324
==========
See accompanying notes to financial statements.
F-57
BROWARD MANAGED CARE, INC.
NOTES TO FINANCIAL STATEMENTS
December 31, 1995
(1) ORGANIZATION AND OPERATIONS
(A) ORGANIZATION
Broward Managed Care, Inc. ("BMC") was incorporated in the
state of Florida on January 21, 1994 and is owned 71.25
percent by Broward Medical Management, Inc. ("BMM"), 23.75
percent by MedExec, Inc. ("MedExec") and 5 percent by the
medical director of the BMC centers.
BMC provides health care services subject to affiliated
provider agreements entered into with Humana Medical Plan,
Inc.; Humana Health Plan of Florida, Inc.; and Humana
Health Insurance Company of Florida, Inc. and their
affiliates (collectively known as "Humana"). Health
services are provided to Humana members through BMC's
primary care medical centers and BMC's network of
physicians and health care specialists. For the year ended
December 31, 1995, approximately 99 percent of BMC's
revenue is from such agreements with Humana.
BMC operates two centers in Broward County, Florida
(collectively known as the "BMC centers"): in Margate
("Margate") and in Plantation ("Plantation").
SPI Managed Care of Broward, Inc. ("SPI Broward") was
incorporated in the state of Florida on July 15, 1992, and
manages Margate and Plantation.
(B) AFFILIATED PROVIDER AGREEMENTS
Effective February 1, 1994 and May 1, 1994, BMC through
Margate and Plantation, respectively, entered into provider
agreements with Humana, which will continue indefinitely
unless terminated according to certain provisions of the
agreements. Such agreements specify that either party may
elect to terminate the agreements, with or without cause,
at any time upon giving 60 days written notice. In
addition, these agreements may be terminated by mutual
written consent of both parties at any time. Amendments to
the original provider agreements with Humana were entered
into effective September 1, 1994 under full-risk agreements
for Margate and Plantation.
Services to be provided by the BMC centers include medical
and surgical services, including all procedures furnished
in a physician's office, such as x-rays, nursing services,
blood work and other incidentals, drugs and medical
supplies. The BMC centers are responsible for providing all
such services and for directing and authorizing all other
care, including emergency and inpatient care for Humana
members. The BMC centers are also financially responsible
for all out-of-area care rendered to a member and provide
direct care as soon as the member is able to return to the
designated medical center.
Humana has agreed to pay the BMC centers monthly for
services provided to members based on a predetermined
amount per member ("capitation"), comprised of in-hospital
services and other services defined by contract ("Part A"),
in-office ("Primary") and other medical services defined by
the agreements ("Part B").
(Continued)
F-58
(C) HUMANA IBNR RECEIVABLE
Humana withholds a certain amount each month from the BMC
centers' Part A, Part B and supplemental funding in order
to cover claims incurred but not reported or paid. This
amount is to be used by Humana to pay the centers' Part A,
Part B and supplemental costs. The amounts withheld by
Humana to cover incurred but not reported on paid claims
varies by center based on the history of the respective
center and is determined solely by Humana. The amounts
withheld are used to pay the centers' medical claims which
Humana pays on the centers' behalf. The remaining amount
after claims have been paid is remitted to the Company [see
note 1(d)].
(D) CLAIMS RESERVE FUNDS
Humana withholds a certain amount each month from the BMC
centers' Part A capitation funding. This amount represents
a "catastrophic reserve fund" to be utilized for the
payment of the centers' Part A costs in the event a center
ceases operations and the incurred but not reported
reserves are not adequate to reimburse providers for Part A
services rendered. This amount is calculated monthly by
Humana.
(E) DUE TO HUMANA
Due to Humana represents amounts advanced to BMC by Humana
to cover certain operating expenses. No interest is charged
by Humana. No due date is specified on the amounts
advanced.
(F) DUE TO RELATED PARTIES
Due to related parties represents current amounts payable
to MedExec for operating expenses covered by MedExec.
(G) PHYSICIAN CONTRACTS
BMC has entered into employment agreements with its primary
care physicians and has entered into contracts with various
independent physicians, to provide specialty and other
referral services both on a prepaid and a negotiated
fee-for-service basis. Prepaid physicians' service costs
are based upon a fixed fee per member, payable on a monthly
basis. Such costs are included in the accompanying
statement of operations as salaries and related benefits.
(H) MALPRACTICE AND PROFESSIONAL LIABILITY INSURANCE
BMC maintains professional liability insurance on a
claims-made basis through July 1996, including
retrospective coverage for acts occurring since the
inception of its operations. Incidents and claims reported
during the policy period are anticipated to be covered by
the malpractice carrier. BMC intends to keep such insurance
in force throughout the foreseeable future.
At December 31, 1995, there are no asserted claims against
BMC that were not covered by the policy. Management of BMC
has accrued approximately $189,700 for incidents which may
have occurred but have yet to be identified under its
incident reporting system, based on industry experience.
Physicians providing medical services to members are
provided malpractice insurance coverage (claims-made
basis), including retrospective coverage for acts occurring
since their affiliation with BMC.
(I) MEMBERSHIP
At December 31, 1995, Humana members assigned to the BMC
centers include approximately 3,000 Medicare members and
7,400 commercial members.
(J) STOP-LOSS FUNDING
The BMC centers are charged a stop-loss funding fee by
Humana for the purpose of limiting a center's exposure to
Part A costs and certain Part B costs associated with a
member's health services.
F-59
For the year ended December 31, 1995, the stop-loss
threshold, which applies to both Part A and Part B costs
for Medicare members, was $40,000 per member per calendar
year. For commercial members, the stop-loss threshold for
both Part A and Part B costs was $20,000 per calendar year.
Since the BMC centers are not responsible for claims in
excess of the threshold, income and the corresponding
expense, both equal to the stop-loss funding are recognized
by BMC. These amounts are included in revenue and medical
expenses, respectively, in the accompanying statement of
operations. For the year ended December 31, 1995, stop-loss
funding for the BMC centers was approximately $2,742,000.
(K) MATERNITY FUNDING
The BMC centers are charged a maternity funding fee on
commercial membership for the purpose of limiting the
centers' exposure to Part A and Part B costs associated
with a commercial member's pregnancy or related illness.
Since the BMC centers are not responsible for claims in
excess of the amount contributed to the maternity fund,
income and expenses both equal to the maternity funding are
recognized by BMC and are included in revenue and medical
expenses, respectively, in the accompanying statement of
operations. For the year ended December 31, 1995, maternity
funding for the BMC centers was approximately $2,473,000.
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(A) CASH AND CASH EQUIVALENTS
Cash and cash equivalents consist of demand deposits. For
purposes of the statement of cash flows, BMC considers all
highly liquid debt instruments with original maturities of
three months or less to be cash equivalents.
F-60
(B) REVENUE AND MEDICAL COST RECOGNITION
Revenue from Humana for primary care, Part A, Part B and
supplemental funds are recognized monthly on the basis of
the number of Humana members assigned to the BMC centers
and the contractually agreed-upon rates. The BMC centers
receive monthly payments from Humana after all medical
expenses paid by Humana on behalf of the BMC centers,
estimated claims incurred but not reported and claims
reserve fund balances have been determined. Medical
expenses paid by Humana on behalf of the Company,
accordingly, are included in the accompanying statement of
operations. In addition to Humana payments, the BMC centers
receive copayments from commercial members for each office
visit depending upon the specific plan and options selected
and receive payments from non-Humana members on a
fee-for-service basis.
Medical services are recorded as expenses in the period in
which they are incurred. Accrued medical claims as
reflected in the balance sheet are based upon costs
incurred for services rendered prior to and up to the
balance sheet date. Included are services incurred but not
reported as of the balance sheet date based upon actual
costs reported subsequent to the balance sheet date and a
reasonable estimate of additional costs. In the
accompanying statement of operations medical expenses
include amounts paid to hospitals, nursing care and
rehabilitation facilities, home health services, diagnostic
services, pharmacy costs, physician referral fees and
hospital-based physician costs.
(C) PROPERTY AND EQUIPMENT
Property and equipment are stated at cost. Depreciation on
property and equipment is calculated on the straight-line
method over the estimated useful lives of the assets.
(D) INCOME TAXES
Effective January 1994, BMC adopted the provisions of
Statement of Financial Accounting Standards No. 109,
"Accounting for Income Taxes" ("SFAS No. 109"). Under the
asset and liability method of SFAS No. 109, deferred tax
assets and liabilities are recognized for the future tax
consequences attributable to differences between the
financial statement carrying amounts of existing assets and
liabilities and their respective tax bases and operating
loss and tax credit carryforwards. Deferred tax assets and
liabilities are measured using enacted tax rates expected
to be applied to taxable income in the years in which those
temporary differences are expected to be recovered or
settled. Under SFAS No. 109, the effect on deferred tax
assets and liabilities of a change in tax rates is
recognized in income in the period that includes the
enactment date.
(E) USE OF ESTIMATES
Management of BMC has made a number of estimates and
assumptions relating to the reporting of assets and
liabilities and the disclosure of contingent assets and
liabilities to prepare these financial statements in
conformity with generally accepted accounting principles.
Actual results could differ from those estimates.
F-61
(3) PROPERTY AND EQUIPMENT, NET
Property and equipment, net consists of the following:
Estimated
useful lives
------------
Computer equipment $113,132 5 years
Medical and office equipment 5,886 5 years
-------
119,018
Less accumulated depreciation 25,175
---------
Property and equipment, net $ 93,843
=======
(4) RELATED PARTY TRANSACTIONS
At December 31, 1995, BMC had a payable of $134,986 to related
parties for operating expenses paid by MedExec on BMC's behalf.
BMC recorded approximately $162,000 in utilization expenses to
MedExec during the year ended December 31, 1995.
(5) FAIR VALUE OF FINANCIAL INSTRUMENTS
The carrying amount of financial instruments including cash, other
receivables, and accounts payable and other accrued expenses
approximates fair value at December 31, 1995 because of the short
maturity of these instruments.
(6) RETIREMENT PLANS
BMC sponsors 401(k) plans (the "Plans"). Employees who have worked a
minimum of six months or 1,000 hours and are at least 21 years of
age may participate in the Plans. Employees may contribute up to 14
percent of their annual salary, not to exceed $9,240 in 1995, to the
Plans. BMC's matching contribution is 25 cents for each dollar of
the employee's elected contribution, up to four percent of the
employee's annual salary. BMC's matching contribution was
approximately $14,000 for the year ended December 31, 1995.
(7) INCOME TAXES
Income tax expense consists of the following:
Current:
Federal $ 7,590
State 2,495
-------
$10,085
=======
F-62
BROWARD MANAGED CARE, INC.
NOTES TO FINANCIAL STATEMENTS
A reconciliation of income tax expense and the amount that would be
computed using the statutory federal income tax rate is as follows:
Tax expense at the statutory rate $ 59,436
Change in the beginning-of-the-year
balance of the valuation
allowance for deferred tax assets
allocated to income tax expense (22,000)
State taxes, net of related federal
benefit 6,346
Other (24,813)
Decrease in tax liability due to
graduated federal tax rates (8,884)
--------
$ 10,085
========
There are no deferred tax assets or liabilities at December 31,
1995.
The valuation allowance for deferred tax assets at January 1, 1995
was $22,000. The net change in the valuation allowance for the year
ended December 31, 1995 is $22,000.
(8) GOVERNMENTAL REGULATION
BMC's operations have been and may continue to be affected by
various forms of governmental regulation and other actions. It is
presently not possible to predict the likelihood of any such
actions, the form which such actions may take, or the effect such
actions may have on BMC.
(9) SUBSEQUENT EVENTS
Effective January 2, 1996, MedExec purchased an additional 71.25
percent interest in BMC from BMM.
F-63
INDEPENDENT AUDITORS' REPORT
The Board of Directors
SPI Managed Care of Broward, Inc.:
We have audited the accompanying balance sheets of SPI Managed Care of Broward,
Inc. as of December 31, 1995 and 1994, and the related statements of operations,
stockholders' equity (deficit) and cash flows for the years then ended. These
financial statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of SPI Managed Care of Broward,
Inc. as of December 31, 1995 and 1994, and the results of its operations and its
cash flows for the years then ended, in conformity with generally accepted
accounting principles.
/s/ KPMG PEAT MARWICK LLP
Miami, Florida
May 17, 1996
F-64
SPI MANAGED CARE OF BROWARD, INC.
BALANCE SHEETS
December 31, 1995 and 1994
ASSETS 1995 1994
------ ---- ----
Cash and cash equivalents $ 20,119 46,762
Due from affiliates and related parties, net 85,303 -
Deferred tax asset - 10,060
------- ------
Total current assets 105,422 56,822
Furniture and equipment, net 10,903 14,377
Other assets 760 760
------- ------
$117,085 71,959
======= ======
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Liabilities:
Accounts payable and accrued expenses 14,442 7,760
Due to affiliates and related parties, net - 71,014
Income taxes payable 11,643 -
Deferred tax liabilities 29,473 10,060
------- ------
Total current liabilities 55,558 88,834
------- ------
Commitments and contingencies
Stockholders' equity (deficit):
Capital stock, $.01 par value.
Authorized 1,000 shares; issued
and outstanding 500 shares 5 5
Retained earnings (accumulated deficit) 61,522 (16,880)
------ -------
Total stockholders' equity (deficit) 61,527 (16,875)
------ --------
$117,085 71,959
======= ======
See accompanying notes to financial statements.
F-65
SPI MANAGED CARE OF BROWARD, INC.
STATEMENTS OF OPERATIONS
Years ended December 31, 1995 and 1994
1995 1994
---- ----
Management consulting fee income $579,951 682,601
Operating expenses:
Consulting fees to stockholders 222,660 450,576
Salaries 163,132 137,707
Depreciation 3,474 3,165
Other 71,167 91,153
-------- --------
Total operating expenses 460,433 682,601
------- -------
Income before income taxes 119,518 -
Income tax expense 41,116 -
------- ----
Net income $ 78,402 -
======== ====
See accompanying notes to financial statements.
F-66
SPI MANAGED CARE OF BROWARD, INC.
STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)
Years ended December 31, 1995 and 1994
Total
Accumulated stockholders'
Capital earnings equity
stock (deficit) (deficit)
----- --------- ---------
Balance, December 31, 1993 $ 5 (16,880) (16,875)
Net income - - -
---- -------- --------
Balance, December 31, 1994 5 (16,880) (16,875)
Net income - 78,402 78,402
---- ------- ------
Balance, December 31, 1995 $ 5 61,522 61,527
==== ======= ======
See accompanying notes to financial statements.
F-67
SPI MANAGED CARE OF BROWARD, INC.
STATEMENTS OF CASH FLOWS
Years ended December 31, 1995 and 1994
1995 1994
---- ----
Cash flows from operating activities:
Net income 78,402 -
Adjustments to reconcile net income to net cash (used in)
provided by operating activities:
Depreciation and amortization 3,474 3,165
Deferred income taxes 29,473 -
Change in assets and liabilities:
Accounts payable and accrued expenses 6,682 7,760
Due to affiliates and related parties, net (156,317) 44,201
Income taxes payable 11,643 -
------ -------
Net cash (used in) provided by operating activities (26,643) 55,126
------- -------
Cash flows from investing activities:
Capital expenditures - (11,171)
------- ------
(Decrease) increase in cash and cash equivalents (26,643) 43,955
Cash and cash equivalents, beginning of year 46,762 2,807
------ -------
Cash and cash equivalents, end of year $20,119 46,762
====== ======
See accompanying notes to financial statements.
F-68
SPI MANAGED CARE OF BROWARD, INC.
NOTES TO FINANCIAL STATEMENTS
December 31, 1995 and 1994
(Continued)
(1) ORGANIZATION AND OPERATIONS
SPI Managed Care of Broward County, Inc. ("SPI Broward"),
incorporated in the state of Florida on July 15, 1992, is owned 50
percent by MedExec, Inc. ("MedExec") and 50 percent by Broward
Medical Management, Inc. ("BMM").
SPI Broward has management services agreements with an affiliate of
BMM and a nonaffiliated multispecialty group practice to manage
their managed care divisions.
MedExec and BMM provide management consulting services to SPI
Broward. The cost of such services are included in the statement of
operations as consulting fees to stockholders.
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(A) CASH AND CASH EQUIVALENTS
Cash and cash equivalents consist of demand deposits. For
purposes of the statements of cash flows, SPI Broward
considers all highly liquid debt instruments with original
maturities of three months or less to be cash equivalents.
(B) FURNITURE AND EQUIPMENT
Furniture and equipment are stated at cost. Depreciation on
furniture and equipment is calculated on the straight-line
method over the estimated useful lives of the assets.
(C) DUE TO AFFILIATES AND RELATED PARTIES, NET
Due to affiliates and related parties, net represents
amounts paid by affiliates and related parties to cover
certain SPI Broward operating expenses. The amounts bear no
interest and have no due date.
(D) REVENUE RECOGNITION
Revenue is recognized monthly on the basis of the number of
members managed at contractually agreed upon rates,
adjusted by the profits and losses of the respective
companies managed.
SPI Broward receives monthly and quarterly payments based
on the above agreements.
(E) INCOME TAXES
Under the asset and liability method of Statement of
Financial Accounting Standards No. 109 ("SFAS No. 109"),
deferred tax assets and liabilities are recognized for the
future tax consequences attributable to differences between
the financial statement carrying amounts of existing assets
and liabilities and their respective tax bases and
operating loss and tax credit carryforwards. Deferred tax
assets and liabilities are measured using enacted tax rates
expected to be applied to taxable income in the years in
which those temporary differences are expected to be
recovered or settled. Under SFAS No. 109, the effect on
deferred tax assets and liabilities of a change in tax
rates is recognized in income in the period that includes
the enactment date.
F-69
(F) USE OF ESTIMATES
Management of SPI Broward has made a number of estimates
and assumptions relating to the reporting of assets and
liabilities and the disclosure of contingent assets and
liabilities to prepare these financial statements in
conformity with generally accepted accounting principles.
Actual results could differ from those estimates.
(3) FURNITURE AND EQUIPMENT, NET
Furniture and equipment, net consists of the following:
Estimated
1995 1994 useful life
---- ---- -----------
Furniture 2,612 2,612 7 years
Equipment 15,513 15,513 5 years
------ ------
18,125 18,125
Less accumulated depreciation 7,222 3,748
------- -------
Furniture and equipment, net 10,903 14,377
====== ======
(4) RELATED-PARTY TRANSACTIONS
At December 31, 1995, SPI Broward had a net receivable from
affiliates and related parties of $85,303 and a net payable to
related parties of $71,014 at December 31, 1994.
At December 31, 1995 and 1994, consulting fees to stockholders
represents SPI Broward's payment of approximate $111,000 and
$225,000, respectively, to each of its stockholders, MedExec and
BMM.
(5) FAIR VALUE OF FINANCIAL INSTRUMENTS
The carrying amount of financial instruments including cash, and
accounts payable and accrued expenses approximate fair value at
December 31, 1995 because of the short maturity of these
instruments.
(6) RETIREMENT PLANS
SPI Broward sponsors 401(k) plans (the "Plans"). Employees who have
worked a minimum of six months or 1,000 hours and are at least 21
years of age may participate in the Plans. Employees may contribute
up to 14 percent of their annual salary, not to exceed $9,240 in
1995 and 1994, to the Plans. SPI Broward's matching contribution is
25 cents for each dollar of the employee's elected contribution, up
to four percent of the employee's annual salary.
SPI Broward's matching contribution was approximately $4,300 and
$100 in 1995 and 1994, respectively.
F-70
(7) INCOME TAXES
Income tax benefit consists of the following:
1995 1994
---- ----
Current (benefit) expense $11,643 -
Deferred expense (benefit) 29,473 -
------ ----
$41,116 -
====== ====
A reconciliation of income tax expense and the amount that would be
computed using the statutory federal income tax rate is as follows:
Tax expense at statutory rate $40,637
State taxes, net of federal benefit 4,339
Other 5,799
Increase in tax liability due to graduated
federal tax rates (9,659)
-------
$41,116
=======
The tax effects of temporary differences that give rise to a
significant portion of the deferred tax assets and deferred tax
liabilities at December 31, 1995 and 1994 are as follows:
1995 1994
---- ----
Deferred tax assets:
Total deferred tax assets $ - 10,060
Less valuation allowance - -
----- ------
Net deferred tax asset - 10,060
Revenue and expenses recognized for financial - -
reporting purposes in a different period
than for income tax purposes
Deferred tax liabilities (29,473) 10,060
------- ------
Net deferred tax (liability) asset (29,473) 10,060
====== =======
There was no valuation allowance at December 31, 1995 and 1994, and
there was no change in the valuation allowance for the year ended
December 31, 1995.
(8) SUBSEQUENT EVENTS
Effective January 2, 1996, MedExec acquired an additional fifty
percent interest in SPI Broward from BMM.
F-71
REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
To The Board of Directors and Shareholders of
The Lehigh Group Inc.:
We have audited the accompanying consolidated balance sheets of The Lehigh Group
Inc. and subsidiaries as of December 31, 1996 and 1995, and the related
consolidated statements of operations, shareholders' equity (deficit) and cash
flows for each of the three years in the period ended December 31, 1996. We have
also audited the schedule listed in the accompanying index. These financial
statements and schedule are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements and
schedule based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements and schedule are
free of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements and
schedule. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
presentation of the financial statements and schedule. We believe that our
audits provides a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the financial position of The Lehigh Group
Inc. and subsidiaries at December 31, 1996 and 1995, and the results of its
operations and its cash flows for each of the three years in the period ended
December 31, 1996, in conformity with generally accepted accounting principles.
Also in our opinion, the schedule presents fairly, in all material respects, the
information set forth therein.
/S/ BDO SEIDMAN, LLP
--------------------
BDO Seidman, LLP
New York, New York
February 18, 1997
F-72
LEHIGH GROUP INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
December 31,
1996 1995
- ------------------------------------------------------------------------------------------------------------------------
(in thousands except for per share data)
ASSETS
Current assets:
Cash and cash equivalents $ 471 $ 347
Accounts receivable, net of allowance for 3,581 4,335
doubtful accounts of $342 and $174 (Notes 6 and 10)
Inventories (Note 6) 1,215 1,823
Prepaid expenses and other current assets 279 22
------- -------
Total current assets 5,546 6,527
Property, plant and equipment, net of 50 61
accumulated depreciation and amortization
(Note 5 and 6)
Other assets 29 34
------- -------
Total assets $5,625 $6,622
====== ======
The accompanying notes to consolidated financial statements are an integral part
of these financial statements.
F-73
THE LEHIGH GROUP INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
December 31,
1996 1995
- --------------------------------------------------------------------------------------------------------------------------
` (in thousands except for per share data)
LIABILITIES AND SHAREHOLDERS'
EQUITY
Current liabilities:
Current maturities of long-term debt (Note 6) $ 390 $ 510
Note payable -bank (Note 6) -- 360
Accounts payable 954 1,839
Accrued expenses and other current liabilities (Notes 5, 6 and 8) 1,642 1,381
------ -----
Total current liabilities 2,986 4,090
----- -----
Long-term debt, net of current maturities 2,725 2,080
----- ------
(Note 6)
Deferred credit applicable to the sale of continued -- 250
------- -------
operations (Note 4)
Commitments and Contingencies (Notes 6 and 8)
Shareholders' equity (Deficit)
Preferred stock, par value $.001; authorized
5,000,000 shares, none issued -- --
Common stock, par value $.001 authorized shares 100,000,000 , in 1996 and 1995;
shares issued 10,339,250 in 1996 and 1995
which excludes 3,016,249 and 3,016,249
shares held as treasury stock in 1996 and
1995 , respectively 11 11
Additional paid-in capital (Note 6) 106,594 106,594
Accumulated deficit from January 1, 1986 (105,037) (104,749)
Treasury stock - at cost (1,654) (1,654)
--------- ---------
Total shareholders' equity (Deficit) (86) 202
---------- ---------
Total liabilities and shareholders' equity (Deficit) $ 5,625 $ 6,622
======= =======
The accompanying notes to consolidated financial statements are an integral part
of these financial statements.
F-74
THE LEHIGH GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
Years ended December 31, 1996 1995 1994
- --------------------------------------------------------------------------------------------------------------------------------
(in thousands except for per share
data)
Revenues earned (Note 10) $10,446 $12,105 $12,247
Costs of revenues earned 7,134 8,628 8,577
------ ------ ------
Gross Profit 3,312 3,477 3,670
Selling, general and administrative expenses 3,874 3,994 4,187
------ ------ ------
Operating loss (562) (517) (517)
------- ------- -------
Other income (expense):
Interest expense (471) (433) (398)
Interest and other income (Note 6) 113 392 505
----- ------ -----
(358) (41) 107
------ ------- -----
Loss before discontinued operations and
extraordinary item (920) (558) (410)
Income from discontinued operations (Note 250 250 5,000
----- ----- -----
4)
Income (loss) before extraordinary item (670) (308) 4,590
Extraordinary item:
Gain on early extinguishment of debt
(Note 6) 382 -- --
----- ------ ------
Net income (loss) $ (288) $ (308) $ 4,590
======== ======== =======
EARNINGS PER SHARE - PRIMARY AND FULLY
DILUTED
Loss before discontinued operations and
extraordinary item $ (0.09) $ (0.05) $ (0.04)
Income from discontinued operations 0.02 0.02 0.49
Income (loss) before extraordinary item (0.07) (0.03) 0.45
Net Income (loss) (0.03) (0.03) 0.45
Weighted average Common Shares
and share equivalents outstanding
Primary and Fully diluted 10,339,250 10,339,250 10,169,000
============ ========== ==========
The accompanying notes to consolidated financial statements are an integral part
of these financial statements.
F-75
THE LEHIGH GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT)
Years Ended December 31, 1996, 1995 and 1994
- -----------------------------------------------------------------------------------------------------------------------------------
(in thousands)
Preferred Stock Common Stock
-------------- -------------------
Additional Treasury
Number of Number Paid-In Deficit From Stock At
Shares Amount of Shares Amount Capital Jan. 1, 1986 Cost Total
------------ ------- -------- -------- ---------- ------------ ----------- ---------
Balance January 1, 1994 -- $-- 7,658 $11 $105,575 $(109,031) $(1,654) $(5,099)
Issuance of common
stock in connection
with private placement 2,681 1,019 1,109
-- $ -- -- -- 4,590 -- $ 4,590
--- ------ ------ ------ ------ ------------ ------ --------
Net Income ------------ -------
Balance December 31, 1994 -- 10,339 $11 $106,594 $(104,441) $(1,654) $ 510
=== ====== ====== === ======== =========== ======== ======
Net Loss -- -- -- -- $ (308) -- $(308)
--- ------ ------ ------ ------ ----------- ------- --------
Balance December 31, 1995 $ -- 10,339 $11 $106,594 $(104,749 ) $(1,654) $ 202
--- ------ ====== === ======== =========== ======== --------
Net Loss -- -- -- $-- $ (288) -- $(288)
--- ------ ------ ---- ------ ----------- ------ --------
Balance December 31, 1996 -- $ -- 10,339 $11 $106,594 ($105,037) $(1,654) $ (86)
--- ------ ====== === ======== ========= ========= --------
The accompanying notes to consolidated financial statements are an integral part
of these financial statements.
F-76
THE LEHIGH GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (Note 11)
Years Ended December 31, 1996 1995 1994
- -----------------------------------------------------------------------------------------------------------------------------
(in thousands)
Cash flows from operating activities:
Net income (loss) (288) $ (308) $4,590
Adjustments to reconcile net income (loss) to net
cash used in operating activities:
Gain on early extinguishment of debt (382) -- --
Depreciation and amortization 29 65 59
Deferred credit applicable to sale of discontinued operations (250) (250) (5,000)
Changes in assets and liabilities:
Accounts receivable 754 276 93
Inventories 608 (78) (108)
Prepaid expenses and other current assets (257) 55
Other assets 5 (1) 6
Accounts payable (885) (72) 64
Accrued expenses and other current liabilities 442 101 81
----- ------ -----
Net cash used in operating
activities (224) (267) (160)
------- ------- ------
Cash flows from investing activities:
Capital expenditures (18) (21) (39)
------ ------ -----
Cash flows from financing activities:
Repayment of capital leases (10) (20) (3)
Net payments under bank debt (2,340) (270) (360)
Payment on subordinated debenture (9) -- --
Net proceeds from sale of stock --- -- 1,019
Issuance of convertible debenture 300 -- --
Net borrowings from C.I.T. revolver 2,425 -- --
------ ----- -----
Net cash provided by (used in) financing
activities 366 (290) 656
--------- ------- ------
Net change in cash and cash equivalents 124 (578) 457
Cash and cash equivalents at beginning of period 347 925 468
----- ----- -----
Cash and cash equivalents at end of period $ 471 $ 347 $ 925
====== ====== ======
The accompanying notes to consolidated financial statements are an integral part
of these financial statements.
F-77
THE LEHIGH GROUP INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(TABLES INCLUDED IN THE FOOTNOTES ARE IN THOUSANDS EXCEPT FOR PER SHARE DATA)
1 - General
The Lehigh Group Inc. (the "Company"), through its wholly owned
subsidiary, HallMark Electrical Supplies Corp. ("HallMark"), is engaged in the
distribution of electrical supplies for the construction industry both
domestically (primarily in the New York Metropolitan area) and for export.
HallMark was acquired by the Company in December 1988. HallMark's sales include
electrical conduit, armored cable, switches, outlets, fittings, panels and wire
which are purchased by HallMark from electrical equipment manufacturers in the
United States. Approximately 70% of HallMark's sales are domestic and 30% are
export. Export sales are made by sales agents retained by HallMark. Distribution
is made in approximately 26 countries.
EXPORT SALES AS A PERCENTAGE OF TOTAL SALES ARE SUMMARIZED AS FOLLOWS:
December 31,
1996 1995 1994
Central America 10% 16% 14%
South America 8% 18% 16%
Caribbean 6% 6% --
West Indies 2% -- 6%
OTHER 4% -- 2%
- ---------------------- --- ---- ---
Total 30% 40% 38%
=== === ===
2 - Summary of Significant Accounting Policies
PRINCIPLES OF CONSOLIDATION - The consolidated financial statements include all
of the accounts of the Company and its wholly owned subsidiaries. All
intercompany accounts and transactions have been eliminated in consolidation.
INVENTORIES - Inventories are stated at the lower of cost or market using a
first-in, first-out basis to determine cost. Inventories consist of electrical
supplies held for resale.
PROPERTY, PLANT AND EQUIPMENT - Property, plant and equipment are carried at
cost. Depreciation is provided on the straight-line method over the estimated
useful lives of the related assets. Amortization of leasehold improvements are
provided over the life of each respective lease.
INCOME TAXES - The Company uses the liability method of accounting for deferred
income taxes. The provision for income taxes typically includes Federal, state
and local income taxes currently payable and those deferred because of temporary
timing differences between the financial statement and taxes bases of assets and
liabilities. The consolidated financial statements do not include a provision
for income taxes due to the Company's net operating losses.
F-78
EARNINGS PER SHARE - Earnings per common share is calculated by dividing net
income (loss) applicable to common shares by the weighted average number of
common shares and share equivalents outstanding during each period. Excluded
from fully diluted computations are certain stock options granted (12,000,000
options which are contingently exercisable pending the occurrence of certain
future events).
TREASURY STOCK - Treasury stock is recorded at net acquisition cost. Gains and
losses on disposition are recorded as increases or decreases to capital with
losses in excess of previously recorded gains charged directly to retained
earnings.
STOCK OPTIONS - The Company uses the intrinsic value method of accounting for
employee stock options as permitted by statement of Financial Accounting
Standards No. 123 "Accounting for Stock-Based Compensation". Accordingly,
compensation cost for stock options is measured as the excess, if any, of the
quoted market price of the Company's stock at the date of the grant over the
amount the employee must pay to acquire the stock. The compensation is
recognized over the vesting period of the options.
ESTIMATES - The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from these estimates.
LONG-LIVED ASSETS - The Company adopted Statement of Financial Accounting
Standards No. 121 "Accounting for the Impairment of Long-Lived Assets and for
Long-Lived Assets to be Disposed Of" in 1996. The Company reviews certain
long-lived assets identifiable intangibles for impairment whenever events or
changes in circumstances indicate that the carrying amount may not be
recoverable. In that regard, the Company assesses the recoverability of such
assets based upon estimated non-discounted cash flow forecasts. The Company has
determined that no impairment loss needs to be recognized for long lived assets.
FAIR VALUE OF FINANCIAL INSTRUMENTS - The carrying values of financial
instruments including cash and cash equivalents, accounts receivable and
accounts payable approximate fair value at December 31, 1996, because of the
relative short maturities of these instruments. It is not possible to presently
determine the market value of the long term debt and notes payable given the
Company's current financial condition.
STATEMENTS OF CASH FLOWS - Cash equivalents include time deposits with original
maturities of three months or less.
REVENUE RECOGNITION - Revenue is recognized when products are shipped or when
services are rendered.
PRESENTATION OF PRIOR YEARS DATA - Certain reclassifications have been made to
conform prior years data with the current presentation.
3 - Merger
On October 29, 1996, the Company and First Medical Corporation ("FMC")
entered into a Merger Agreement. Under the terms of the Merger Agreement, each
share of the FMC Common Stock would be exchanged for (i) 1,033.925 shares of
Lehigh Common Stock and (ii) 95.1211 shares of Lehigh Preferred Stock. Each
share of Lehigh Preferred Stock will be convertible into 250 shares of Lehigh
Common Stock and will have a like number of votes per share, voting together
with the Lehigh Common Stock. Currently, there are outstanding 10,000 shares of
FMC Common Stock. As a result of these actions, immediately following the
Merger, current Lehigh stockholders and FMC stockholders will each own 50% of
the issued and outstanding shares of Lehigh Common Stock. In the event that all
of the shares of Lehigh Preferred Stock issued to the FMC stockholders are
converted into Lehigh Common Stock, current Lehigh stockholders will own
approximately 4% and FMC stockholders will own approximately 96% of the issued
and outstanding shares of Lehigh Common Stock. In addition, under the terms of
the Merger Agreement Lehigh will be renamed "First Medical Group, Inc.".
Although the Company has entered into this merger agreement there can be no
assurance at this time that the Company will be able to consummate this
transaction.
F-79
4 - Discontinued Operations
On December 31, 1991, the Company sold its right, title and interest in
the stock of the various subsidiaries which made up its discontinued interior
construction and energy recovery business segments subject to existing security
interests. The Company did not retain any of the liabilities of the sold
subsidiaries. The excess of liabilities over assets of subsidiaries sold
amounted to approximately $9.6 million. Since 1991, the Company has reduced this
deferred credit (the reduction is shown as income from discontinued operations)
due to the successful resolution of the majority of the liabilities for amounts
significantly less than was originally recorded. The deferred credits were
reduced as follows:
1992 $ 2,376
1993 $ 1,760
1994 $ 5,000
1995 $ 250
1996 $ 250
5 - Property, Plant and Equipment
December 31
------------------------- Estimated
Useful Lives
------------
1996 1995
---- ----------
Machinery and equipment $ 483 $ 475 3 to 5 years
Leasehold improvements 295 285 Term of leases
----- -----
778 760
Less accumulated depreciation and
amortization (728) (699)
------ ------
$ 50 $ 61
====== ======
6 - Long-Term Debt
December 31,
-----------------------------------------------
INTEREST RATE 1996 1995
-------------
Subordinated Debentures 14-7/8% $ 290 $ 400
Senior Subordinated Notes 13-1/2% 100 100
Convertible Debenture 10.25% 300 --
Note Payable-BNL 10.56% -- 2,440
Revolving Credit Facility-C.I.T. 10.56% 2,425 --
Other Long-Term Debt Various -- 10
-------- --------
3,115 2,950
F-80
Less Current Portion (390) (870)
--------- ---------
Total Long-Term Debt $ 2,725 $ 2,080
======= =========
Subordinated Debentures and Senior Subordinated Notes
On March 15, 1991, pursuant to a restructuring done by the Company (the
"1991 Restructuring"), the holders of $8,760,000 principal amount of the 14-7/8%
Debentures exchanged such securities, together with the accrued but unpaid
interest thereon, for $2,156,624 principal amount of Class B Notes and
53,646,240 shares of Common Stock. Additionally, the holders of $33,840,000
principal amount of the 13-1/2% Notes exchanged such securities, together with
the accrued but unpaid interest thereon, for $8,642,736 principal amount of
Class B Notes and 212,650,560 shares of Common Stock.
The Company was in default of certain covenants to the holders of Class
A Notes and Class B Notes (the "Notes") at December 31, 1992 and 1991 and, as a
consequence, the Notes were classified as current in the 1992 and 1991 Financial
Statements. The Company continues to be in default in the payment of interest
(approximately $628,000 and $653,000 of interest past due as of December 31,
1996 and 1995) on the $500,000 principal amount of 13-1/2% Notes and 14-7/8
Debentures that were not tendered in the Company's 1991 Restructuring. In May
1993 the Company reached an agreement (the "1993 Restructuring") whereby
participating holders of the Notes ("Noteholders") surrendered their Notes,
together with a substantial portion of their Common Stock, and, in exchange
therefore, the Noteholders acquired, through a newly formed corporation ("LVI
Holding"), all of the stock of LVI Environmental Services Group Inc. ("LVI
Environmental"), a subsidiary of the Company that conducted its asbestos
abatement operations. Management of LVI Environmental have a minority equity
interest in LVI Holding. As a consequence, the Company's outstanding
consolidated indebtedness was reduced from approximately $45.9 million to
approximately $3.6 million (excluding approximately $120,944 of indebtedness
under Class B Notes that LVI Holding agreed to pay in connection with the 1993
Restructuring but for which the Company remains liable). Since the Noteholders
were also principal stockholders of the Company, the gain from this transaction,
net of the carrying value of LVI Environmental, was credited directly to
additional paid-in capital.
In accordance with Statement of Financial Accounting Standards No. 15,
the Class A Notes and the Class B Notes were carried on the consolidated balance
sheet at the total expected future cash payments (including interest and
principal) specified by the terms of the Notes. A gain on early extinguishment
of debt occurred as a result of the carrying amounts of the 13-1/2% Notes,
14-7/8% Debentures and Senior Secured Notes (including accrued but unpaid
interest and unamortized deferred financing costs) being greater than the fair
market value of the common stock issued, the net assets transferred to a
liquidating trust, and total expected future cash payments of the Class A Notes
and Class B Notes, net of direct restructuring costs.
Included in interest and other income in 1996 and 1995 is approximately
$106,000 and $380,00 respectively of other income which represents an adjustment
to the value of certain items which relate to the Company's 1991 Restructuring.
During 1996, the Company retired $110,000 of the 14-7/8% debentures
plus accrued and unpaid interest of $181,000 for approximately $9,000. The gain
on extinguishment of debt of approximately $282,000 is included in extraordinary
item of $382,000.
F-81
REVOLVING CREDIT FACILITY
In November 1996, HallMark entered into a three year revolving credit
facility with a financial institution, which provides a maximum line of credit
equal to the lesser of eligible accounts receivable and inventory or $5 million.
The credit facility bears interest at the prime rate plus 2%, and is
collaterized by the Company's accounts receivable, inventory and property and
equipment.
The Company used proceeds from the revolving credit facility to pay
down its outstanding note payable with a bank. The extinguishment of debt
resulted in a gain of approximately $100,000. This gain is included in the
extraordinary item of $382,000.
Convertible Debenture
On October 29, 1996 in connection with the execution of the definitive
merger agreement described in Note 3 between the Company and FMC, the Company
issued a convertible debenture in the amount of $300,000 plus interest at two
(2%) percent per annum over the prime lending rate of Chase Manhattan Bank, N.A.
payable on the first day of each subsequent month next ensuing through and
including twenty four months thereafter. On the twenty fourth month, the
outstanding principal balance and all accrued interest shall become due and
payable.
The proceecs of the loan from FMC were used to satisfy the loan the
Company previously obtained from DHB Capital Group Inc. on June 11, 1996. On
February 7, 1997, First Medical Corporation elected to convert the debenture in
937,500 shares of the Company's common stock.
7 - Income Taxes
At December 31, 1996 and 1995, the Company had a net deferred tax asset
amounting to approximately $2.2 million and $1.6 million, respectively. The net
deferred tax asset consisted primarily of net operating loss ("NOL")
carryforwards, and temporary differences resulting from inventory and accounts
receivable reserves, and it is fully offset by a valuation allowance of the same
amount due to uncertainty regarding its ultimate utilization. The following is a
summary of the significant components of the Company's deferred tax assets and
liabilities:
DECEMBER 31, 1996 1995
- ------------
Deferred tax assets:
Nondeductible accruals and allowances $ 206 $ 65
Net operating loss carryforward 2,008 1,575
------ ------
2,214 1,640
Deferred tax liabilities:
Depreciation and amortization 30 30
------ -----
Net deferred tax asset $2,184 $1,610
Less: Valuation Allowance 2,184 1,610
----- -----
Deferred Income Taxes --- ---
------ -----
--- ---
====== =====
The Company did not have Federal taxable income in 1996, 1995, and 1994
and, accordingly, no Federal taxes have been provided in the accompanying
consolidated statements of operations. As of December 31, 1996, the Company had
NOL carryforwards of approximately $5 million expiring through 2011.
F-82
8 - Commitments and Contingencies
Leases
The Company and its subsidiaries lease machinery, office and warehouse
space, as well as certain data processing equipment and automobiles under
operating leases. Rent expense aggregated $165,000, $177,000 and $148,000, for
the years ended December 31, 1996, 1995 and 1994, respectively.
Future minimum annual lease commitments, primarily for office and
warehouse space, with respect to noncancellable leases are as follows:
1997 104
1998 105
1999 114
2000 118
2001 121
Thereafter 313
-------
$ 875
======
In addition to the above, certain office and warehouse space leases
require the payment of real estate taxes and operating expense increases.
Employment Agreements
On August 22, 1994 the Company and Mr. Salvatore Zizza entered into an
employment agreement providing employment to Mr. Zizza through December 31, 1999
as President, Chairman of the Board and Chief Executive Officer of the Company
at an annual salary of $200,000. On December 20, 1996, the Company agreed to
extend Mr. Zizza's employment contract through December 31, 2000.
On January 1, 1995 the Company and Mr. Robert Bruno entered into an
employment agreement providing employment to Mr. Bruno through December 31, 1999
as Vice President and General Counsel of the Company at an annual salary of
$150,000. The agreement calls for deferral of $50,000 of Mr. Bruno's salary each
year until the Company's annual revenues exceed $25 million. The $50,000
deferral has not been accrued due to uncertainty regarding the Company achieving
$25 million in sales. On December 20, 1996, the Company agreed to extend Mr.
Bruno's employment agreement through December 31, 2000. Mr. Bruno reduced his
annual salary to $120,000 no part of which shall be deferred pending
consummation of the proposed merger with First Medical Corporation.
Litigation
The State of Maine and Bureau of Labor Standards commenced an action
against the Company and Dori Shoe Company (an indirect former subsidiary) to
recover severance pay under Maine's plant closing law. The case was tried
without a jury on December 12 and 13, 1994 in Maine Superior Court. Under that
law, an "employer" who shuts down a large factory is liable to the employees for
severance pay at the rate of one week's pay for each year of employment.
Although the law did not apply to the Company at the time that the Dori Shoe
plant was closed it was amended so as to arguably apply to the Company
retroactively.
F-83
In a prior case brought against the Company (then known as Lehigh
Valley Industries) and its former subsidiary under the Maine severance pay
statute prior to its amendment the Company was successful against the State of
Maine (see CURTIS V. LOREE FOOTWEAR AND LEHIGH VALLEY INDUSTRIES, 516 A. 2d 558
(Me. 1986)).
The Superior Court by decision docketed April 10, 1995 entered
judgement in favor of the former employees of Dori Shoe Company against Dori
Shoe and the Company in the amount of $260,969. plus prejudgment interest and
reasonable attorneys' fees and costs to the Plaintiff upon their application
pursuant to Maine Rules of Civil Procedure 54(b) (3) (d). Interest and other
fees are approximately $100,000 at December 31, 1996. The Company filed a timely
appeal appealing the decision and the matter was argued before the Maine Supreme
Judicial Court on December 7, 1995. On February 18, 1997 the Supreme Judicial
Court of Maine affirmed the Superior Court's decision. The Company is currently
considering an appeal to the United States Supreme Court. Approximately $350,000
has been accrued for by the Company relating to this judgement.
9 - Stock Options
The following table contains information on stock options for the three
year period ended December 31, 1996:
Exercise price Weighted average
Option shares range per share price
- -----------------------------------------------------------------------------------------------------------------------------
Outstanding, January 1, 1994 0 0 0
Granted 18,402,187 $0.50 to $1.00 $0.75
Exercised 0 0 0
Forfeited 0 0 0
- -----------------------------------------------------------------------------------------------------------------------------
Outstanding, December 31, 1994 18,402,187 $0.50 to $1.00 $0.75
Granted 295,000 $0.50 $0.50
Exercised 0 0 0
Forfeited 0 0 0
- -----------------------------------------------------------------------------------------------------------------------------
Outstanding, December 31, 1995 18,697,187 $0.50 to $1.00 $0.75
Granted 55,000 $0.50 $0.50
Exercised 0 0 0
F-84
Forfeited 0 0 0
- -----------------------------------------------------------------------------------------------------------------------------
Outstanding, December 31, 1996 18,752,187 $0.50 to $1.00 $0.75
The Company issues stock options from time to time to certain employees
and outside directors. The Company applies APB Opinion 25, "Accounting for Stock
Issued to Employees", and related Interpretations in accounting for stock
options issued. Under APB Opinion 25, because the exercise price of the
Company's stock options equals the market price of the underlying stock on the
date of grant, no compensation cost is recognized.
FASB Statement 123, "Accounting for Stock-Based Compensation", requires
the Company provide pro forma information regarding net income and earnings per
share as if compensation cost for the Company's stock option plans had been
determined in accordance with the fair market value based method prescribed in
FASB Statement 123. The Company estimates the fair value of each stock option at
the grant date by using the Black-Scholes option-pricing model with the
following weighted-average assumptions used for grants in 1995 and 1996,
respectively: no dividends paid for both years; expected volatility of 30% for
both years; risk-free interest rates of 6.78% and 6.42%; and expected lives of 4
and 5 years.
Under the accounting provisions of FASB Statement 123, the Company's
net loss per share would have been adjusted to the pro forma amounts indicated
below:
1996 1995
---- ----
Net Loss
As reported (288) (308)
Pro forma (304) (310)
Primary earnings per share
As reported (0.03) (0.03)
Pro forma (0.03) (0.03)
Fully diluted earnings per share
As reported (0.03) (0.03)
Pro forma (0.03) (0.03)
F-85
Options Outstanding Options Exercisable
-------------------------------- --------------------------------
Weighted-
Average Weighted- Weighted-
Number Remaining Average Number Average
Range of Outstanding Contractual Exercise Exercisable Exercise
Exercise Prices at 12/31/96 Life Price at 12/31/96 Prices
--------------- ----------- ---- ----- ----------- ------
$0.50 to $1.00 18,752,187 3 years $0.75 6,752,187 $0.50
Twelve million of the eighteen million options and warrants granted in 1994 are
contingently exercisable pending the occurrence of certain future events. These
events include the Company acquiring any business with annual revenues in the
year immediately prior to such acquisition of at least $25 million dollars. The
occurrence of this event as well as certain other events will constitute the
measurement date for those options and the Company will recognize as
compensation the difference between measurement date price and the granted
price.
10 - Significant Customer
Sales to a customer accounted for approximately 21%, 25% and 22% for years ended
December 31, 1996, 1995 and 1994, respectively. This customer accounted for
approximately 14%, 21% and 15 % of accounts receivable on December 31, 1996,
1995 and 1994, respectively.
11 - Supplementary Information
STATEMENTS OF CASH FLOWS
YEARS ENDED DECEMBER 31
1996 1995 1994
---- ---- ----
Cash paid during the year for:
Interest $252 $278 $264
Income taxes 1 12 78
Supplemental disclosure of non-cash financing activities:
DECEMBER 31, 1996 and 1995
Accounts payable and operating loss were both reduced by approximately $106,000
and $380,000 for December 31, 1996 and 1995, respectively relating to an
adjustment to the value of certain items which relate to the Company's 1991
Restructuring.
F-86
THE LEHIGH GROUP INC. AND SUBSIDIARIES
Valuation and Qualifying Accounts
Years Ended December 31, 1996, 1995 and 1994
(Dollar Amounts in Thousands)
Balance at Charged to
Beginning of Costs and Charged to Other Charges Balance at End
Dec. 31, Description Year Expenses Other Accounts Add (Deduct) of Year
- ------------------------------------------------------------------------------------------------------------------------------------
1996 Allowance for doubtful accounts $174 38 -- 206 $342
Inventory obsolescence reserve $158 -- 33 50 $175
1995 Allowance for doubtful accounts $275 -- -- (101) $174
Inventory obsolescence reserve $158 -- -- $158
1994 Allowance for doubtful accounts $300 -- -- (25) $275
Inventory obsolescence reserve $158 -- -- -- $158
F-87
THE LEHIGH GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
SIX MONTHS ENDED MARCH 31, 1997 1996
- --------------------------------------------------------------------------------
Revenues earned $ 5,765 $ 5,988
Cost of revenues earned 3,776 4,201
------------ ------------
Gross profit 1,989 1,787
Selling, general and administrative expenses 1,966 1,969
------------ ------------
Operating income (loss) 23 (182)
Other income (expense):
Interest expense (236) (220)
Interest and other income 12 7
Amortization of deferred finance (14) --
------------ ------------
(238) (213)
Loss before income taxes (215) (395)
------------ ------------
Net Loss $ (216) $ (396)
============ ============
Loss per share-Primary and Fully Diluted
Net Loss $ (0.02) $ (0.04)
Weighted average Common Shares
and share equivalents outstanding
Primary and Fully diluted 11,089,000 10,339,250
============ ============
The accompanying notes to consolidated financial statements are an integral part
of these statements.
F-88
THE LEHIGH GROUP INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS)
June 30, December 31,
1997 1996
--------- ------------
(Unaudited) (Audited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $ 463 $ 471
Accounts receivable, net of
allowance for doubtful
accounts of $404 and $342 4,897 3,581
Inventories, net 1,645 1,215
Prepaid expenses and other current assets 91 279
------ ------
Total current assets 7,096 5,546
Property, plant and equipment, net of
accumulated depreciation and
amortization 55 50
Other assets 26 29
------ ------
Total assets $7,177 $5,625
====== ======
The accompanying notes to consolidated financial statements are an integral part
of these balance sheets.
F-89
THE LEHIGH GROUP INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS)
June 30, December 31,
1997 1996
--------- ------------
(Unaudited) (Audited)
LIABILITIES AND
SHAREHOLDERS' EQUITY (DEFICIT)
CURRENT LIABILITIES:
Current maturities of long-term debt $ 390 $ 390
Accounts payable 1,585 954
Accrued expenses and other liabilities 1,775 1,642
--------- ---------
Total current liabilities 3,750 2,986
--------- ---------
Long-term debt, net of current maturities 3,429 2,725
--------- ---------
Commitments and contingencies -- --
Preferred stock, par value $.001;
authorized 5,000,000
shares none issued
Common stock, par value $.001
authorized shares 100,000,000,
in 1996 and 1995; shares issued
10,339,250 in 1996 and 1995
which excludes 3,016,249 shares
held as treasury stock in 1996 and 1995,
respectively 12 11
Additional paid-in capital 106,893 106,594
Accumulated deficit from January 1, 1986 (105,253) (105,037)
Treasury stock - at cost (1,654) (1,654)
--------- ---------
Total shareholders' equity (deficit) (2) (86)
--------- ---------
TOTAL LIABILITIES AND
SHAREHOLDERS' EQUITY (DEFICIT) $ 7,177 $ 5,625
========= =========
The accompanying notes to consolidated financial statements are an integral part
of these balance sheets.
F-90
THE LEHIGH GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF CHANGES
IN SHAREHOLDERS' EQUITY (DEFICIT)
(UNAUDITED)
(IN THOUSANDS)
Additional Accumulated Treasury
Common Paid in Deficit From Stock
Stock Capital Jan. 1, 1986 At Cost Total
-------- -------- ------------ ------- -------
Balance January 1, 1996 $ 11 $ 106,594 $(104,749) $ (1,654) $ 202
Net loss -- -- (396) -- (396)
Balance June 30, 1996 $ 11 $ 106,594 $(105,145) $ (1,654) $ (194)
========= ========= ========= ========= =========
Balance January 1, 1997 $ 11 $ 106,594 $(105,037) $ (1,654) $ (86)
Debenture Conversion $ 1 299 -- -- 300
Net loss -- -- (216) -- (216)
Balance June 30, 1997 $ 12 $ 106,893 $(105,253) $ (1,654) $ (2)
========= ========= ========= ========= =========
The accompanying notes to consolidated financial statements are an integral part
of these statements.
F-91
THE LEHIGH GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
SIX MONTHS ENDED JUNE 30, 1997 1996
- ------------------------------------------------------------------------------------------------------------------
(in thousands)
Cash flows from operating activities:
Net loss $(216) $(396)
Adjustments to reconcile net loss to net
cash used in operating activities:
Depreciation and amortization 43 18
Changes in assets and liabilities:
Accounts Receivable (1,316) (134)
Inventories-net (430) (230)
Prepaid and other current assets 188 (28)
Accounts payable 631 159
Accrued expenses 129 155
----- -----
Net cash used in operating activities (971) 4
----- -----
Cash flows from investing activities:
Capital expenditures -- --
Net cash provided by (used in) investing activities (41) (11)
----- -----
Cash flows from financing activities:
Net borrowings from C.I.T. Revolver 1,004 --
Net payments under bank debt -- (180)
Repayment of Capital leases -- (7)
Convertible Debenture -- 300
Net cash provided by (used in) financing activities 1,004 113
----- -----
Net changes in cash (8) 106
Cash at beginning of period 471 347
----- -----
Cash at end of period $ 463 $ 453
===== =====
The accompanying notes to consolidated financial statements are an integral part
of these statements.
F-92
THE LEHIGH GROUP INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. BASIS OF PRESENTATION
The financial information for the six months ended June 30, 1997 and 1996 is
unaudited. However, the information reflects all adjustments (consisting solely
of normal recurring adjustments) which are, in the opinion of management,
necessary for the fair statement of results for the interim periods.
Certain information and footnote disclosures normally included in financial
statements prepared in accordance with generally accepted accounting principles
have been condensed or omitted. These consolidated financial statements should
be read in conjunction with the consolidated financial statements and related
notes included in the Company's December 31, 1996 Report on Form 10-K.
The results of operations for the six month period ended June 30, 1997 are
not necessarily indicative of the results to be expected for the full year.
Loss per common share is calculated by dividing net loss by the weighted average
number of common shares and share equivalents outstanding. For the periods
presented, there were no common stock equivalents included in the calculation,
since they would be anti-dilutive.
2. SUPPLEMENTARY SCHEDULE
1997 1996
---- ----
(in thousands)
Statement of cash flows
Six months ended June 30,
Cash paid during the six months for:
Interest $155 $134
Income taxes 1 1
Supplemental disclosure of non-cash financing activities:
On February 7, 1997, First Medical Corporation elected to convert the debenture
into 937,500 shares of the Company's common stock.
F-93
PRO FORMA COMBINED FINANCIAL STATEMENTS
INTRODUCTION
The pro forma data presented in the pro forma combined financial statements are
included in order to illustrate the effect on the financial statements of Lehigh
and FMC of the transactions described below. The pro forma information is based
on the historical financial statements of FMC and Lehigh.
In the opinion of management, all adjustments have been made that are necessary
to present fairly the pro forma data.
The pro forma combined financial statements should be read in conjunction with
the audited consolidated financial statements and the notes thereto of FMC and
the audited consolidated financial statements and Notes thereto of Lehigh
appearing elsewhere in this document. The pro forma combined statement of
operations data are not necessarily indicative of the results that would have
been reported had such events actually occurred on the date specified, nor are
they indicative of the companies' future results.
F-94
FIRST MEDICAL CORPORATION AND SUBSIDIARIES AND LEHIGH GROUP INC. AND
SUBSIDIARIES PRO FORMA COMBINED STATEMENT OF OPERATIONS
FOR THE YEAR ENDED DECEMBER 31, 1996
(unaudited)
(unaudited in thousands except share and per share data)
Combined
FMC Lehigh Adjustments(1) Proforma
--- ------ -------------- --------
REVENUE $53,014 $10,446 -- $63,460
Medical expense 43,526 -- -- 43,526
Cost of sales -- 7,134 -- 7,134
------- -------- -------- --------
Group profit 9,488 3,312 12,800
Selling, general and administrative
expenses 8,696 3,874 -- 12,570
--------- -------- --------- ---------
Operating Income (loss) 792 (562) -- 230
Other Income (expense):
Interest expense (55) (471) -- (526)
Other Income -- 113 -- 113
--------- -------- --------- ---------
(55) (358) (413)
Amortization of goodwill-Lehigh -- -- 147 (147)
Income (loss) before taxes,
discontinued operations and
extraordinary item 737 (920) (147) (330)
Provision for income taxes 413 -- -- 413
-------- --------- --------- ----------
Income (loss) before discontinued
operations and extraordinary item 324 (920) (147) (743)
Income from discontinued operations -- 250 -- 250
-------- --------- --------- ---------
Income (loss) before extraordinary
item 324 (670) (147) (493)
Extraordinary item-gain on early -- 382 -- 382
-------- --------- --------- ----------
extinguishment of debt
Net Income (loss) $ 324 $ (288) $ (147) $ (111)
Net loss per share $ (.01)
Weighted average number of shares
outstanding after consummation of
the merger 9,397,292
1. To amortize the goodwill on the FMC and Lehigh acquisition over a period of
15 years.
F-95
FIRST MEDICAL CORPORATION AND SUBSIDIARIES AND LEHIGH GROUP INC. AND
SUBSIDIARIES PRO FORMA COMBINED STATEMENT OF OPERATIONS
FOR NINE MONTHS ENDED SEPTEMBER 30, 1997
(unaudited)
(unaudited in thousands except share and per share data)
Combined
FMC Lehigh Adjustments Proforma
--- ------ ----------- --------
Revenue $48,213 $9,561 -- $57,774
Medical expense 43,843 -- -- 43,843
Cost of sales -- 6,419 -- 6,419
------- ------ -------- -------
Gross profit 4,370 3,142 7,512
Selling, general and administrative expenses 6,302 3,746 -- 10,048
------- ------- -------- -------
Operating income (loss) (1,932) (604) -- (2,536)
Other income (expense):
Interest expense (186) (378) -- (564)
Other income (expense) 0 7 -- 7
------ ------- ------- -------
(186) (371) -- (557)
Amortization of goodwill-Lehigh(1) -- -- (141) (141)
Income (loss) before taxes (2,118) (975) (141) (3,234)
Provision for income taxes 0 1 -- 1
------ ------- ------- -------
Net (loss) $(2,118) $ (976) $ (141) ($3,235)
(Loss) Earnings per share:
Primary $(0.14)
Fully diluted
=======
$(0.01)
Weighted average number of common shares
and share equivalents outstanding:
Primary $22,513
=======
Fully diluted 281,918
=======
1. To amortize the goodwill on the FMC and Lehigh acquisition over a period
of 15 years.
F-96